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Abstract 
The acquisition of protective immunity is a critical feature of the immune system. It is the 
unique ability of the adaptive immune response to generate and maintain long-lived 
antigen specific memory cells, which is the key to preventing reinfection and achieving the 
goal of protective immunity. The importance of secondary lymphoid tissue (such as lymph 
nodes) as a site of effector CD4 T cell responses and the generation, dissemination and 
maintenance of memory CD4 T cells is well accepted. However, a key research area 
needing investigation is the basic biology of the CD4 T cell, particularly the recirculation, 
distribution and maintenance of CD4 T cells at sites throughout the body. 
To address these issues we used Nippostrongylus brasiliensis as a model of CD4 mediated 
protective immunity, combined with G4/IL-4 reporter mice. We show that the lung 
environment is critical for the priming of CD4 T cells and conferring protective immunity. 
In contrast to others we find no protective role for the CD4 T cell population of the skin 
and only a minor role for the population within the gut. 
In a separate study we used the drug fingolimod (FTY720) to block the cellular trafficking 
between lymph node and lung tissue during immune responses. Interestingly, our findings 
show that protection against N. brasiliensis infection is maintained when CD4 T cell 
recirculation between the lung and lymph node is blocked.  
Furthermore, we reveal that peripheral lung residing CD4 T cells are sufficient for 
conferring protective immunity in the N. brasiliensis model, generating support for the 
model of effector lymphoid tissue. When N. brasiliensis experienced CD4 T cells were 
localised to the lung by intranasal adoptive transfer they were able to confer protection 
against infection in otherwise naïve animals, as early as 48 hours post infection.  
The most striking finding of this work is the discovery that memory CD4 T cells residing 
in the lung that are sufficient to confer protection against reinfection. Identifying the 
factors in the lung and lymph node that induce and support this CD4 T cell subset will be 
an important area of future research given its high relevance to the design of vaccines 
against parasite infections. 
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1.1. Introduction 
A unique feature of the adaptive immune response is its ability to mount memory 
responses when re-exposed to the same pathogen. During an initial encounter with antigen, 
long-lived memory cells expand and gain functionality, which are capable of rapid 
response when reinfection occurs. The mechanisms of protective immunity are often 
broadly defined, but for the purposes of this thesis are defined as protection from 
reinfection with the invading pathogen (Fig 1.1). Protection may be partial or complete 
with the gold standard being a ‘sterile cure’ where pathogens are contained and cleared 
from the host. The tissues and cells that confer immunity are divided into the innate and 
adaptive arms of the immune system, which work together to achieve pathogen clearance. 
A key regulator of immunity is the CD4 T helper cell. CD4 T cells activate and drive the 
immune response in both innate and adaptive arms through the production of inflammatory 
cytokines. These secreted messengers have an integral role to play in the orchestration of 
the immune response, both attracting and interacting with other cells. The recirculation, 
distribution and maintenance of CD4 T cells at sites throughout the body is of critical 
importance to defend against pathogenic insult. Lymph nodes provide strong hubs of 
immune connection where CD4 T cells are able to enter from the blood and sample antigen 
on antigen presenting cells (APCs) draining via the lymphatics from the surrounding 
tissues. Antigen experienced CD4 T cells exit from the lymph node to peripheral tissues 
and as such are able to provide a much faster and effective memory immune response at 
the site of pathogen exposure. The recirculation and traffic of CD4 T cells between lymph 
nodes and peripheral tissues is an integral part of the CD4 T cell response.  
To study in further detail these aspects of CD4 T cell mediated protective immunity we 
used an established model of Th2 mediated protective immunity. Nippostrongylus 
brasiliensis is a rodent nematode parasite that induces a strong Th2 immune response with 
production of cytokines and recruitment of accessory cells. N. brasiliensis travels from 
skin to lung and then gut before being expelled after 10 days in a primary response. Upon 
reinfection with N. brasiliensis there is a reduction of worm burden in the lung and gut, 
making this a useful model to study the parameters of Th2 mediated protective immunity.  
This thesis explores the N. brasiliensis model of Th2 mediated protective immunity, using 
G4/IL-4 reporter mice to clarify and define the key parameters of this protective response 
with respect to the tissues and IL-4 producing T cells involved. With this goal in mind this 
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introduction reviews the current literature addressing the development of CD4 mediated 
protective immunity (in the N. brasiliensis model). An understanding of T cell activation, 
effector function, memory generation and recirculation is required to fully investigate this 
N. brasiliensis model of protective immunity. As CD4 T cells are drivers of other cellular 
responses a brief overview of adaptive and innate cells and their interactions will be 
covered also.  
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Figure 1.1 The relationship of adaptive cellular response to pathogen infection in 
protective immunity. 
During a primary pathogen infection pathogen numbers increase quickly. As the adaptive 
immune response is initiated effector cells expand and exert effector function, leading to a 
decline in pathogen numbers until the infection is controlled. Contraction of the immune 
cell population occurs as the pathogen numbers decline, however a small number of cells 
are maintained as memory cells. Upon reinfection, memory cells respond rapidly and the 
infection is contained, resulting in a reduced pathogen burden and shorter infection that we 
define as protection. 
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1.2. Innate immune responses 
In evolutionary terms the innate arm of the immune system is the oldest part of the 
immune system; present in protists, plants and animals it has been conserved for millions 
of years [1], with the adaptive immune system arising later with the divergence of jawed 
vertebrates [2]. Innate immunity consists of physical barriers such as skin and mucosal 
surfaces, physiological barriers like temperature and chemical barriers such as 
complement. In addition there are cellular responses; phagocytic cells which take up and 
contain invading pathogens and granulocytes that release chemical mediators to destroy 
infectious agents.  
Although qualitatively different, the innate and adaptive immune responses are 
intertwined; the innate response is able to work independently and without the involvement 
of the adaptive response, but is also able to activate the adaptive immune system. 
Conversely, the adaptive immune response can coordinate and recruit the cells of the 
innate system. 
Upon infection, innate cells directly recognise conserved molecular patterns (PAMPs – 
Pathogen Associated Molecular Patterns) expressed on microbes through specialised 
pattern recognition receptors (PRRs) to respond to invading pathogens. There are three 
types of PRR; phagocytic PRRs like mannose receptor that enable uptake of foreign 
material; secreted PRRs that can activate complement and PRRs that signal infection such 
as Toll Like Receptors (TLRs). As well as activation through recognition of PAMPs, 
innate immune responses can also be activated by the adaptive immune response. The 
following focuses on the cellular aspect of innate immunity. 
1.2.1. Cells of the innate immune system 
The cells of the innate immune system are the first cellular line of defence and can act 
directly, killing pathogens but also function to activate the adaptive immune response. 
Granulocytic cells are able to directly kill pathogens via the release of toxic granules, but 
also carry out other functions. Neutrophils are short-lived phagocytic cells that are 
recruited to sites of inflammation where they destroy pathogens directly using reactive 
oxygen and nitrogen species in addition to their toxic granules. Mast cells degranulate in 
response to ligation of FcεRI surface receptors by IgE releasing histamine, which when 
released to an innocuous antigen, forms part of an allergic response. Eosinophils (and 
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basophils) are strongly associated with parasitic infection in addition to asthmatic and 
allergic responses [3-6]. 
Phagocytic cells, such as macrophages, ‘scavenge’ - phagocytosing apoptotic or senescent 
cells and cell debris via phagocytic PRRs such as the mannose and scavenger receptors. 
Also by directly engulfing foreign particles and microbes phagocytic cells provide 
immediate defence against pathogens and also help “clean up” after infection. This is 
important to control antigen accessibility and the resulting immune response. 
1.2.2. Initiation of adaptive responses by innate cells 
The initiation of adaptive immunity occurs through presentation of antigen on innate cells 
for adaptive recognition. T cells, through their T cell receptor (TCR), recognise specific 
antigenic peptides as a complex with the major histocompatibility complex (MHC) 
expressed on antigen presenting cells (APC). There are two types of MHC; MHC I that is 
expressed on all cell types and presents intracellularly derived antigen and MHC II, 
expressed on professional APCs that presents extracellular antigens. Optimal signalling 
through the peptide/MHC/TCR complex requires the assistance of co-receptors [7]; cluster 
of differentiation 4 (CD4) interacts with MHC II molecules, and CD8 interacts with MHC 
I. Although interaction of the TCR complex and MHC initiates signalling, this signal alone 
is not enough for naïve T cell activation, and has been shown to render T cells non-
functional/anergic. A second signal or costimulation is required for full activation of a 
functional effector T cell. Costimulatory molecules expressed by T cells include CD28, 
CD154 and OX40 that interact with CD80/6, CD40 and OX40L respectively on APC. 
These costimulatory molecules enhance TCR signalling and/or provide additional signals 
to help expand T cell populations and drive effector function [6]. 
The presentation of antigen to CD4 T cells to initiate an antigen specific response is 
restricted to cells expressing MHC II and there are several innate cells that have this 
capacity. Dendritic cells (DCs), macrophages and monocytes express MHC II, and it has 
recently been determined that basophils also express MHC II with the ability to initiate 
CD4 T cell responses [8, 9]. Of these APCs, DCs are well accepted as the most efficient 
activator and stimulator of CD4 T cell responses, as such the following focuses on DC, but 
also covers other innate APCs. 
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1.2.2.1. Dendritic cells as initiators of adaptive immune responses 
Dendritic cells bridge innate and adaptive responses, identifying danger from pathogen 
infection through recognition of PAMPs to become activated themselves and also to 
activate the specificity of the adaptive immune response through MHC II restricted 
presentation of antigen and the secretion of soluble mediators [6]. The information 
received by the DC through pattern recognition allows the DC to influence the 
corresponding T cell response. In the instance of a microbial infection, DC recognise 
components of the bacterial cell wall such as lipopolysaccharide (LPS) through pattern 
recognition, causing secretion of interleukin (IL)-12. The signal of IL-12 in conjunction 
with T cell/peptide/MHC II (pMHC II) signalling educates the responding cognate T cell 
to become a Th1 effector cell, the most appropriate lineage to fight such an infection.  
One of the properties making DC such efficient activators of T cell immunity is the 
transport of antigen from peripheral sites of inflammation to the lymph nodes, increasing 
the likelihood of finding T cells specific for the invading pathogen. In their immature state 
DC constantly sample the surrounding environment, taking up and presenting antigen on 
their MHC molecules. In the absence of infection/inflammation these presented antigens 
can act to tolerise T cells. Upon infection DC receive information through their PRRs and 
begin to mature; they stop taking up further antigen and present what they already have, 
they also begin to express a variety of costimulatory molecules and secrete inflammatory 
mediators [10, 11]. Upon maturation migratory DC travel from the site of inflammation to 
the draining lymph node via the afferent lymph, carrying their antigenic cargo to the T 
cells and involving the adaptive immune response [12]. 
It is important to realise that although some DC are migratory, carrying antigen to the 
draining lymph nodes, antigen presentation also occurs within the tissues themselves. 
Memory T cells are reactivated in the periphery by local antigen presentation and effector 
T cell populations are expanded upon arrival in peripheral tissues. Recent evidence for T 
cell priming in peripheral tissues DC subsets comes from the work of Wakim et al who 
show that host derived DCs can present antigen to donor T cells residing within the grafted 
tissue [13]. 
There are many subsets of DC that have distinct specialised roles. Langerhans cells and 
dermal DC reside in the skin and carry cutaneous antigen to the lymph nodes [14]. Unique 
CD8α DC in the lymph nodes specialise in cross presentation of antigen, activating both 
CD4 and CD8 T cells to fight infection. A recent review of lung DC reveals no less than 
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five distinct lineages, each functionally specialised [15]. This diversity means that not all 
functions are shared equally within the DC subsets, some are efficient at tolerisation, 
others are migratory and yet others are better at antigen uptake.  
 
1.2.2.2. Macrophages and monocytes as initiators of adaptive responses 
Macrophages also function as APCs and can present antigen on both MHC I and II. In 
chronic infections macrophages can be important for the containment and 
compartmentalisation of microbes through the formation of granulomas, clusters of 
immune cells including T cells. Macrophages contain infection by taking up microbes but 
can also directly kill pathogens with antimicrobial products such as reactive oxygen 
intermediates (ROI) and reactive nitrogen intermediates (RNI). In Th1 mediated protective 
immunity to Tuberculosis, macrophages act to contain and eventually clear infection 
through containment within granuloma and direct killing with ROI [16, 17]. Granulomas 
can also be a feature of Th2 mediated immunity, as in the liver granulomas surrounding the 
eggs of Schistosoma sp [18]. 
A subset of macrophages, termed alternately activated macrophages, are associated with 
Th2 immune responses, particularly with parasite infections [19]. These cells differ from 
classically activated macrophages in that they produce arginase in preference to the iNOS 
made by classically activated macrophages. Alternately activated macrophages can also be 
identified by the expression of YM-1 and Fizz-1 (also known as RELMα) [20], and play a 
role in tissue remodelling. Importantly, nematode elicited macrophages can induce the 
differentiation of naïve T cells into Th2 cells [21]. 
Monocytes are circulating mononuclear cells that extravasate to tissues in times of 
inflammation. Inflammatory monocytes migrate to tissues and differentiate, becoming 
macrophages or DC’s, providing an additional source of APCs at inflamed sites. 
1.2.2.3. Basophils as initiators of adaptive responses 
Basophils are a relatively rare population of blood circulating granulocytes that are able to 
bind IgE via FcεRI expressed on the cell surface. Recent studies in humans by Chen et al 
detail IgD binding by basophils, with a resultant production of cytokines and antimicrobial 
molecules [22]. A new role for basophils has recently been postulated, suggesting they 
may act as antigen presenting cells that drive Th2 immunity [8, 9, 23]. Studies by 
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Yoshimoto et al, as well as those by Perrigoue et al show that antigen presentation by 
basophils to CD4 T cells is MHC II dependent [8, 23]. Furthermore, experiments by Sokol 
et al suggest that basophils can replace the role of dendritic cells in the initiation of Th2 
immune responses [9]. This is an interesting development in the field of Th2 immunity, but 
as discussed by Fred Finkelman recently in an Immunology and Cell Biology commentary, 
“I believe it would be premature to judge the relative importance of basophil vs DC 
antigen presentation” [24]. 
 
1.3. Activation of CD4 T cells and expression of effector function  
1.3.1. T cell priming and activation 
The adaptive arm of the immune system has evolved in such a way that it is able to mount 
very specific responses against defined antigens through the expression of a highly diverse 
repertoire of receptors. The alpha and beta chains of the T cell receptor allow specific 
recognition of peptide and signal using a series of protein dimers known as CD3, together 
these molecules make up the T cell receptor complex (TCR). In the thymus, recombination 
of gene segments for variable (V), diversity (D) and joining (J) regions by RAG enzymes 
assembles a diverse repertoire of antigen specific αβTCR [25, 26].  
Activation of naïve CD4 T cells is contact dependent, requiring TCR-pMHC interaction 
along with costimulation to ensure sufficient activation [27, 28]. The immunological 
synapse describes the interface between APC and T cell. Generation of the immunological 
synapse stabilises the TCR/pMHC interaction allowing for effective activation of the T cell 
by clustering all the relevant molecules together and allowing sustained signalling [29]. 
CD4 T cells seem to require longer stimulation by APC than CD8 T cells before 
differentiating to their effector lineages [30]. 
When a threshold of stimulatory and costimulatory signals are met and the T cell is 
activated proliferation occurs – a process called clonal expansion. Clonal expansion 
describes the generation of many antigen specific T cells from the activation of the initial 
naïve cell. Early during activation T cells transiently up regulate CD69, which is inversely 
related to S1P1 expression. The up-regulation of CD69 and corresponding down-regulation 
of S1P1 retains activated effector cells in the lymph node, enabling more effective 
activation and prolonged antigen presentation [31]. Activation induces changes in the 
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expression of cell surface proteins; effector cells down regulate the lymph node homing 
selectin CD62L and up regulate adhesion molecules such as CD44 in preparation for 
migration to the site of inflammation in the periphery. Activated cells also gain effector 
function with production of soluble inflammatory cytokines and in the case of CD8 T cells, 
production of cytotoxic granules. The effector responses of CD4 T cells are discussed 
below. 
1.3.2. CD4 T cell effector responses  
Effector CD4 T cells effectively direct the immune response through the release of soluble 
cytokine mediators, and expression of CD40L. The initial discovery of the two distinct 
Th1/Th2 CD4 effector lineages in the early eighties [32, 33] saw the field begin to define 
the different lineages based on their production of effector cytokines. As technologies have 
improved the CD4 T cell family has expanded significantly, with Tregs and Th17 cells 
being revealed as important lineages [34] and increasing evidence suggesting the addition 
of Tfh and Th9 cells. The following section summarises the development of CD4 T cell 
lineages and their effector functions upon activation (Fig 1.2). NKT cells are briefly 
mentioned as they also express CD4 and contribute to T cell effector responses. 
1.3.2.1. Th1  
Th1 effector responses are driven by IFNγ and are effective against intracellular bacteria 
and viruses. The production of IFNγ by Th1 cells plays an important role in resistance to 
intracellular pathogens such as mycobacteria, with IFNγ activating macrophages to 
increased metabolic activity able to contain and clear the bacteria. Pro-inflammatory Th1 
responses are efficient at clearing pathogens and mounting anti-tumour responses, often 
involving cell mediated cytolytic activity, but can also cause tissue damage and elicit 
autoimmunity. IFNγ itself is toxic to cells, including those immune cells that produce it. 
The presence of IL-12 during antigen presentation drives the differentiation of a Th1 
response. IL-12 signalling through signal transducer and activator of transcription (STAT) 
4 can directly stimulate production of IFNγ, inducing an IFNγ positive feedback loop and 
playing an important role in amplifying Th1 responses. IFNγ stimulates the transcription 
factor T-bet through STAT 1 mediated signalling. T-bet (known as the master Th1 
regulator) goes on to elicit further IFNγ production, amplifying and maintaining the Th1 
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response [34]. A key function of IFNγ is the inhibition of IL-4 and therefore Th2 immune 
responses, driving the polarity of the T cell response towards Th1. 
1.3.2.2. Th2  
Th2 cells mediate effector function through production of IL-4 and also IL-5, IL-10, IL-13 
and 25 [34]. Much like it’s Th1 counterpart IFNγ, IL-4 inhibits Th1 responses by inhibiting 
IFNγ production, promoting Th2 polarity. IL-4 also promotes B cell responses and induces 
isotype switching to IgE. Binding of IgE crosslinks FcεR expressed on the surface of mast 
cells and basophils, leading to the release of inflammatory mediators such as histamine and 
also the production of cytokines IL-4 and 13. Eosinophil recruitment is mediated by IL-5 
and IL-10 suppresses Th1 proliferation and can also suppress DC function. IL-13 plays an 
important role in the expulsion of helminth parasites and in the induction of airway 
hypersensitivity. IL-25 can enhance the production of IL-4, IL-5 and IL-13 by a unique c-
kit+ FcεRI- non-lymphocyte population [34]. Innate cells associated with Th2 responses 
include eosinophils and mast cells, which release toxic granules upon activation.  
The events regulating the initiation of Th2 immune responses has been a subject of intense 
scrutiny, in vitro studies showed priming in the presence of IL-4 drives Th2 [35]; however 
recent work has shown that although IL-4 is necessary for amplification and maintenance 
of a Th2 immune response (in a similar fashion to that seen for IFNγ and T-bet), induction 
can occur through IL-4 and STAT 6 independent pathways [36-39]. Th2 induction requires 
IL-2 to help drive differentiation. IL-2 signals through STAT 5, which has been shown to 
bind directly to DNase hypersensitivity sites in the Il4 locus [40]. Strong STAT 5 
signalling is required as the loss of STAT 5a causes defects in Th2 differentiation [41, 42]. 
In the presence of IL-4, GATA 3 is directly activated by STAT 6, however in the absence 
of IL-4, IL-2 signalling through STAT 5 leads to the production of limited amounts of IL-4 
that is then able to signal GATA 3 through STAT 6 dependent pathway to amplify and 
maintain the response. 
 
1.3.2.3. Th17 
The recently discovered lineage of Th17 cells produces IL-17a, IL-17f, IL-21 and IL-22 
upon stimulation of effector function. The generation of Th17 cells occurs when naïve T 
cells are primed in the presence of TGFβ and IL-6 [43-45], activating the transcription 
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factor RORγt. There are three stages of Th17 differentiation; initiation of differentiation by 
TGFβ and IL-6, expansion mediated by IL-21 and stabilisation via IL-23 [34]. The IL-21 
produced by these cells has a positive feedback, reinforcing the Th17 phenotype [46, 47]. 
Th17 cells have been found in the autoimmune diseases experimental autoimmune 
encephalomyelitis (EAE) and collagen induced arthritis (CIA) and also have a role to play 
in fungal and bacterial frontline defence [48-50].  
 
1.3.2.4. Th9  
Th9 effector cells produce IL-9, which has effects on mast cells and lymphocytes as well 
as inducing mucin production in epithelial cells [34]. Th9 cells are associated with Th2 
immune responses and differentiation of Th9 cells requires the Th2 cytokine IL-4 along 
with TGFβ [51, 52]. Th9 cells are a relatively poorly characterised T cell subset and as 
such they are tentatively identified as a new CD4+ lineage [53]. 
1.3.2.5. Tfh  
Follicular helper T cells (Tfh) are a subset of CD4 effector T cells that assist with antibody 
production and the generation of plasma cells through the production of IL-21. IL-21 is 
also fundamental in the generation of Tfh [54]. Although Th17 cells also produce IL-21, 
Tfh are distinct as they differentiate independently of RORγt and TGFβ [53] - requiring the 
transcription factor Bcl6 [55, 56]. Experiments by Zaretsky et al describe how Tfh can 
differentiate from Th2 cells in a helminth model, highlighting the plasticity of CD4 T 
effector responses [57].  
1.3.2.6. Regulatory T cells 
Initially known as suppressor T cells, regulatory T cells (Tregs) are a lineage of CD4 T 
cells that work to regulate immune responses through suppression of T cell effector 
function. Activated Tregs regulate the immune response through the production of IL-10 
and also in a contact dependent fashion [34].  
Improved technologies and the identification of forkhead box transcription factor FoxP3 as 
the master regulator of Tregs controlling regulatory molecule transcription have facilitated 
a resurgence in the exploration of regulatory T cells. Studies have revealed there are two 
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distinct types of CD4+ FoxP3+ Treg, the thymically derived “natural” Tregs and inducible 
Tregs (iTregs) that arise during infection. Activated CD4 T cells, strongly stimulated by 
TGFβ in the absence of proinflammatory cytokines, develop into Foxp3+ iTregs that are 
antigen specific.  
The cytokines produced by effector T cells in addition to driving each of the lineages also 
have an important suppressive role to inhibit other lineages to maintain a polarised immune 
response. 
1.3.2.7. NKT cells 
NKT cells are a unique CD4 T cell subset that can rapidly produce large amounts of 
cytokine, making either IFNγ or IL-4 depending on the stimuli. Interestingly NKT cells 
have been found to contribute to the amplification of Th2 responses in a parasite model 
[58].  
Although not a traditional CD4 effector cell, NKT cells that express αβTCR can also 
express CD4 and therefore can be included in the CD4 T cell family. NKT cells are unique 
in that they recognise lipid and glycolipid antigens when they are presented on the CD1d 
complex, unlike traditional CD4 T cells that recognise antigen presented in the context of 
MHC II. Diversity of the TCR is limited in NKT cells.  
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Figure 1.2 CD4 T cell effector lineages.  
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Naïve CD4 T cells (Tn) are activated by antigen presented on MHC II by APCs, in the 
presence of coreceptors and costimulatory molecules to become effector T cells (Teff). The 
black arrows indicate the four commonly accepted CD4 T cell lineages, indicated by grey 
arrows are two newly suggested CD4 T cell subsets. Th1 cells: IL-12 production by DC 
drive a Th1 response. Effector functions of Th1 cells are controlled by the transcription 
factor Tbet which drives production of IFNγ. Th1 cells also produce IL-2 and LTα. Th2 
cells: IL-4 and IL-2 help to drive a Th2 response, although Th2 immune responses can be 
initiated independently of IL-4[39]. Transcription factor GATA 3 initiates the production 
of effector cytokines including IL-4, IL-5, IL-13 and IL-25. Th17 cells: Generation of 
Th17 cells occurs in the presence of TGFβ and IL-6. IL-21 mediates cellular expansion 
and IL-23 is necessary to stabilise the response. Transcription factor RORγt drives the 
production of IL-17a, IL-17f, IL-21 and IL-22. Treg cells: T regs can be derived from the 
thymus (natural Tregs) or induced upon infection (iTregs) and express the transcription 
factor Foxp3. Strong TGFβ stimulation on the absence of proinflammatory cytokines can 
induce antigen specific iTregs. Tregs can act to suppress through production of IL-10 and 
also produce TGFβ. Th9 cells: Associated with Th2 responses, little is known about the 
Th9 cell. Th9 cells are thought to arise in the presence of IL-4 and TGFβ, and produce IL-
9. Tfh cells: A recently characterised CD4 cell type Tfh cells can differentiate 
independently of other CD4 lineages in the presence of IL-6 and IL-21. Tfh differentiation 
requires the transcription factor Bcl6, and differentiated Tfh assist with antibody 
production through the release of IL-21. Inset: NKT cells also express CD4, but differ 
from conventional CD4 T cells in that they recognise glycolipid antigen presented on 
CD1d molecules. NKT cells can produce large quantities of both IFNγ and IL-4. 
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1.4. Memory  
1.4.1. Generation of memory T cells 
The generation of cellular memory is a unique feature of the adaptive immune system 
enabling protective immunity. Both memory T and B cells have important roles to play in 
protective responses, however this thesis focuses on T cell mediated responses. Memory T 
cells are long-lived and able to respond rapidly to reinfection. Current dogma accepts two 
lineages of memory T cell, effector memory T cells (TEM) and central memory T cells 
(TCM) [59]. TCM preferentially reside in the secondary lymphoid organs and are able to 
proliferate rapidly upon re-exposure to antigen generating effector cells that can then 
migrate to the site of inflammation. They are characterised as CCR7+ and CD62L+. TEM 
reside in the periphery and are characterised by CCR7- and CD62L-. These cells are able 
to rapidly regain effector function and proliferate upon re-exposure to antigen [60].  
The generation of memory T cells is controversial and many models have been put 
forward. The models are diverse; incorporating the linear model that describes the 
development of memory T cell from effector precursors and also the intriguing divergent 
model that shows unequal cell division of an activated naïve precursor gives rise to both 
effector and memory daughter cells. Other models suggest memory T cells arise at various 
times during infection and their potency depends on the conditions at their generation. The 
truth behind the generation of memory T cells is most likely to involve several of the 
current models (summarised in Fig 1.3) – perhaps dependent on the infectious organism 
protection is being developed against. Current models of memory T cell lineage generation 
are well reviewed in Kaech et al [30]. 
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Figure 1.3 Models for the generation of T cell memory. 
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A. Linear model of memory generation. The linear model of memory T cell generation 
proposes that naïve T cells (Tn) are activated and differentiated during primary infection to 
become T effector cells (Teff) before the population contracts and a small subset of cells 
develop into TMEM.  Studies by Jacob and Baltimore and Hu et al support to this model [61, 
62]. B. Divergent model of memory generation. The divergent model of memory T cell 
generation proposes that naïve T cells give rise to distinct precursors of Teff or TMEM 
lineage in a branched fashion. Experiments by Chang et al support the divergent model of 
memory generation [63]. C. Early and late activation model of memory generation. The 
early and late model of memory generation advocates that memory subsets (TEM, TCM) are 
differentially generated depending on whether they arise from early or late Teff. D. 
Decreasing potential model of memory generation. The decreasing potential model of 
memory generation is based on the idea that T cell effector functions steadily decrease 
with persisting antigen exposure and memory T cells can be generated at varying times 
giving rise to functional and non-functional memory cells. This model proposes that the 
key to memory development is the level and duration of antigen exposure, which dictates 
whether a cell goes on to become a functional TMEM cell or dies. E. Intersecting pathway 
model of memory generation. The intersecting pathway model incorporates the ideas of 
antigen exposure, proliferative response and effector potential in the development of 
memory cells. This model suggests that pre- memory cells (lighter colour) can arise at 
different times during activation and effector response when T cells have different effector 
potential and variance in the number of rounds of proliferation they have undergone. 
Development of memory cells is speculated to occur upon withdrawal of antigen making it 
antigen independent in contrast to the antigen driven development of effector cells. 
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1.4.2. Maintenance of memory T cells 
An important issue relevant to T cell memory is how both the pool of memory T cells and 
the diversity of the TCR repertoire within that pool is maintained. The number of memory 
T cells appears to be stable and the memory T cell pool is under strict homeostatic control 
to remain at equilibrium. After cell expansion from an immune response a contraction of 
the memory pool is required, if T cells are lost (as in some viral infections) there is 
expansion to compensate. Homeostatic control of memory T cells is controlled 
independently to that of naïve cells, for example, depleting all naïve cells will not cause an 
increased number of memory cells, although they will represent a higher proportion of 
total T cells [64].  
The pool of memory T cells appears to be maintained by competition for survival factors 
between each of the antigen specific memory cells. Neither cognate antigen or MHC 
molecules seem to be required for the long term maintenance of CD4 or CD8 memory cells 
[65, 66]. Homeostasis of CD8 memory T cells is maintained in part by IL-15; mice that are 
deficient in IL-15 show a significant reduction in the number of CD8 memory cells. IL-7 
also plays a role in maintenance of CD8 memory T cells. Homeostasis of CD4 T cells is 
not entirely clear. CD4 T cells are unaffected by IL-15 deficiency, however depletion of 
IL-7 leads to a loss of both naïve and memory T cells. Studies of IL-7 requirements in 
memory homeostasis are complicated by the fact that an excess of IL-7 will lead to 
expansion of T cells [67]. Further support for a role for IL-7 in CD4 memory T cell 
survival comes from the experiments of Garcia et al where recovery of adoptively 
transferred memory cells in IL-7 deficient RAG -/- recipients was impaired [68].  
Diversity of the TCR repertoire can itself influence the diversity of the memory TCR 
repertoire. Low diversity of the memory TCR repertoire can influence the expansion of 
naïve T cells with novel TCR to achieve a memory compartment with a more diverse 
repertoire. This adds a further level of complexity to the maintenance of memory T cells. 
Min et al show that monoclonal memory T cells fail to suppress proliferation of polyclonal 
naïve T cells, whereas polyclonal memory CD4 T cells are capable of suppressing 
proliferation of naïve T cells [69]. The size of the memory compartment remains constant, 
so limited diversity in the TCR repertoire would lead to a larger proportion of memory 
cells specific for a given antigen, and higher diversity to fewer clones of the same 
specificity.  
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1.5. Immune system structure and function 
The anatomy and structural organisation of the immune system allows it to be efficient at 
pathogen surveillance and response to infection. The requirements of immunity are not 
only to respond appropriately to contain and resolve new infections but also to remember 
foreign pathogens and protect against reinfection with them. Development of lymphocytes 
from T cell precursors to long-lived memory cells happens within the defined tissues of the 
immune system. T cell precursors enter the primary lymphoid tissues to develop into 
antigen specific naïve T cells. The secondary and tertiary lymphoid organs are where 
induction of immune responses and the development of memory occur as well as activation 
and effector function [70-72]. That these events occur in secondary lymphoid tissues is 
clear however the role of tertiary tissues is less defined.  
1.5.1. Primary Lymphoid Organs 
The primary lymphoid organs are where lymphocytes mature from B- and T-precursors 
into naïve B and T cells. The thymus has a key role in T cell development and B cells 
develop in the bone marrow, the remainder of this section focuses on the development of 
αβ T cells in the thymus.  
T cell precursors migrate from the bone marrow to the thymus where they undergo TCR 
generation in the subcapsular area. Once TCRs are successfully assembled thymocytes 
begin to express both CD4 and CD8 coreceptors [73, 74] before undergoing the processes 
of positive and negative selection. Positive selection ensures the TCR is capable of 
interacting with antigen presented on MHC and also drives lineage development of 
different T cell subsets based on the interaction of MHC with coreceptors; either MHC 
I/CD8 or MHC II/CD4 [75]. 
The now single positive cells (expressing either CD4 or CD8) are subject to the process of 
negative selection, which causes T cells with high affinity for self-peptides to apoptose in 
order to eliminate self-reactive cells, which could otherwise lead to autoimmune disease 
[76]. T cells meeting these criteria emerge into the circulation as single positive non-self 
reactive naïve T cells [77]. These stringent processes allow for the generation of a 
population of naïve T cells with a diverse repertoire of antigen specificities against non-
self antigens. 
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1.5.2. Secondary lymphoid tissues 
The traditional view of the events involved in the initiation of an immune response is that 
they are confined to highly organised and structured lymphoid tissues. Secondary 
lymphoid organs are organised, encapsulated compartmentalised tissues, which are 
arranged as nodes through which lymphatic fluid draining all peripheral tissues must pass 
through before entering the bloodstream via the thoracic duct (Fig 1.4). This structural 
arrangement ensures that the lymph node is the place of first contact between pathogenic 
antigens and immune cells. Secondary lymphoid tissues are dispersed around the body and 
include lymph nodes, spleen and Peyers patches as well as some mucosal associated 
lymphoid tissues. This section will focus on lymph nodes as the major secondary lymphoid 
organs, however similar structure and processes exist for other secondary lymphoid organs 
also.  
The characteristic anatomical structure and organisation of secondary lymphoid organs 
creates a tightly regulated yet productive environment where many cell types are drawn 
together to facilitate the efficient creation of an effector response to invading pathogens. 
Frequency of naïve cells specific for any one given antigen is estimated at two to 200 cells 
per mouse [78]. Secondary lymphoid organs are sites where naïve T cells are concentrated, 
enhancing opportunities to meet antigen presenting cells (APCs) loaded with specific 
antigen, enabling maturation into effector and memory T cells.  
Lymph nodes are organised structurally so that the expression of key chemokines and 
adhesion molecules directs the arriving cells to migrate into specific areas within the node. 
Entry into the lymph node is restricted to those T cells that express CD62L (L-selectin) 
[79], LFA-1 and CCR7 [80], as these molecules mediate rolling, adhesion and diapedesis 
from the high endothelial venules (HEVs) into the lymph node.  The CCR7 ligands CCL21 
(expressed on stromal cells) and CCL19 (expressed by macrophages, DCs and some non-
hemopoietic cells) are present within T cell areas and direct T cell migration and maintain 
the organisation of the T cell areas of the secondary lymphoid organs. The expression of 
CCL21 and CCL19 also facilitate the migration of CCR7 expressing mature DCs to 
interact with and present antigen to the T cells.  
The fate of a naïve T cell within the lymph node is dependant on activation, however 
effector, memory and naïve T cells all exit through the efferent lymphatics. The 
sphingophospholipid sphingosine-1-phosphate (S1P) has recently been shown to regulate 
lymphocyte migration into efferent lymph [81, 82]. A gradient of S1P attracts T cell  
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Figure 1.4 Secondary lymphoid anatomical structure and lymphocyte trafficking.  
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A. Naïve T cells (Tn) enter lymph nodes in a CD62L dependent manner through high 
endothelial venules (HEV). If Tn meet an APC bearing their cognate antigen they form an 
immune synapse, and if stimulatory and costimulatory signals are met they become 
activated effector T cells (Teff) before leaving the lymph node. If Tn do not detect their 
cognate antigen they exit the lymph node. B. APCs and TMEM drain from the tissues 
through the afferent lymphatics into the lymph node. C. T cells egress the lymph node into 
the efferent lymphatics in response to a chemotactic gradient of sphingosine-1-phosphate. 
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migration out of the node and into the efferent lymphatics [82], where they return to the 
blood via the thoracic duct. 
1.5.3. Tertiary (peripheral) lymphoid tissues 
Tertiary lymphoid tissues are concentrated accumulations of lymphoid cells in non-
lymphoid tissues sometimes referred to as peripheral lymphoid tissues. The tissues of 
mucosal associated lymphoid tissue (MALT) can fall within this category and will be 
discussed later. Defining secondary vs. tertiary lymphoid tissues can be problematic and 
controversial, as there is a distinct plasticity to these tissues. A major difference between 
secondary and tertiary lymphoid tissues is the fact that tertiary lymphoid tissue can arise in 
almost any organ and seems to be inducible upon infection. A tentative descriptor is that 
tertiary lymphoid tissues arise when necessary to deal with localised insult, and in some 
cases can be resolved by treating the initial inflammation instigator (for example with 
antibiotics).   
Tertiary lymphoid tissue can be found in any tissue and provides an important immediate 
defence, as it is located at the point of pathogen entry in the periphery. The structure of 
tertiary lymphoid tissue is loosely similar to that of secondary lymphoid tissue, with B and 
T cell areas (although ratios of T:B cells differ), naïve lymphocytes, DC’s and lymphoid 
chemokines like CCL21. HEV like vessels have been observed in tertiary lymphoid 
structures and lymphatic vessels have also been detected although whether acting as 
efferent or afferent is unknown [6].  
T cell entry to peripheral tissues is restricted to the T cells recognising the correct 
“addressins” expressed on endothelial cells of HEVs, similarly to secondary lymphoid 
tissues. Although homing is still incompletely understood, combinations of selectin and 
ligand expression by T cells and endothelial cells as well as other myeloid cells determines 
the homing potential of T cells to peripheral tissues. Studies of T cells in the bronchus 
associated lymphoid tissue (BALT) have shown a requirement for α4β1integrin as well as 
L-selectin (CD62L) for T cell entry, with strong staining of VCAM-1 and PNAd on HEVs 
entering the lung [83].  Skin entry is restricted to T cells that are capable of binding 
ELAM-1 [84] (expressed in cutaneous venules during chronic inflammation), and α4β7 
integrin allows access to the gut tissues [85]. The expression of both selectin and ligand 
can change in response to the state of inflammation the tissue is undergoing [86] (with the 
corresponding T cell requirements) and also depend on the activation state of the T cell 
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itself. Activated effector and memory T cells express different integrin and selectin 
molecules and therefore respond to different ligands than naïve cells and as such have 
different tissue accessibility. 
Recent evidence suggests that priming of T cell responses is possible in tertiary lymphoid 
tissue. Naïve T cell proliferation has been demonstrated in islets of NOD mice after the 
removal of pancreatic lymph node [87]. Bertolino et al demonstrate that adoptively 
transferred transgenic auto reactive CD8 T cells are able to infiltrate the liver of recipient 
mice, expressing activation markers within two hours of transfer. In addition within 24 
hours these cells have divided up to four times and started to recirculate in the blood, 
where CD8 T cells that were retained in the lymph nodes took between two-three days to 
recirculate, although showing similar activation and division to the liver based 
lymphocytes [88]. Feuerer et al show the ability of T cells to home to and be primed in the 
bone marrow [89]. A recent paper by Gelman et al discovers that alloreactive T cells are 
primed within lung tissue independently of secondary lymphoid organs, leading to 
transplant rejection [90]. Experiments by Wakim et al support the proliferation of T cells 
in peripheral tissues, demonstrating the antigen specific proliferation of HSV specific graft 
residing T cells after transplantation of previously infected Dorsal Root Ganglion (DRG) 
into naïve hosts [13]. Research into skin immunity is increasingly finding an important role 
for tissue residing T cells, independent of those recruited from the circulation [14]. A 
recent paper by Greter et al [91] describes how cell mediated immunity can be initiated in 
mice lacking secondary lymphoid tissues, with the generation of productive CD4 and CD8 
systemic responses and the ability of liver tissue to support T cell priming. Although T cell 
responses were found to be able to be generated independently of secondary lymphoid 
tissues, B cell responses were not. Collectively these papers add weight to the idea that T 
cell priming and initiation of an immune response can occur outside of secondary 
lymphoid organs. 
1.5.3.1. Mucosal Associated Lymphoid Tissue (MALT) 
Mucosal Associated Lymphoid Tissues (MALT) are considered to be secondary lymphoid 
tissues for the most part. MALT structures such as Peyers patches in the Gut Associated 
Lymphoid Tissue (GALT) and Nasal Associated Lymphoid Tissue (NALT) are well 
established, encapsulated and structured, similar to secondary lymphoid tissues. However, 
the categorisation of Bronchial Associated Lymphoid Tissue (BALT) is unclear. 
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The presence of BALT in mice is diffuse and does not share the same regularity of 
structure as other MALT such as Peyers patches or NALT [92]. Often BALT does not 
appear until mice are older, in the case of Balb/c and C57BL/6 mice more than one year, 
but can be more easily found in NOD mice, especially those older than seven months [83]. 
Only 43% of four month old mice kept in special pathogen free (SPF) conditions exhibit 
BALT [93] – suggesting that it is an inducible tissue arising after infection (iBALT) rather 
than a pre-exisiting tissue such as the Peyers patches present in the Gut Associated 
Lymphoid Tissue (GALT). Isolated Lymphoid Follicles (ILFs) in the GALT have also 
been considered as tertiary lymphoid tissue as they are inducible and shaped by microbial 
stimuli [94]. Splenectomised Lta -/- mice lack secondary lymphoid organs, however these 
mice can develop iBALT and are capable of mounting effective immune responses [70]. 
The inducibility of BALT after infection along with its ability to arise in a compensatory 
fashion for a lack of secondary lymphoid organs in splenectomised Lta -/- mice and lack of 
consistent structure and location cause me to consider it as a tertiary lymphoid 
structure/tissue. 
1.6. Recirculation of immune cells between lymphoid tissues 
The recirculation of immune cells between the different lymphoid tissues allows cells to 
travel to sites of specialised immune activity. The recirculation of adaptive immune cells 
between lymphoid tissues is distinct from the migration of innate cells to sites of 
inflammation. Migration of innate cells such as neutrophils to inflammatory sites happens 
in a unidirectional fashion. The innate cells are attracted to signals of inflammation, which 
they follow to the inflamed tissue, exert effector function and perish.  
In contrast to innate cells, after development in the primary lymphoid tissues T cells travel 
to the secondary and tertiary lymphoid tissues where APC are screened for their specific 
antigen. APCs travel between tertiary and secondary lymphoid tissues presenting antigen 
to large numbers of naïve T cells. Recirculation and mixing of these immune cells 
throughout the different tissues and organs of the body is required for the immune system 
to efficiently detect and respond to infection. We have chosen to focus on T cells as they 
orchestrate the immune response. 
Chapter 1: General Introduction 
 27 
1.6.1. T cell recirculation 
In the early 1990’s, work by Mackay et al investigated the recirculation patterns of naïve 
and memory T cells in sheep[95]. T cells were divided into naïve or memory phenotype 
based on the expression of adhesion molecules CD2, CD11a, CD58, CD44 and importantly 
CD45R; memory T cells exhibited increased CD2, CD11a, CD58 and CD44 expression, 
but lacked CD45R, where naïve T cells exhibited low adhesion molecules and were 
CD45R+. T cells from the blood, afferent and efferent lymph were collected and analysed 
for their activation phenotype, and also for their proliferative capacity. Memory-like T 
cells were found to accumulate in the afferent lymph, where most cells in the efferent 
lymph (~90%) exhibited a naïve phenotype. Blood T cells showed a somewhat mixed 
population. The memory-like T cells in the afferent lymph did not express CD45R, 
expressed increased adhesion molecules and were shown to proliferate in response to recall 
antigen. This data led to the conclusion that naïve and memory T cells trafficked 
differentially; naïve T cells circulating through the blood and HEV to the lymph node, with 
memory T cells patrolling tissues and returning to the lymph node via the afferent 
lymphatics [95].  Further work showed that subsets of memory T cells show tissue 
selective migration patterns which likely develop after antigen encounter in a particular 
environment, such as the skin (reviewed in [96]) or gut [97], with differential expression of 
adhesion molecules between the differentially homing cell subsets. A review of 
lymphocyte recirculation and homing by Butcher et al reinforces this view, discussing the 
ability of memory and effector T cells to recirculate through extra-lymphoid sites, while 
naïve T cells remain confined to recirculation through secondary lymphoid tissues [79]. 
Addition of antigen into the immune system understandably alters T cell migration 
patterns. An increase in T cells migrating through inflamed lymph nodes and a drop in 
cells travelling through the efferent lymph was observed in experiments by Mackay et al 
[98]. This increased lymph node traffic was largely due to an increase in the number of 
memory-type T cells recirculating through the node [98]. Experiments by Weninger et al 
followed the recirculation of adoptively transferred in vitro generated CD8 effector and 
memory T cells in the steady state and in inflammatory conditions. They found that 
memory but not effector cells homed to secondary lymph node and Peyers patches and that 
this lymph node homing required CCR7 and CD62L for entrance through HEV. Both 
effector and memory T cells were able to respond to inflammatory chemokines and 
migrate to sites of inflammation [99]. This data highlights the different migration 
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capacities of T cells depending on their activation status. Interestingly further experiments 
by Weninger et al suggest that naïve T cells can migrate to peripheral tissues under 
inflammatory conditions, due to interactions with CCL21 expressed on inflamed 
endothelium [100], this is particularly interesting in light of the findings of Mackay et al 
[98] where naïve T cells were observed trafficking in the afferent lymph of antigen 
challenged animals. T cell recirculation between primary, secondary and tertiary lymphoid 
tissues is described in Fig 1.5. 
A recent paper by Cose et al demonstrates that a population of naïve T cells can be found 
in a large number of non-lymphoid tissues under steady state conditions including lung, 
liver, skin and brain [101]. These cells have been classified as naïve, effector or memory 
based on the expression of CD11a and CCR7 and further characterised as to CD62L and 
CD44 expression. The T cells were assessed as to their function and effector cytokine 
production was observed only in those cells that were CD11ahi, and not in the CD11aint 
CCR7hi naïve subset. To assess the migration of naive cells through peripheral tissues the 
drug FTY720 was used. FTY720 blocks egress of naïve cells from the lymph node and 
causes lymphopenia in the blood, it was reasoned that if the CD11aint CCR7hi population 
seen in peripheral tissues was naïve then the drug would selectively deplete it. The cell 
populations of the lung, liver and lamina propria were assessed and both CD4 and CD8 
percentages were greatly reduced; importantly it was the naïve subset of cells that 
disappeared following treatment [101]. This preferential depletion of naïve cells from 
peripheral tissues has also been observed in other independent studies [102]. Further 
testing of this hypothesis was carried out by generating bone marrow transgenic chimeras; 
TCR x RAG-/- chimeras were created generating cells which are TCR specific and lacking 
RAG - ensuring they remain naïve unless stimulated with their specific antigen. These 
chimeras revealed that although naïve cells predominantly remain within lymphoid tissues, 
transgenic T cells could be found in non-lymphoid tissues including the brain and testes. 
Treatment with pertussis toxin did not prevent naïve cells entering peripheral tissues, 
suggesting that entry is not mediated by chemokine receptors. The implications of this 
work are that naïve T cells enter non-lymphoid organs as part of a normal migratory 
pathway [101].  
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Figure 1.5 T cell recirculation between primary, secondary and peripheral lymphoid 
tissues. 
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A. Single positive naïve T cells egress the thymus and enter circulation. Naïve T cells enter 
lymph nodes from the blood in a CD62L dependant manner. B. Naïve T cells egress lymph 
nodes through the efferent lymphatics and rejoin the circulation through the thoracic duct. 
C. Recent evidence suggests that naïve cells can migrate through peripheral tissues [101]. 
D. Effector (Teff) and memory T cells (TMEM) exit the lymph nodes through the efferent 
lymphatics and traffic to peripheral sites of inflammation or infection. E. TMEM can return 
to the lymph nodes from the tissues through the afferent lymphatics. F. Recent studies 
suggest that mature memory like T cells migrate back to the thymus to mediate positive 
selection [103]. Grey arrows indicate controversial recent publications. 
Chapter 1: General Introduction 
 31 
Recirculation of antigen bearing DCs is important in the generation of efficient T cell 
effector responses. Not all DCs are migratory but under inflammatory conditions, mature 
antigen loaded DC’s drain to the lymph node via the afferent lymph. This migration 
ensures the efficient activation of the immune response in the draining lymph node, 
although some soluble antigens may drain to the lymph node independently. Other APCs 
and DC subsets remain in the periphery stimulating the immune response there. 
 
1.7. Current paradigms of protective immunity  
Recently a proposition was put forward that the development of a memory population in 
the tertiary lymphoid tissue is an important goal of the immune response to drive 
protection against reinfection [104]. This Effector Lymphoid Tissue (ELT) paradigm 
suggests that the local tissue response plays a critical role in protective immunity by 
mounting a swift effector response at the site of infection.  
In the original opinion paper, it was postulated that ELT could form TEM from Teff cells 
that had migrated from the lymph node during primary infection. Upon reinfection the TEM 
could be reactivated rapidly becoming Teff, lymph node derived TCM maintain the supply 
of Teff to the inflamed tissue. Experiments by David Woodlands group have led to the 
development of a three phase model for the immune response to control viral reinfection in 
the lungs [105]. They propose that the recall response to reinfection is mediated by 
memory T cells (TMEM) residing in the lung airways (phase 1), non-proliferating TMEM that 
are recruited to the lungs (phase 2) and proliferating TMEM that are recruited to the lung 
airways (phase 3). Roberts et al maintain that the contribution of TEM and TCM changes 
over time; early after infection Tem dominate the memory pool, however at later times 
after infection TCM dominate [106]. Using a sendai virus model of infection Ely et al show 
that the CD8 Tem population in the lung is maintained by continual recruitment, indicating 
a requirement for lymph node derived T cells [107].  
Recent work by Wakim et al [13] demonstrates in a Herpes simplex viral (HSV) model 
that locally resident T cells can be presented with antigen in the periphery to initiate and 
maintain protective immunity. Previously infected dorsal root ganglia (DRG) were grafted 
to the kidney capsule of recipient mice that were then reinfected with HSV. It was shown 
that the HSV specific memory CD8 T cells transferred within the graft were able to 
proliferate after being stimulated by recipient derived DCs, in a CD4 dependent manner. 
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Further work by this same group demonstrates that when memory T cells are recruited 
from the circulation to the site of reinfection they are able to proliferate locally rather than 
being continuously recruited [108]. A recent publication by Gebhardt et al describes a 
unique skin resident protective memory T cell population [109]. Collectively these 
experiments strengthen the theory that development of localised ELT in peripheral tissues 
is essential in pathogen containment and protection after reinfection. 
1.8. Separating lymph node and peripheral responses: S1P and 
FTY720 
1.8.1. S1P 
The naturally occurring small lysosphingophosolipid molecule sphingosine-1-phosphate 
(S1P) has been found to be involved in a number of cellular processes. The 
phosphorylation of sphingosine in vivo by sphingosine kinases (SphK 1 and 2) [110] 
generates biologically active S1P. S1P is produced in the plasma by erythrocytes [111] by 
platelets [112] and is found naturally in the plasma at 0.1-1µM [113] and is produced in 
the lymph by a distinct radiation resistant cell type [111]. S1P signals through a number of 
G-protein coupled receptors S1P1-5 (first noticed on endothelial cells and named 
Endothelial differentiating gene - Edg - receptors), with each receptor coupled to a 
different type of G protein to give a distinct signal transduction (well reviewed in [114]).  
S1P receptors are differentially expressed on the cells of the immune system and are 
associated with a variety of outcomes including chemotaxis, polarity of the immune 
response and cell proliferation [115]. CD4 T cells predominantly express S1P1 and to a 
lesser extent S1P4. CD8 T cells also express these receptors and have additionally been 
shown to express S1P5 mRNA [116, 117]. 
1.8.2. FTY720  
The natural immune suppressive properties of myriocin, an immunosuppressant derived 
from the fungus Ischaria sinclairii led to the development of a less toxic yet more 
suppressive synthetic analog, FTY720 (2-amino-[2-(4-octylphenyl) ethyl]-1,3-propanediol 
hydrochloride) [118]. Interestingly it was soon discovered that FTY720 had the ability to 
bind to S1P receptors [82, 117].  Phosphorylation of FTY720 by sphingosine kinases in 
vivo gives the active FTY720-P form; a potent direct agonist of four of five S1P receptors 
(S1P2 unaffected by FTY720 treatment) [110]. Low nanomolar concentrations of the drug 
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have been demonstrated to inhibit signalling through receptors 1, 2 and 5 but not 3 and 4 
by rapidly inducing prolonged internalisation of the S1PR [117]. Affected receptors remain 
internalised up to several days post treatment [117]. FTY720 does not stimulate the 
activation of the receptor; it simply causes recycling without directly competing with 
ligand [117]. FTY720 has varying affinity to each of the S1P receptors and receptor 
ligation by FTY720 can have different outcomes.  
1.8.3. Effects on lymphocyte recirculation 
S1P has a critical involvement in lymphocyte recirculation, with several hypothesised 
mechanisms. It has been postulated that the lymphopenic effects of S1P are due to 
increased chemokine dependent homing to lymphoid organs [119]. Another proposed 
mechanism behind reduced lymphocyte recirculation was S1P strengthening of endothelial 
tight junctions (reviewed in Rosen et al [120]) however experiments in mice lacking 
secondary lymphoid organs showed that T cells remained sequestered and reduced in the 
circulation, showing that a physical endothelial barrier to lymph node egress was unlikely 
[121]. 
It has been convincingly shown that S1P is chemotactic to CD4 T cells through S1P1 [122, 
123]. A chemotactic gradient of S1P controls lymphocyte egress from the lymph nodes 
[81, 82], inducing lymphopenia by preferentially depleting naïve T cells from circulation 
[102]. High S1P levels in the blood facilitate binding to S1P1, which is then internalised. 
The lymph node environment has very low levels of S1P present, so after entry into the 
lymph node S1P receptors are re-expressed over time. This re-expression of S1P1 allows 
the cells to become responsive to moderate levels of S1P emanating from the efferent 
lymph, causing migration out of the lymph node and into the lymph along a chemotactic 
gradient [82]. This is shown diagrammatically in Fig 1.6. The chemotactic gradient of S1P 
is established and maintained by the S1P degrading enzyme S1P-lyase that ensures low 
S1P levels in lymphoid tissues, with S1P-lyase deficiency also preventing lymphocytes 
egress (through S1P gradient destruction) [81]. Oral FTY720 treatment has been shown to 
induce the sequestration of lymphocytes from peripheral blood and spleen, causing homing 
to lymph nodes [119, 124]. The internalisation of S1P1 caused by FTY720 treatment leads 
to a blockade of lymphocyte egress by preventing the T cells following the S1P 
chemotactic gradient into the efferent lymphatics [125].  
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Activation of T cells has been shown to suppress S1P receptor expression. In vitro studies 
show that activation of T cells with αCD3/αCD28 significantly suppresses S1P receptor 
expression [116]. TCR dependent activation of T cells results in a decrease in S1P1 
expression making the cells less responsive to signal through this receptor [122]. 
Furthermore it has been shown that S1P1 expression is inversely related to the expression 
of C-type lectin CD69 (associated with early T cell activation), with surface expression of 
CD69 suppressing S1P expression [31]. It is thought that this may relate to an extended 
stay in the lymph node for activated cells allowing them to interact longer in the lymph 
node environment with Ag bearing APCs – enabling the efficient generation of effector T 
cells.  
The egress of mature T cells from the thymus is also mediated by S1P, specifically CD4 T 
cells, Tregs and iNKT cells (reviewed in Drennan et al [126]). S1PR agonist administration 
has been shown to down modulate CD69 expression in thymocytes and also to inhibit 
thymocyte egress [127]. S1P1 in particular has been shown to play a role in the thymic 
egress of T cells, as egress of T cells was prevented in a T cell specific S1P1 knock out 
mouse [128] and also by FTY720 induced retention of S1P1 [125]. Allende et al show that 
S1P1 expression is necessary for dissemination of NKT cells into peripheral tissues, 
although not essential for their development within the thymus. Furthermore FTY720 
treatment did not seem to alter the pre-existing distribution of NKT cells within peripheral 
tissues [129]. However varying results have been observed with iNKT and Treg cells  – “it 
may be that the relationship between T cell export from the thymus, peripheral 
recirculation and S1P1 may differ depending on the T cell subset being investigated” [126]. 
The low S1P concentrations in the tissues allow cells to recirculate through tissues and 
then to the lymph node. Recent findings by Ledgerwood et al speculate that agonism of 
S1P1 causes lymphocyte retention within the peripheral tissues, due to an inability for 
lymphocytes to traffic via the afferent lymphatics [130]. The experiments show FTY720 
treated lymphocytes are able to initially adhere to, but not cross the basement membrane of 
the lymphatic endothelium into the afferent lymphatics [130]. A paper by Hofmann et al 
follows the lymphopenia induced by FTY720; finding that while naïve T cells do pass 
through peripheral tissues during their recirculation, FTY720 treatment preferentially 
depletes these naïve cells from the periphery [102] and sequesters them in the peripheral 
lymph nodes [119], with effector/memory phenotype cells being less affected by the drug. 
It can also be noted that this depletion of effector/memory type cells varied depending on 
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the organ or tissue being analysed, as lung tissue seemed to be depleted of 
memory/effector cells more readily than liver [102]. FTY720 treatment was shown to 
enhance T cell accumulation in Peyers patches due to increased integrin mediated arrest in 
HEVs. This effect was not shown in S1P1 -/- cells, showing it to be an FTY720 effect 
independent of S1P1 [131]. An intriguing study performed by Sugito et al looks at the 
effects of FTY720 treatment on mice lacking secondary lymphoid organs. Using 
splenectomised aly/aly mice, which lack lymph nodes and Peyers patches, it was found 
that FTY720 treatment still induced lymphopenia in the peripheral blood; prolonging graft 
survival in this model by preventing infiltration of CD4 lymphocytes into grafts. However 
the fate of these sequestered lymphocytes is unclear [121]. 
The accumulating data shows a key role for S1P in regulating the recirculation of 
lymphocytes between primary, secondary and tertiary lymphoid tissues. This regulation 
can be exploited experimentally as administration of FTY720 effectively ceases S1P 
mediated migration of lymphocytes between the lymphoid tissues. 
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Figure 1.6 S1P controls lymphocyte egress from lymph nodes.  
S1P concentrations are high in the blood, leading to S1P1 receptor internalisation. Low S1P 
in the lymph nodes allows S1P1 receptor re-expression, making the lymphocytes 
responsive to a S1P chemotactic gradient trafficking out through the efferent lymphatics. 
FTY720 binds to S1P1 and prevents lymphocyte egress by maintaining receptor 
internalisation, thus making lymphocytes unresponsive to the S1P chemotactic gradient. 
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1.8.4. Immunological effects 
A review of the immunological effects of signalling through S1P receptors reveals a 
variety of effects. Inhibition of proliferation has been observed in in vitro studies using 
S1P. T cells stimulated to proliferate with αCD3/αCD28, PMA and ionomycin or 
allogeneic DC’s were inhibited by the addition of S1P [115]. Additionally S1P signalling 
through S1P4 has been shown to mediate suppression of T cell proliferation and inhibition 
of effector cytokine production using a combination of S1PR deficient and transfected cell 
lines and ex vivo splenocytes [132]. 
FTY720 treatment leads to a reduced expansion of antigen specific CD4 T cells in the 
draining lymph node, however both in vitro and in vivo proliferation of antigen specific T 
cells is unimpaired, as shown using a local antigen-challenge mouse model by Xie et al 
[133]. They suggest that this reduced expansion is due to a low precursor frequency of 
naïve Ag specific T cells being present in the draining lymph node as a result of the 
FTY720 mediated reduction in recirculating naïve T cells. The observation that both naïve 
and activated cells were reduced equally in the peripheral blood, implies that both T cell 
subsets were unable to egress from the lymph node. Hofmann et al show preferential 
sequestering of naïve T cells from peripheral tissues, this is most likely because the naïve 
cells are recirculating, whereas peripheral memory cells are tissue residing and not 
recirculating through lymph nodes for FTY720 to affect them [102]. Lymph node based 
expansion of CD8 T cells and induction of cytotoxic activity remained unaffected by 
FTY720 treatment in an LCMV model (as shown ex vivo), although footpad inflammation 
is reduced due to the sequestering effects of FTY720 preventing T cells entering and 
inflaming the peripheral site [134].  
Long term FTY720 treatment (up to six months at ~0.5mg) causes a decline in peripheral 
T cell numbers over time and a consequent increase in homeostatic proliferation is 
observed. This in turn changes the composition of naïve/memory T cell pools to smaller 
populations that have a higher proportion of memory phenotype cells. Memory phenotype 
T cells are over-represented in FTY720 enhanced homeostatic proliferation. The increased 
proportion of memory cells correlated with increased functional activity as measured by 
numbers of IFNγ producing cells after stimulation with phorbol ester and ionomycin; 
FTY720 treated animals had two-three fold more pre-existing memory cells capable of 
producing IFNγ than matched untreated mice [135]. 
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Optimal suppressive function of CD4+ CD25+ Tregs requires S1P. Tregs express S1P1 and 
S1P4 similarly to other CD4 T cell subsets. Using in vitro assays Wang et al show that 
Tregs could better inhibit the proliferation and IL-2 production of αCD3/αCD28 
stimulated CD4+ CD25- T cells, when exposed to S1P at concentrations consistent with 
that found in normal blood and lymph. Using FTY720 to down regulate S1P1 also 
decreased the suppressive activity of these cells, implicating an important role for S1P1 in 
their suppressive function. Neutralisation of the IL-10 generated by these Treg cells 
abolished the previously observed suppression. Regulatory T cells are differentially 
sequestered by FTY720, with CD4+ CD25+ Tregs seen in increased numbers in the blood 
and spleen of FTY720 treated animals, in contrast to CD4 and CD8 T cells, which are 
depleted in blood and spleen and accumulate in the lymph nodes [136]. In a Th1 mediated 
model of colitis FTY720 treatment improved disease by enhancing Treg function. 
Increased IL-10, TGF-β and FoxP3 expression was measured in FTY720 treated animals 
and the therapeutic effects of treatment were abrogated by administration of anti-IL-10 or 
anti-CTLA-4 [137]. 
S1P dependent migration of APCs can be impaired by FTY720 treatment. FTY720 has 
been shown to inhibit migration of CFSE labelled skin DC’s to the draining lymph node. 
Czeloth et al [138] found that mature, but not immature DC migrated in response to S1P – 
correlating with an upregulation of S1P1 and S1P3, which was abrogated by FTY720 
treatment. Subsequently mature murine dendritic cells have been shown to migrate in a 
S1P3 dependent manner using in vitro DC’s prepared from S1P3 deficient mice [139]. This 
group also demonstrated that pre treatment with FTY720-P significantly inhibited the 
migration of these DC’s. In an in vivo model of OVA induced experimental asthma, Idzko 
et al found a direct intratracheal administration of FTY720 into the lung inhibited the 
trafficking of antigen bearing DC’s to the mediastinal lymph node. This method of 
treatment also rendered the DC’s less effective at activating T cells due to a reduced ability 
to form stable interactions for immunological synapse [140]. In in vitro human monocyte 
derived DC populations, both immature and mature DC’s show reduced chemotaxis in the 
presence of FTY720 and FTY720-P, as well as reduced expression of S1P1 and S1P4 
[141]. Work by Martino et al looked at the role of S1P during the differentiation of human 
monocytes into dendritic cells. Including S1P in cultures with GMCSF and IL-4 generated 
DC’s that did not express CD1a, but acquired some aspects of mature DC in the absence of 
maturation stimuli [142]. The above data clearly show that FTY720 treatment can affect 
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APC, however more studies will be required to reveal the effects of FTY720 on different 
APC subsets. 
1.8.5. FTY720 in disease models 
FTY720 is an excellent candidate drug for a variety of diseases due to its 
immunosuppressive properties; as such FTY720 has been administered in many disease 
models with varied success. Kurashima et al have abrogated allergic diarrhoea in a food 
allergy model by preventing trafficking of pathogenic CD4 T cells and mast cells through 
FTY720 treatment [143]. Eosinophil recruitment and IgE response remained unaffected by 
the treatment. Using a diabetes model mediated by CD8+ T cells Pinschewer et al showed 
that although CD8 memory induction remained unaffected, the lymphocyte sequestration 
induced by FTY720 treatment prevented autoimmune destruction of pancreatic islets and 
corresponding development of diabetes in the majority of animals [134]. Diabetes in NOD 
mice has also been prevented by FTY720 administration [144] 
FTY720 has been evaluated for use in avoiding graft rejection (GVHD) and was found to 
prevent lymphocyte infiltration into grafts, thereby delaying rejection (reviewed in [145-
147]). Experiments by Taylor et al [148] suggest that the delay of GVHD caused by 
FTY720 treatment is due to a number of mechanisms including reducing donor effector 
cells through lymph node trapping and apoptosis; reduction in splenic DC’s thereby 
reducing effector expansion in the spleen and that the observed delay is additive to the 
effect of donor Treg cells. 
FTY720 treatment reduced severity of disease in a Th2 mediated oxalone colitis model. 
The therapeutic effects of FTY720 treatment correlated with a reduction of Th2 cytokines 
IL-4, 5 and 13, but also an inhibition of expression of GATA3 and T1/ST2; which are 
associated with induction and secretion of Th2 cytokines respectively [149]. FTY720 
treatment prevented the development of colitis in SCID mice after transfer of CD4+ CD44 
high CD62L - effector memory T cells suggesting that FTY720 treatment may potentially 
treat memory cell mediated autoimmune conditions [150]. 
The work of Sawicka et al investigates the effects of FTY720 on Th1 and Th2 mediated 
airway inflammation, delivering in vitro generated OVA specific Th1 or Th2 differentiated 
T cells and oral FTY720 treatment. Both Th1 and Th2 inflammatory infiltrates were 
reduced after OVA sensitisation with FTY720 treatment and bronchial hyper 
responsiveness was also reduced in this model [151]. Interestingly a recent paper 
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investigates the effect sphingosine kinase plays in OVA induced allergic asthma. Using a 
knockdown of SphK1 they show a reduction in IL-4, 5, eotaxin and IgE [152]. 
The treatment of wistar rats with FTY720 completely prevented the development of EAE 
(experimental autoimmune encephalomyelitis) [145] leading to the subsequent testing of 
FTY720 as a treatment for multiple sclerosis (MS) in humans. FTY720 (known also as 
Fingolimod) has shown great promise as a treatment for MS with success in phase II 
clinical trials (proof of concept studies) [153, 154] and is currently in phase III clinical 
trials.  
1.9. Nippostrongylus brasiliensis 
N. brasiliensis is a rodent model of hookworm infection. N. brasiliensis is an excellent 
parasitic model to study Th2 immune responses as it generates a very rapid and robust Th2 
immune response with production of cytokines, antibodies and recruitment of accessory 
cells. The generation of this strong Th2 response is CD4 dependent and can occur 
independently of B cells, eosinophils and CD8 T cells [155]. Additionally N. brasiliensis 
provides a good model to study protective immunity as mice are protected against 
reinfection.  
1.9.1. Parasite lifecycle  
The lifecycle of N. brasiliensis occurs mostly within the host tissues. Like many parasites, 
N. brasiliensis migrates extensively throughout the host during its life cycle, inducing 
immune responses at various peripheral sites (Fig 1.7). Infective 3rd stage larvae (iL3) 
invade the host by burrowing through the skin before migrating through the vasculature 
until they burst through into the lung parenchyma, where they mature into 4th stage larvae 
(L4). These L4 are swept up into the oesophagus via the mucocilliary ladder prior to being 
ingested and establishing a population in the gastrointestinal tract. Here they mature to 5th 
stage adult worms (L5), mate and lay eggs before being expelled by an immunocompetent 
host in a “self cure” reaction by day 10 post-infection. The eggs go on to hatch in the 
infected faeces into 1st stage larvae (L1) before maturing into 2nd stage larvae (L2), and 
then maturing further into the iL3 parasite. 
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Figure 1.7 Lifecycle and experimental model of N. brasiliensis. 
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The infectious third stage larvae (iL3) of N. brasiliensis infects the host through the skin 
(A). Experimental infection is performed via intradermal or subcutaneous injection in 
order to reduce variation in number of infecting parasites. From the skin site of infection 
the worms migrate to the lung tissue (B), arriving from 16 hours post infection. Here the 
migrating worms mature into fourth stage larvae (L4). Worms can be found in the lung 
tissue up to day three post infection, after which worms travel up the trachea before being 
swallowed and establishing a population in the intestine (C) which peaks at day six post 
infection. In the intestine the L4 mature to the adult stage (L5), mate and lay eggs prior to 
expulsion from the host by day ten post infection (primary infection). The eggs are passed 
in the faeces (D) and when they hatch the resulting L1, and later L2 stage larvae develop 
within the faecal matter. We recreate this experimentally by making faecal “patties” [156] 
that are incubated in a moist environment at 26°C. Within one week of incubation, iL3 
migrate away from the faecal culture and are ready to infect a new host. 
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Previous studies with N. brasiliensis have explored the mechanisms and requirements of 
gut expulsion in great detail. Experiments by Finkelman, Urban and colleagues have 
defined roles for CD4 T cells with IL-4, IL-13 and STAT 6 playing major roles in worm 
expulsion [157-159]. Studies by Dent and colleagues focus more on the immune response 
at the skin. Using an air pouch model of N. brasiliensis infection in combination with IL-5 
transgenic mice and eosinophil deleted mice they propose that boosting eosinophil 
numbers can confer resistance to reinfection most particularly at the skin site and lung [3, 
160, 161]. Shin et al also support a protective role for eosinophils in immune responses 
against N. brasiliensis [162]. 
1.9.2. Immune evasion by parasites 
Parasites have evolved with their hosts for millions of years to achieve a fine balance of 
immune response and infectious load. Too high a burden of parasites will cause host 
mortality, whilst too much of an immune response will kill the parasites, therefore it is in 
the best interest of the parasite to maintain a low level chronic infection without inducing 
too strong an immune response. To this end many parasites have developed 
immunoevasion strategies, from rapid tissue migration to the manipulation of host immune 
regulatory mechanisms in an effort to maximise survival.  
The rapid tissue migration of parasites has been postulated as a method of escaping the 
host immune response [163]. N. brasiliensis passes rapidly from skin site of infection to 
the lung before further migration into the gastrointestinal (GI) tract. From studies with this 
model we know that the during primary infection the Th2 immune response induced by N. 
brasiliensis is maximal well after the worm has left the affected tissue (G. LeGros, M. 
Camberis, M. Prout, M. Harvie unpublished observation). 
Regulatory T cells have been reported as a feature of many parasitic responses [164-168]. 
The role of Tregs in parasite infection may be to protect the parasite from the host immune 
response, but also to protect the host tissue against inflammatory damage [163]. Parasite 
induced Tregs have been shown to suppress unrelated immune responses using bystander 
suppression [169, 170].  
The development of alternately activated macrophages (AAM) in N. brasiliensis infection 
has been documented [19, 171, 172]. They appear to function in a regulatory role and it has 
been suggested that AAMs are active in parasitic infection in three different ways; firstly 
suppressing the inflammatory response to the parasite, secondly releasing molecules that 
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directly affect the parasite and lastly repairing tissue damage caused by the parasite 
infection [165]. Physical changes to the lung after N. brasiliensis are marked [171, 173]. 
The delicate tissues of the lung are damaged during worm migration and the postulated 
role of AAMs in wound repair and tissue remodelling would be advantageous to the host. 
 
1.10. Aims 
While the development of cellular memory is critical to establish protective immunity 
against many pathogens, the relative importance of peripheral tissues in this process is 
unclear. The N. brasiliensis model is a useful tool to study the relevance of peripheral 
immune responses in protective immunity, as during parasite migration immune responses 
are initiated at multiple peripheral tissue sites within the host. Use of G4/IL-4 reporter 
mice provides a sensitive measure of the in vivo immune response with minimal ex vivo 
manipulation. Drug treatment with FTY720 provides a tool to separate the immune 
responses of secondary and tertiary lymphoid tissues in vivo, to determine their roles in 
protective immune responses. Separation of the immune responses of secondary and 
tertiary lymphoid tissues using FTY720 in a Th1 mediated model will further investigate 
the roles of these different lymphoid tissues in protective immunity. The use of G4/IL-4 
reporter mice and FTY720 treatment in the N. brasiliensis model provides us with the 
framework to address the following aims; 
 
• To determine which tissues are key for priming protective CD4 T cell responses 
against N. brasiliensis. 
• To compare the relative contribution of CD4 T cell responses of the lung and 
lymph node using FTY720 to block T cell recirculation.  
• To characterise the key CD4 T cell subtypes of the protective response against N. 
brasiliensis. 
• To compare these findings in a Th1 mediated model of protective immunity 
 
2. Chapter 2:  
Materials and Methods 
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2.1. Materials 
2.1.1. Labware 
Product Supplier/Distributor 
 
Acrodisc 25mm syringe filter with 0.2µm 
Supor membrane 
PALL lifeSciences, Cornwall U.K 
Axygen Microtubes 1.7 mL Falcon Polystyrene Axygen Scientific Inc., Union City, 
CA, USA  
BD 10, 5, 2 mL Syringes & BD 1 mL tuberculin 
syringes  and BD Ultra-fine™ 29 gauge needle & 
syringe 
BD BioSciences, Bedford, MA, USA 
Cheesecloth/muslin fabric Spotlight 
Eppendorf Combitips plus Eppendorf AG, Hamburg, Germany 
Falcon Polystyrene round bottom tubes: 
5mL 
BD BioSciences, Bedford, MA, USA 
Falcon Polystyrene tissue culture plates: 
6 well plates, Multiwell plates & Microtest U-
bottom 96 well plates, V-bottom 
BD BioSciences, Bedford, MA, USA 
Falcon Polystyrene conical tubes: 
Blue max 50 mL and Blue Max Jr  15 mL 
BD BioSciences, Bedford, MA, USA 
Falcon Polystyrene serological pipettes BD BioSciences, Bedford, MA, USA 
Nylon cell strainers (70µm and 40µm) BD BioSciences, Bedford, MA, USA 
Nylon gauze (70µm) NZ Filter specialists Ltd., Onehunga, 
Auckland, NZ 
PrecisionGlide Needles (25, 23, etc gauge) BD BioSciences, Bedford, MA, USA 
TitreTubes Micro Tubes BioRad, Hercules, CA, USA  
Transfer pipettes (1 mL) Samco Scientific, Mexico 
Ultra-Fine™ needle Insulin syringes (29 
gauge) 
BD BioSciences, Bedford, MA, USA 
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2.1.2. Reagents and buffers 
2.1.2.1. Cell culture and flow cytometry reagents 
Alsever’s Solution 
Dextrose (BDH Laboratory Supplies, Poole, England), NaCl (BHD Laboratory Supplies, 
Poole, England) and sodium citrate.2 H2O (BHD Laboratory Supplies, Poole, England) 
were added to 1 L distilled (MilliQ) H2O to give final concentrations of 20.5 mg/mL 
dextrose, 4.2 mg/mL NaCl and 8.0 mg/mL sodium citrate.2 H2O. The pH was adjusted to 
6.1 with 1 M citric acid (BDH Laboratory Supplies, Poole, England). The solution was 
filter-sterilised and stored at room temperature. 
5-(and-6)-carboxyfluorescein diacetate, succinimidyl ester (CFSE) 
CFSE was purchased from Molecular Probes (Eugene, OR, USA) and was stored at -20°C, 
as a 10 mM solution in DMSO (Sigma, St. Louis, MO, USA). 
Collagenase I 
Collagenase I was purchased from Invitrogen (Auckland, NZ). The lyophilised powder 
was stored at 4°C and made up fresh in IMDM to a concentration of 2.4 mg/mL before 
use. 
DNase I 
DNase I was purchased from Roche (Mannheim, Germany). The lyophilised powder was 
dissolved to a concentration of 10 mg/mL in PBS and stored at -20°C. 
Enzymatic digestion solution 
Collagenase I and DNAse I were added to cIMDM, to give a final concentration of 2.4 
mg/mL collagenase I and 120µg/mL DNAse I. The solution was prepared fresh as 
required. 
Fluorescence Activated Cell Sorting (FACS) Buffer  
NaN3 (Sigma, St. Louis, MO, USA) and FBS were added to 1 L PBS, to give final 
concentrations of 0.01 % NaN3 and 2 % FBS. The buffer was stored at 4°C. 
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FACS sort buffer 
FBS and DNAse I were added to PBS to give final concentrations of 5% FBS and 0.002% 
DNAse. The buffer was stored at 4°C. 
Foetal Bovine Serum 
Mycoplasma and virus screened and performance tested FBS, with 27 EU/mL endotoxin, 
was purchased from GIBCO (Invitrogen, Auckland, NZ), and stored at -20°C. 
Iscove’s Modified Dulbecco’s Medium (IMDM) IMDM supplemented with 
GlutaMAX™, 25 mM HEPES buffer and 3.024 mg/L NaHCO3 was purchased from 
GIBCO (Invitrogen, Auckland, NZ). 
Complete Iscove’s Modified Dulbecco’s Medium (cIMDM) 
cIMDM was made by adding Penicillin-Streptomycin (GIBCO, Invitrogen, Auckland, 
NZ), 2 ME and FBS to 0.5 L IMDM to give final concentrations of 100 U/mL Penicillin, 
100 µg/mL Streptomycin, 55 µM 2 ME (GIBCO, Invitrogen, Auckland, NZ) and 5 % FBS. 
cIMDM was stored for up to 1 month at 4°C. 
Magnetic Cell Sorting (MACS) Buffer 
EDTA, BSA and DNAse I were added to 1 L PBS to give final concentrations of 2 mM 
EDTA, 0.5 % BSA and 0.012% DNAse I. The buffer was filter-sterilised and stored at 
4°C. 
2 Mercaptoethanol (2 ME) 
2 ME was purchased from Sigma (St. Louis, MO, USA) as a 55 mM (1000 x) solution in 
PBS and stored at 4°C. 
Phosphate Buffered Saline (PBS) 
One 47.8 g bottle of Dulbecco’s PBS without CaCl2 and MgCl2 (GIBCO, Invitrogen, 
Auckland, NZ) was dissolved in 0.5 L distilled (MilliQ) H2O to make a 10 x solution or in 
5 L d H2O to make a 1 x solution. pH was adjusted to 7.4. The solutions were filter 
sterilised and stored at 4°C. 
Red Blood Cell Lysis Buffer 
Purchased from Sigma (St. Louis, MO, USA) as a 8.3g/L NH3Cl solution in 0.001M Tris-
HCl, pH 7.5. 
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2.1.2.2. Antibodies and flow cytometry reagents 
Antibodies specific for murine markers 
Specificity Clone Source 
FcγRII/III (CD32/CD16) 2.4G2 Purified from a B cell hybridoma line 
B220 RA3-6B2 Purchased from BD Pharmingen™ 
CD3 2C11 eBioscience 
CD4 GK1.5 
RM4-5 
Purchased from Invitrogen 
CD8 56-6.7 Purchased from BD Pharmingen™ 
CD44 IM7 Purchased from BD Pharmingen™ 
CD45 30-F11 Purchased from BD Pharmingen™ 
CD45RB 16A Purchased from BD Pharmingen™ 
CD62L Mel 14 Purchased from BD Pharmingen™ 
CD127 A7R34 eBioscience 
TCRβ H57-597 Purchased from BD Pharmingen™ 
 
Intracellular and Isotype Control Antibodies 
IFNγ XMG1.2 Purchased from BD Pharmingen™ 
Rat IgG1 - APC  Purchased from BD Pharmingen™ 
 
Flurophores 
Specificity Source 
SA-Qdot 565 Purchased from Molecular Probes 
SA-PE Purchased from BD Pharmingen™ 
DAPI Purchased from Invitrogen 
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2.2. Methods 
2.2.1. Mice 
2.2.1.1. Maintenance and Ethical approvals 
All mice used in these experiments were bred and maintained in the specific pathogen free  
(SPF) Biomedical Research Unit (BRU), Malaghan Institute of Medical Research, 
Wellington, New Zealand, with the exception of inbred athymic nude mice. Nude mice 
were imported from the Animal Resource Centre (Canning Vale, Australia), quarantined 
according to MAF regulation for 30 days and maintained in the Biomedical Research Unit, 
Malaghan Institute of Medical Research, Wellington, New Zealand. Where indicated mice 
were housed in individually ventilated cages (IVC) maintained at 60-100 air changes per 
hour. 
 
Age and sex matched mice were used in all experiments, from the age of six weeks. All 
experimental procedures described in this study were approved by the Victoria University 
Animal Ethics Committee (AEC #2006R20, #2006R19, #2009R14M, 2009R8M) and 
carried out in accordance with the guidelines of the Victoria University of Wellington, 
New Zealand, and the standard operating procedures (SOP) of the BRU, Malaghan 
Institute of Medical Research, Wellington, New Zealand. 
 
2.2.1.2. Mouse strains 
B6Aao (MHC II-/-) mice were from breeding pairs obtained from Biological Research 
Laboratories Ltd. Wolferstrasse 4, Switzerland [174]. These mice are maintained in IVC 
units. 
Balb/c mice were from breeding pairs obtained from the Jackson Laboratory (Bar 
Harbour, ME, USA). 
Balb/c STAT 6 -/- mice were from breeding pairs originally derived from mice generated 
by Kaplan et al [175]. 
C57BL6 mice were from breeding pairs obtained from the Jackson Laboratory (Bar 
Harbour, ME, USA). 
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CD1 -/- mice (on a C57BL6 background) were obtained from C.R. Wang (the Department 
of Pathology, University of Chicago, IL, USA). Generated as described in Chen et al [176]. 
eGFP mice [177] (on a C57BL6 background) were from breeding pairs obtained from the 
Hercus Taieri Research Unit, Dunedin, NZ. 
Foxp3gfp mice were from breeding pairs obtained from and were used with permission of 
A. Rudensky [178]. 
G4/IL-4 mice were from breeding pairs obtained from W. E. Paul at the Laboratory of 
Immunology, National Institute of Allergy and Infectious Diseases, National Institute of 
Health, Bethesda MD 20892-1892, USA [179]. 
Nu/Nu homozygous mice on a Balb/c background (BALB/c-Foxn1nu/ARC) were 
purchased from the Animal Resources Centre (Canning Vale, Western Australia).  
 
2.2.1.3. Drug treatments 
FTY720 treatment Lyophilised FTY720 (Novartis Biopharma) was dissolved into sterile 
milli Q water and frozen in 10mg/mL aliquots at -80°. FTY720 was further diluted for use 
in in vivo experiments and stored at required concentration at -20°C. FTY720 was 
administered by daily gavage at a dose of  ~0.5mg/kg unless otherwise stated. 
Anti-helmintic treatment pyrantel embonate was administered where specified by oral 
gavage daily, at a concentration of 1mg/mouse. 
Antibiotic treatment To clear remaining bacilli after BCG vaccination, mice received 
1mg/mL of isoniazid (Sigma-Alderich, St Louis MO) in their drinking water, daily for 
4 weeks. Following treatment, CFU of BCG were undetectable in lung or spleen 
homogenates from vaccinated mice. 
Anaesthetic Administration Mice were injected i.p. with a ketamine/xylazine mix at a 
final concentration of 8.6mg/mL ketamine and 0.26mg/mL xylazine. Anaesthetic was 
administered at 10µL/g for restraint purposes, or at 1mL/mouse for lethal overdose. 
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2.2.2. Nippostrongylus brasiliensis model 
N. brasiliensis is maintained by passage through Lewis rats [156]. 
 
2.2.2.1. Parasite preparations 
Preparation of infective L3 Infective L3 were harvested from faecal cultures and washed 
(worms suspended in sterile PBS, briefly pulsed in the centrifuge to “pellet”, PBS 
discarded, then worms resuspended in sterile PBS) three times before being counted and 
suspended in PBS at the correct concentration for infection. 
 
Preparation of dead infective L3 Infective L3 were harvested from faecal cultures and 
washed five times in sterile PBS (as above). Larvae were made up to a concentration of 
~600 iL3 per 30µl in PBS and put through three freeze-thaw cycles. Larvae were then 
checked for viability. 
 
Recovery of L4 lung dwelling larvae The lungs of N. brasiliensis infected mice (or rats) 
were collected at day two post infection, diced, placed on cheesecloth and suspended in 
PBS at 37°C for at least 2 hours. Viable worms were migrated out and accumulated at the 
bottom of the container. These recovered worms were then washed at least three times (as 
above) in sterile PBS before being used for infection. 
 
Recovery of L5 adult worms The gut tissues of N. brasiliensis infected mice (or rats) 
were collected at day 5-6 post infection, diced, placed on cheesecloth and suspended in 
PBS at 37°C for at least 2 hours. Viable worms migrated out and accumulated at the 
bottom of the container. These recovered worms were then washed at least three times in 
sterile PBS (as above) before being used for infection. 
 
2.2.2.2. Parasite infections 
Primary infections, unless otherwise stated, primary infections consist of ~600 infective 
L3 administered subcutaneously in the scruff of the neck. 
Challenge infections mice were reinfected at 30 days post primary infection (unless 
otherwise stated) with ~600 infective L3 administered subcutaneously in the scruff of the 
neck (unless otherwise stated). 
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For intradermal infections, mice were anaesthetized using xylazine and ketamine  
(Phoenix, New Zealand) and 30µl sterile PBS containing 600 dead or live infective L3 
were injected into the ear pinnae using a B-D Ultra-fine™ 29 gauge needle & syringe 
(Becton-Dickinson, NSW, Australia). 
For subcutaneous infections, mice were physically restrained and injected with 200µL 
sterile PBS containing ~600 infective L3 subcutaneously into the scruff of the neck using a 
1mL syringe and 25 gauge needle (PrecisionGlide). 
 
For intranasal infections, mice were anaesthetized using xylazine and ketamine  
(Phoenix, New Zealand) and 50µL sterile PBS containing either L4 worms was instilled 
into the nostrils using a glass pipette. 
Helminth segregated priming Mice were infected with 600 live infective L3 on day 0 and 
re-infected with live iL3 on day 30 to investigate protection. L4 priming was achieved by 
intranasal administration of ~200 freshly harvested L4 stage. L5 priming was achieved by 
gavage of ~300 freshly harvested L5 adult worms. Anti helminthic pyrantel embonate was 
administered where specified by oral gavage daily, 1mg/mouse. 
 
2.2.2.3. Parasite migration assays 
In vitro Skin Penetration Assay. Abdomen skin was shaved and 2cm2 was harvested from 
naïve or previously infected mice. Skin was placed on 15ml tubes containing PBS. 200 L3 
were added to each tube and incubated overnight at 37°C. Larvae penetrating the skin 
accumulated at the bottom of the tube. Method adapted from Brown et al 1999 [180]. 
Tissue migration assay. Tissue (lung or gut) was diced, placed on cheesecloth and 
suspended in PBS at 37°C for at least 2 hours. For ears, dorsal and ventral sheets were 
separated placed on cheesecloth and suspended in PBS at 37°C. Viable worms migrated 
out and accumulated at the bottom of the container, before being counted on gridded plate. 
 
CFSE labelling of parasites. Infective L3 stage were washed several times in PBS then 
incubated at room temperature for 8 minutes in 2.5mM carboxyl fluorescein succinimidyl 
ester (CFSE). Worms were then washed three times in PBS before infection into host. 
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Imaging of larvae in ear tissue. CFSE labelled L3 were injected intra-dermally into the 
ear pinna. Ears were excised and dorsal and ventral sheets separated. Images were captured 
using Olympus BX51 microscope, Olympus DP70 camera and AnalySIS LS software. 
2.2.3. Bacillus Calmette-Guèrin (BCG) model  
2.2.3.1. Infections 
BCG subcutaneous vaccination M. bovis BCG Pasteur strain 1173P2 was briefly 
sonicated and diluted in phosphate buffered saline solution (PBS). Mice were vaccinated 
s.c. on the left flank with 100µL of PBS containing 1 x106 colony forming units (CFU) of 
BCG. 
BCG intranasal infection Mice were anaesthetized with ketamine and xylazine i.p. prior 
to an intranasal challenge with 1 x104 CFU of BCG in 50µL of PBS. 
2.2.3.2. Determination of bacterial load  
Tissue samples were mechanically homogenized in 3mL of PBS with 0.5% Tween 80 and 
plated in tenfold serial dilutions on selective Middlebrook 7H11 agar supplemented with 
10% oleic acid-albumin-dextrose-catalase enrichment (BD, Franklin Lakes NJ). Plates 
were incubated at 37°C for 2-3 weeks before counting colonies. 
2.2.3.3. T cell restimulation 
To evaluate IFNγ production by CD4+ T cells, CD45+ cells from individual lungs were 
cultured overnight at a concentration of 2 x106 cells/mL in supplemented IMDM with 
10µg/mL M. bovis culture filtrate protein (CFP) (AgResearch, Hopkirk Building, 
Palmerston North, New Zealand) and 2µg/mL anti-CD28 mAb (clone 37.51). Monensin 
was added to the cultures 2 hours prior to harvest to enable intracellular staining. 
 
2.2.4. Preparation of lymphocyte suspensions from tissue 
Blood was collected (either from the tail vein or from the vena cava of euthanised animals) 
into 1.5mL microtubes (eppendorf). A known volume was pipetted into 500µL of 
Alsievers solution and stored on ice. Collected blood was centrifuged at 1200 rpm for 8 
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min and the resulting soft pellet was incubated with red blood cell lysis buffer (Sigma, St. 
Louis, MO, USA) at 37°C, before being washed and resuspended in IMDM. 
Lung tissue was perfused with 10mL sterile PBS (with the exception of those mice 
receiving BCG infection) before being stored in IMDM on ice. Lungs were finely minced 
and enzymatically digested in 5mL of enzymatic digestion solution for 1 hour at 37°C. 
Lung cells were resuspended using a 1mL pipette to break up any clumps before being 
passed through a 70µM cell strainer, washed in IMDM and then counted. The resulting 
single cell suspension was incubated with CD45+ magnetic microbeads (Miltenyi Biotec, 
Germany) as per manufacturers instructions. After incubation with MACs beads, cells 
were washed in MACs buffer and passed through a 40µM cell strainer before being 
separated on an AutoMACs separator (Miltenyi Biotec, Germany) using POSSEL 
programme for positive selection of CD45+ cells. Collected CD45+ cells were then 
counted using trypan blue exclusion to exclude dead cells. 
Lymph Nodes were harvested into IMDM before being pressed through a 70µM cell 
strainer with a sterile 3mL syringe plunger for a single cell suspension. Cells were then 
washed in IMDM and counted using trypan blue exclusion to exclude dead cells. 
Alternatively, after harvest into IMDM the lymph nodes were enzymatically digested. 
Lymph nodes were placed into 1mL of enzymatic digestion buffer and the capsule was 
physically disrupted with a fine gauge needle before being incubated for 1 hour at 37°C. 
After digestion cells were resuspended using a 1mL pipette to break up any clumps before 
being passed through a 70µM cell strainer, washed in IMDM and then counted using 
trypan blue exclusion to exclude dead cells. 
Spleens were harvested into IMDM before being pressed through a 70µM cell strainer 
with a sterile 3mL syringe plunger for a single cell suspension. Red blood cells were lysed 
using Red Blood Cell Lysis buffer (Sigma) at 5mL/spleen for 2 min at 37°C. Cells were 
then washed in IMDM and counted using trypan blue exclusion to exclude dead cells. 
 
2.2.5. Adoptive transfer of T cells 
Preparation and adoptive transfer of immune CD4 lymph node T cells into the lungs 
of mice. Donor mice were infected with ~600 infective L3. After at least 28 days rest 
mediastinal lymph nodes were harvested and enzymatically digested for one hour at 37°C. 
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Cells were washed and then enriched for CD4+ cells using MACsbeads (as per 
manufacturers instructions) and an AutoMACs separator (Miltenyi Biotec, Germany). 
Recipient mice were anaesthetised using Xylazine and Ketamine (Phoenix, New Zealand). 
CD4 enriched cells were adoptively transferred intranasally to recipients in a volume of 
50µL PBS. 
 
CFSE labelling of cells Cells were washed in PBS before suspension at a concentration of 
2x107/ml. Immediatey prior to use CFSE was diluted in PBS to give a final concentration 
of 2.5µM before being added in an equivalent volume to the cells, to a new tube and 
vortexed to mix well. Cells were then incubated for 8min at room temp, and mixed 
occasionally. To quench staining an equal volume of FBS was added before four washes in 
cIMDM, transferring to a new tube with every wash. 
 
2.2.6. Flow Cytometry  
2.2.6.1. Detection of surface expressed molecules 
To evaluate surface expression of molecules cells were resuspended in FACS buffer and 
Fc receptors blocked before staining with primary monoclonal antibodies. Cells were 
washed and if required a secondary antibody was applied. Once stained cells were 
suspended at a maximum number of 1 x 107 and collected on a four colour flow cytometer. 
If cells were to be collected on the LSR II multicolour flow cytometer (Beckton-
Dickinson, Mountain View, CA, USA) addition of DAPI immediately prior to collection 
allowed exclusion of dead cells. 
2.2.6.2. Detection of intracellularly expressed molecules 
To evaluate IFNγ production by CD4 T cells, cells were restimulated as described above. 
Monensin was added to the cultures 2 hours prior to harvest. Cells were washed and 
blocked for FcγRI/II using anti-CD32/16 mAb and then labelled with anti-CD4-PerCP 
before being fixed and permeabilized for intracellular staining with anti-IFNγ-APC or 
isotype control APC -labelled antibodies (BD Pharmingen™). At least 100000 events were 
collected from the lymphocyte gate for each sample. 
Chapter 2: Materials and Methods 
 57 
2.2.6.3. Acquisition and analysis 
Live cells were resuspended in 200 µL of FACS buffer, for acquisition. Live cells were 
identified based on Forward Scatter (FSC) and Side Scatter (SSC) properties. When using 
the LSR II for collection, cells were diluted with a solution of DAPI at a final 
concentration 50ng/mL immediately prior to collection. Unlabelled samples and single 
labelled controls for each fluorochrome were included in all cases for calibration of 
voltages and compensation. In some cases isotype control antibodies were used to control 
for background fluorescence caused by non-specific antibody binding. Data was acquired 
using a FACSort, FACScalibur  (both four colour capacity) or LSR II flow cytometer 
(Beckton-Dickinson, Mountain View, CA, USA) and analysed using FlowJo software 
(Tree Star, San Carlos, CA, USA). 
2.2.6.4. FACS sorting of cells 
Cells were sorted by the staff of the flow cytometric suite on a FACSVantage cell sorter, 
using DIVA software (Beckton-Dickinson, Mountain View, CA, USA). 
2.2.7. Statistics 
Statistical calculations were performed using the Graphpad Prism® Version 4 statistical 
package (Graphpad Software Inc., San Diego, CA, USA).  
Student’s t test analysis was used when comparing between two samples  
One-way ANOVA was used to analyse the variance of multiple groups 
Tukey post test was used to compare variances between groups 
Dunnets post test was used to compare variances to a selected control 
The assumptions of a one-way ANOVA are 
o Normal distribution of sample 
o Independent samples 
o Equal variances 
If these assumptions are not met then a more stringent non-parametric Kruskal Wallis or 
Mann-Whitney test was used. 
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Two-way ANOVA was used to analyse the variance of multiple groups in relation to a 
second X variable, usually time (days). When samples were repeatedly taken from the 
same animal a repeated measures analysis of variance was used, with time as the repeated 
factor and group as the between subjects factor. 
Bonferroni post test was used to compare variances between groups 
The assumptions of a two way ANOVA are 
o Normal distribution of sample 
o Independent samples 
o Equal variances 
If these assumptions are not met then a more stringent non-parametric Kruskal-Wallis or 
Mann-Whitney test was used. 
Specific statistical tests used are detailed in figure legends. 
 
3. Chapter 3:  
The lung is a key site for protective immunity in a 
Nippostrongylus brasiliensis model of infection 
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3.1. Introduction 
This thesis investigates the recirculation of protective CD4 T cells in a parasitic model of 
protective immunity. In the N. brasiliensis model immune responses are initiated at 
multiple peripheral sites. The chapter herein examines the critical peripheral tissues 
required for the priming of CD4 T cells to confer immune protection.  
3.1.1. Nippostrongylus brasiliensis 
During migration through the host N. brasiliensis induces immune responses at three 
distinct peripheral sites; skin, lung and gut. Exposure to an infection with N. brasiliensis 
confers immunity to the host upon reinfection with the parasite, resulting in a reduced 
worm burden in mucosal sites. As such N. brasiliensis can be used as a model of protective 
immunity and the following experiments describe the levels of protection seen in the 
various tissues and the corresponding immune response. 
The skin is the initial site of infection where iL3 invade the skin barrier and enter the host. 
iL3 are the only stage capable of penetrating through otherwise intact skin. Experiments 
have been performed in IL-5 transgenic and deficient animals using air pouch models to 
study the immunity against parasites at the skin site. From data collected using an air 
pouch model, Dent and colleagues have proposed a role for eosinophils in parasite killing 
at the infection site using knock in IL-5 transgenic mice [3]. 
iL3 burst through into the lung parenchyma as early as 16 hours post-infection. The lung 
migration is traumatic for the host tissue as the migrating worms cause damage to the 
delicate lung tissue [171], damage that can easily be seen upon dissection as red petechia 
on the lung surface. It is here in the lung that the iL3 mature into L4 stage parasites. There 
are few reported experiments investigating lung immune responses in N. brasiliensis 
infection, particularly examining protective immunity. However, work investigating 
vaccination strategies in other parasite infections have highlighted the importance of this 
organ. A recent publication by Knott et al [160] proposes that damage during the lung 
phase, or pre-lung phase is responsible for reduced worm burdens in FVB/N mice, a strain 
found to be resistant to N. brasiliensis infection. Experiments by Reece et al investigate the 
impact of N. brasiliensis infection on the lung environment at mRNA transcript level and 
find that N. brasiliensis infection induces the development of alternately activated 
macrophages in a STAT 6 dependent manner [173]. This finding builds on the earlier work 
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of Marsland et al who also investigated lung pathology and saw the induction of 
alternately activated macrophages after N. brasiliensis infection [171]. Both of these 
groups focused on the physical pathological changes in the lung and related the parasite 
induced alternately activated macrophages to the ongoing repair of tissue damage. 
Extensive research has focused on investigating immune responses at the gut site of 
infection in the N. brasiliensis model. Dependent on CD4 T cells and STAT 6, gut 
expulsion is mediated by the production of IL-4 and IL-13 by immune cells that acts on 
goblet cells to increase mucous secretion and also causes contraction of smooth muscle 
leading to the expulsion of the worms[158]. IL-5 and IL-9 are also thought to play a role in 
worm expulsion[181].  
3.1.2. Peripheral tissue sites of N. brasiliensis migration 
The initial site of N. brasiliensis infection is the skin. The skin is of course a site of much 
host interaction with foreign pathogens.  The skin offers a physical barrier to protect the 
host, but this is easily penetrated by the iL3 during N. brasiliensis infection. Similarly to 
the lung and gut mucosal sites, the skin is well vascularised and immune cells traffic in a 
directed manner to the skin. Many immune cells are present within the skin, leading to the 
theoretical concept of skin associated lymphoid tissue (SALT) [182], similar to the 
previously introduced MALT tissues (chapter 1). Specialised subsets of APC reside within 
the skin tissues, including Langerhans cells and dermal DC. These APC are activated upon 
infection and can present antigen locally to induce proliferation of skin residing T cells 
[13]. Recently it has been proposed that skin resident T cells rather than recruited T cells, 
have a major role in skin immune homeostasis and pathology, from work with human 
psoriasis [183]. The skin is also a site of allergic Th2 mediated responses including 
dermatitis, psoriasis and eczema.  
The lung tissue is also traversed by N. brasiliensis larvae as they pass through the host. 
Similarly to the skin the lung is a site that is constantly exposed to inhaled foreign 
pathogens. The lung has a significant population of immune cells present, including APC 
such as lung resident alveolar macrophages and alveolar DC, and also T cells. Recently it 
has been proposed there are as many as five distinct subsets of DC present within the lung 
[15]. The formation of BALT has been documented in many species including mouse [71, 
92, 93]. In the absence of secondary lymphoid organs, protective immune responses have 
been shown to occur within the lung tissues [70].  
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The final host tissues of the N. brasiliensis migration are the gut tissues. The gut is also an 
important immune site that is frequently exposed to ingested foreign material. The gut 
contains MALT in the form of Peyers patches, isolated lymphoid follicles and 
cryptopatches [92], all containing specialised APC and gut resident T cells. Similarly to 
the immune response at the skin and lung, the immune response at the gut site needs to be 
carefully regulated to avoid allergic responses such as colitis, food allergies or 
inflammatory bowel disease (IBD).  
All of these peripheral tissues traversed by N. brasiliensis during infection are highly 
immune responsive with resident APC and T cells ready to respond to infection. These 
peripheral tissues are primary sites of pathogen exposure, which all contain their own 
lymphoid tissue. Any of these peripheral sites of N. brasiliensis migration could be 
considered as potential candidates in conferring protective immunity against reinfection 
with this parasite. 
3.1.3. Aims 
The following experiments were designed to investigate N. brasiliensis infection as a 
model for protective immunity. In particular these experiments aim to reveal the tissue 
location where priming of protective immunity against reinfection by N. brasiliensis 
occurs by: 
• Creating robust and unique experimental methods for tissue specific infection and 
analysis 
• Identify the role of different tissues in priming protective immune responses using 
tissue specific infection 
3.2. Results 
3.2.1. N. brasiliensis as a model of Th2 protective immunity 
3.2.1.1. Mice are protected from secondary infection in both the lung and gut 
To establish the levels of protection against reinfection in the N. brasiliensis model, G4/IL-
4 mice were infected with 600 iL3, rested for 30 days and then reinfected with 600 iL3 
worms. Over the course of infection lung and gut tissues were harvested and viable worms 
migrated out using the viable worm recovery assay (as described in materials and methods, 
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chapter 2) and enumerated (Fig 3.1A and B). To assess the level of protection in reinfected 
mice, tissue worm burdens were compared to those of primary infected mice (Fig 3.1 A 
and B).  
During primary infection worms could be recovered from the lung from as early as day 
one, with peak numbers in this tissue being observed at day two post-infection (Fig 3.1A). 
As worm numbers decrease in the lung tissue at day three post-infection, they can be 
detected in the gut tissue, with numbers peaking at day six post-infection (Fig 3.1B). When 
mice are reinfected with N. brasiliensis the number of viable worms recovered from both 
lung and gut tissues are dramatically reduced, with a 75% reduction in lung worm burden 
and 90% reduction in gut worm burden (Fig 3.1 A and B). 
The results from these experiments detail the kinetics of worm migration through host 
tissues during primary infection and reinfection. A dramatic reduction in worm burden of 
both lung and gut tissue is observed upon reinfection with N. brasiliensis, facilitating a 
model that can be used to study protective immunity. 
3.2.1.2. Protection from N. brasiliensis correlates with induction of a Th2 
immune response  
In order to further characterise the N. brasiliensis model of protective immunity the 
development of Th2 immune responses were followed using G4/IL-4 reporter mice. Mice 
were infected and challenged with N. brasiliensis as described above. During the course of 
infection lymph nodes draining the lung and gut (mediastinal and mesenteric lymph nodes 
respectively) were harvested and assessed for the development of IL-4 producing CD4 T 
cells, using a GFP reporter gene (as described in materials and methods, chapter 2). 
Development of a Th2 immune response during primary infection follows worm infection. 
By day three post-infection worms have migrated through the lungs, yet the number of 
GFP+ cells present in the mediastinal lymph node peaks at day nine post infection (Fig 
3.1C). A similar trend is seen in the mesenteric lymph node where GFP+ CD4 T cell 
numbers peak at day nine (Fig 3.1D), yet the peak of worm burden is day six post-
infection, with the majority of worms expelled from the gut by day nine to ten post-
infection (Fig 3.1B). 
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Figure 3.1 N. brasiliensis infection as a model of Th2 mediated protective immunity. 
G4/IL-4 mice (n=4/group/time point) were infected with N. brasiliensis (closed squares) 
and 30 days post-infection mice were reinfected with N. brasiliensis (open squares). A. 
Parasite burden in the lung during primary N. brasiliensis infection and reinfection. At the 
indicated time points lung tissues were harvested and viable worms migrated out and 
enumerated. Values represent mean number of worms recovered ± S.E.M. B. Parasite 
burden in the gut during primary N. brasiliensis infection and reinfection. At the indicated 
time points gut tissues were harvested and viable worms migrated out and enumerated. 
Values represent mean number of worms recovered ± S.E.M. C. GFP+ CD4 T cell 
responses during primary N. brasiliensis infection and reinfection. At the indicated time 
points mediastinal lymph nodes from N. brasiliensis infected animals (n=4/group/time 
point) were harvested and surface stained for CD3 and CD4 expression. Values represent 
mean number of cells ± S.E.M. D. GFP+ CD4 T cell responses during primary N. 
brasiliensis infection and reinfection. At the indicated time points mesenteric  lymph nodes 
were harvested and surface stained for CD3 and CD4 expression. Values represent mean 
number of cells ± S.E.M. Statistics (A-D) represent differences between primary infection 
and secondary infection for each data set. Statistics were calculated using two-way 
ANOVA with Bonferroni post test * P < 0.05 ** P < 0.01 *** P < 0.001. Data from A-D 
are representative of at least three independent experiments.  
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During a secondary infection, however, the Th2 immune response is initiated faster and is 
of greater magnitude than that seen in the primary response in both the mediastinal and 
mesenteric lymph nodes (Fig 3.1C and D). This stronger, faster immune response 
correlates with the reduced worm burden seen during reinfection (Fig 3.1A and B). 
This data suggests that during reinfection with N. brasiliensis there is a rapid Th2 immune 
response initiated in the mediastinal and mesenteric lymph nodes that is of increased 
magnitude and that also coincides with a reduced worm burden in both the lung and gut 
tissues. 
3.2.2. Protection does not occur at the skin site of infection 
In the life cycle of N. brasiliensis the larvae travel through many tissues of the host, 
beginning with penetration through the skin. Published work has suggested that immunity 
against reinfection occurs at the skin site of infection [3] and the following experiments 
were undertaken to determine if the skin plays an important role in protection from 
reinfection with N. brasiliensis. 
An in vitro assay was developed to assess the ability of N. brasiliensis iL3 to penetrate 
naïve or previously primed (immune) skin. Skin was harvested from naïve animals or from 
previously primed animals (from the site of priming) and placed securely over PBS filled 
tubes. Tubes were incubated in a 37°C water bath and ~200 iL3 were placed onto the skin 
and allowed to migrate through (Fig 3.2). Worms that had successfully migrated were 
collected from the bottom of the tube and enumerated. 
When the number of worms migrating through naïve skin was compared to the number of 
worms migrated through immune skin, there was no difference in the ability of worms to 
traverse immune skin. This suggests that immunity against reinfection is not due to an 
inability of the worms to penetrate through the skin of previously primed immune mice. 
However the in vitro nature of this assay does not allow for the migration of immune cells 
towards the site of worm penetration, which has been shown by Daly et al [3]to occur over 
a two hour time period.  
To investigate protection at the skin site in a more physiologically relevant way, an in vivo 
assay was developed where iL3 were injected intradermally into the ear pinnae of naïve or 
previously primed mice and their migration from the site of injection was evaluated. At 
various time points post-infection, ears were removed and worms migrated out using the 
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viable worm recovery assay and enumerated. An initial study used CFSE labelled worms 
to enable visualisation under the fluorescent microscope (Fig 3.3A), which allowed us to 
test the efficiency of the viable worm recovery assay. 
Migration of iL3 away from the injection site in the ear was rapid, with more than 50% of 
larvae leaving the ear within 30 min (Fig 3.3B). There was no difference in migration 
between naïve or previously primed animals implying that worms are able to migrate away 
from the site of infection in both naïve or immune mice and are not trapped by scar tissue 
or immune responses as has been previously suggested [3]. 
These in vivo experiments support our in vitro findings that the skin is not the site where 
protective immunity against N. brasiliensis occurs. The observation that equivalent 
numbers of worms are able to be recovered from the lungs of primary or reinfected mice at 
day one post infection (Fig 3.1 A) also supports this finding. 
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Figure 3.2 N. brasiliensis penetrate the skin of both naïve and immune animals. 
Efficiency of iL3 skin migration in vitro. Skin harvested from naïve or previously infected 
mice (n=4/group) was suspended over PBS. iL3 N. brasiliensis were placed on the skin 
samples and numbers of iL3 N. brasiliensis able to migrate through naïve or immune skin 
were enumerated. Values represent mean number of larvae migrated ± S.E.M. Statistics 
were calculated using Student’s t test. 
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Figure 3.3 N. brasiliensis migrate from the infection site in immune animals. 
A. Representative photomicrograph of CFSE labelled iL3 N. brasiliensis injected 
intradermally into ear at five minutes post-infection. Inset, DIC vs fluorescence. Pictured 
worms are 0.5mm in length. B. Number of larvae migrating from skin site of infection. 
G4/IL-4 mice (n=3/time point) were infected intradermally into the ear pinna with N. 
brasiliensis (open squares) or left uninfected (closed squares), and at day 30 post-infection 
were reinfected with N. brasiliensis. At indicated time-points, viable larvae were migrated 
out from excised ears & enumerated. Values expressed as percent burden ± S.E.M. and are 
representative of three independent experiments. Statistics were calculated using two-way 
ANOVA with Bonferroni post test and data was found to be not significantly different. 
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3.2.3. Priming in the lung and not the gut can confer protection against 
N. brasiliensis reinfection 
Having established that the skin is not a critical site conferring protective immunity against 
N. brasiliensis we next sought to investigate the relative importance of the mucosal sites in 
generating protective immunity. N. brasiliensis passes through both the lung and gut 
tissues during migration, so it was important to develop a method of separating the 
migration through these sites to assess where priming of protective immunity is occurring. 
The following experiments describe the development of a partial infection model where 
the lung and gut phases of the N. brasiliensis life cycle are isolated. This model was then 
used for segregated priming to ascertain where protective immunity is initiated. 
3.2.3.1. Tissue specific priming – development of the partial infection model 
With the knowledge that prior infection significantly reduced the number of tissue 
migrating N. brasiliensis iL3/L4 that gain access to the lung, it was important to determine 
what immune priming mechanisms mediated this effect. Therefore, we exploited the 
secondary infection model using distinct phases of the N. brasiliensis life cycle (illustrated 
in Fig. 3.4) and examined the relative contribution of immune priming within the skin, the 
lung or the gut towards protective immunity against reinfection. To do this, N. brasiliensis 
of different stages were harvested; infective iL3 worms were harvested as usual, L4 worms 
were harvested from the lungs of infected mice and adult L5 worms were harvested from 
the gut tissues. Tissue specific priming was then achieved as follows: (Group A) skin and 
lung priming was achieved by infection with iL3 and infection of the gastrointestinal tract 
prevented by anti-helmintic treatment from days two to nine of infection; (Group B) Lung 
only priming was achieved by intranasal administration of L4 and infection of the GI tract 
prevented by anti-helmintic treatment from days two to nine of infection; (Group C) Gut 
priming was achieved by gavage of adult L5; (Group D) skin, lung and gut priming was 
achieved by conventional infection with iL3. Once primary infections had cleared and 
immune responses dissipated (days 25 - 30 post-infection – see appendix Fig A.1), all 
groups were reinfected with iL3 and a group of naïve mice (Group E) was included for 
comparison of worm burden, cellular response and protective immunity.  
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Figure 3.4 Experimental design to create partial infections restricted to individual 
peripheral tissues. 
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A. Skin and lung priming (S/L). Mice were infected with ~600 iL3 N. brasiliensis 
subcutaneously and gavaged daily from days two to nine with anti-helmintic to prevent 
establishment of gut population. Mice were re-infected with 600 iL3 N. brasiliensis at day 
30 post infection. B. Lung priming (L). Mice were intranasally administered ~ 200 L4 N. 
brasiliensis and gavaged daily from days two to nine with anti-helmintic to prevent 
establishment of gut population. Mice were re-infected with 600 iL3 N. brasiliensis day 30 
post infection. C. Gut priming (G). Mice were gavaged with ~300 L5 N. brasiliensis 
worms. Mice were challenged with 600 iL3 N. brasiliensis day 30 post infection. D. Skin, 
lung and gut priming (S/L/G). Mice were infected with ~600 iL3 N. brasiliensis 
subcutaneously. Mice were re-infected with ~600 iL3 N. brasiliensis day 30 post infection. 
E. No priming (Primary control) Mice were infected with ~600 iL3 N. brasiliensis 
subcutaneously at the same time as other groups were re-infected to allow for measurement 
of protection. The reduced numbers of worms used for priming groups B and C were due 
to difficulty recovering enough worms for infection, as these stages of worm had to be 
recovered from passage through mice rather than from faecal cultures. 
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Figure 3.5 Validation of tissue specific priming. 
A. Treatment with anti-helmintic prevents establishment of a gut residing worm 
population. G4/IL-4 mice (n=3/time point) were infected with ~600 iL3 N. brasiliensis, 
one group received anti-helmintic treatment from day 2 post infection (squares) and the 
other did not (triangles). At the indicated time points guts were excised, worms migrated 
out and enumerated. Values represent mean number of larvae present ± S.E.M.  Data is 
representative of two independent experiments. Animals treated with anti-helmintic had 
significantly (**) less worms recovered than untreated animals. Statistics were calculated 
using two-way ANOVA with Bonferroni post test * P < 0.05 ** P < 0.01 *** P < 0.001. B. 
Worm burden in the lung (circles) & guts (crosses) following i.n. administration of lung 
larvae. G4/IL-4 mice (n=3/time point) were intranasally infected with 150 freshly 
harvested lung larvae and on indicated time points, lungs and guts were excised, worms 
migrated out and enumerated. Values represent mean number of larvae present ± S.E.M. 
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Figure 3.6 Gavaged L5 worms are not cleared from immune deficient animals. 
Balb/c (squares), STAT 6 -/- (triangles) and MHC II -/- (inverted triangles) mice (n=2/time 
point) were gavaged with ~300 freshly isolated and washed L5 N. brasiliensis worms. At 
the indicated time points guts were excised, worms migrated out and enumerated. Values 
represent mean number of worms present ± S.E.M.  Data is representative of two 
independent experiments. The difference in number of worms recovered between Balb/c 
and STAT 6 -/- or MHC II -/- strains is significant (**), in that the worms are cleared from 
the Balb/c strain over time, but not the immune deficient mice. Statistics were calculated 
using two-way ANOVA with Bonferroni post test * P < 0.05 ** P < 0.01 *** P < 0.001 
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It is important to note that anti-helmintic treatment restricted infection, preventing the 
establishment of a worm population within the gut (Fig 3.5A). L4 introduced intranasally 
to non-drug treated mice were able to complete their life cycle to the L5 stage and to egg  
production, suggesting that they were not affected by the extraction procedure (Fig 3.5B). 
Also, adult L5 gavaged into normal mice were cleared with normal kinetics (expulsion day 
6-10) while those gavaged into MHC II -/- or STAT 6 -/- mice failed to be cleared, 
indicating that the L5 worms were not affected by the extraction and gavage procedure 
(Fig 3.6).  
3.2.3.2. The effects of tissue specific priming on protective immunity against N. 
brasiliensis reinfection 
Mice whose primary infection was confined to the skin and lung (S/L), or to the lung alone 
(L) significantly reduced the number of migrating larvae in their lungs when compared 
with primary infected naive mice (Fig 3.7A). In contrast, mice whose primary infection 
with N. brasiliensis was restricted to gut infection (G) failed to significantly reduce their 
lung worm burden when reinfected. Analysis of the lymph nodes draining the infected sites 
revealed that the presence of more than 104 CD4 GFP+ cells per mediastinal lymph node 
(Fig 3.7B) in groups that were primed in the lung alone (L), skin and lung (S/L), or skin, 
lung and gut (S/L/G). This correlated with a significant reduction in worm burden in the 
lung (Fig 3.7A). By comparison significantly lower numbers of CD4 GFP+ cells were 
found in the mediastinal lymph nodes of gut-primed and naive mice (G and Primary 
respectively, Fig 3.7B). 
In contrast to the distinct effect of different priming regimens on the lung worm burden of 
reinfected mice, all mice that had received either skin, lung or gut only primary infection 
significantly reduced the numbers of gut dwelling adult L5 at day six following reinfection 
(Fig 3.7 C). This protective effect was associated with high numbers of CD4 GFP+ T cells 
in the mesenteric lymph node (Fig 3.7 D) of all reinfected mice. Interestingly, it would 
appear that lung only priming is sufficient to protect mice from reinfection with the adult 
L5, as mice primed in the lung and reinfected with gut (L5) worms are able to maintain 
protection (Fig 3.8).  
The observation that protection in the lung was only achieved in mice primed with worms 
that migrated through the lungs implies that lung priming is critical for the establishment 
of protective immunity against N. brasiliensis. In contrast, immune protection in the gut 
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Figure 3.7 Protection against reinfection and corresponding immune response in 
tissue specific primed animals. 
G4/IL-4 mice (n=4/group/time point) were infected via skin & lung (S/L), lung only (L), 
gut only (G), complete infection (S/L/G), or remained uninfected (Primary) as described in 
Fig 3.4. At day 30 post infection, mice were reinfected with ~600 N. brasiliensis iL3 A. 
Worm burden in the lung following priming with distinct phases of N. brasiliensis life 
cycle.  At day two post reinfection lungs were excised, worms migrated out and 
enumerated. Values represent mean number of larvae present in the lung ± S.E.M. B. 
GFP+ CD4 T cell responses in mediastinal lymph node during distinct phases of N. 
brasiliensis life cycle. Mediastinal lymph nodes were harvested on day two post 
reinfection and surface stained for CD3 and CD4. Values represent mean cell numbers ± 
S.E.M. C. Worm burden in the gut following priming with distinct phases of N. 
brasiliensis life cycle. At day six post reinfection guts were excised, worms migrated out 
and enumerated. Values represent mean number of larvae present in the gut ± S.E.M. D. 
GFP+ CD4 T cell responses in mesenteric lymph node during distinct phases of N. 
brasiliensis life cycle. Mesenteric lymph nodes were harvested at day six post reinfection 
and surface stained for CD3 and CD4. Values represent mean cell numbers ± S.E.M. Data 
are representative of three independent experiments. Statistics were calculated using one-
way ANOVA with Dunnets post test * P < 0.05 ** P < 0.01 *** P < 0.001. 
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Figure 3.8 Priming in the lung can protect from reinfection in the gut tissues. 
G4/IL-4 mice (n=3/group/time point – last time point n = 1/group) were infected in the 
skin and lung, or the skin/lung and gut as described in Fig 3.4. At 30 days post infection 
mice were reinfected with ~300 gavaged L5 N. brasiliensis worms, also at this time a naïve 
group received ~300 gavaged L5 N. brasiliensis worms to measure any protection 
conferred by previous infection. At the indicated time points mice were sacrificed and gut 
tissues harvested. Worms were migrated out and enumerated. Values represent mean 
number of worms present in the gut ± S.E.M. Statistics were calculated using two-way 
ANOVA with Bonferroni post test and the difference in worm burden between Primary 
infected mice and those receiving a secondary infection (S/L/G and S/L) was significant 
(***) * P < 0.05 ** P < 0.01 *** P < 0.001.  
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could be achieved when the primary infection was restricted to either the lung or gut (Fig 
3.7C). 
3.2.3.3. Priming with dead N. brasiliensis does not confer protection from 
reinfection 
Following on from the characterisation of live N. brasiliensis infection a question was 
raised whether dead N. brasiliensis could act as an antigen depot and prime a protective 
immune response, conferring protection against reinfection with live parasites. To address 
this question mice were injected intradermally in the ear pinnae with ~600 dead iL3 
worms, rested for 30 days and then reinfected with ~600 live iL3. The number of worms 
present in the lung tissue was then assessed using the viable worm recovery assay (as 
described in Chapter 2).  
As seen previously, mice primed with a live infection prior to reinfection were protected 
exhibiting a reduced worm burden within the lung, however animals that had been primed 
with dead iL3 were unprotected(Fig 3.9 A). 
A similar experiment was carried out with the L4 stage lung dwelling larva. Mice were 
primed intranasally (i.n.) with ~200 dead L4, rested for 30 days and then reinfected 
subcutaneously with ~600 live iL3. Mice that had been primed with dead L4 were not 
protected from reinfection when compared to mice that had received a live primary 
infection, animals primed with dead L4 exhibited a worm burden similar to that of mice 
which had a primary infection (Fig 3.9 B). 
Taken together these data show that a live infection is required to generate a protective 
response against N. brasiliensis as priming with dead iL3 or L4 does not confer protection 
against reinfection. 
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Figure 3.9 Infection with dead worms does not confer protection against reinfection 
with N. brasiliensis. 
A. Worm burden in the lung following intradermal priming with dead iL3 N. brasiliensis 
worms. G4/IL-4 mice (n=3) were primed intradermally in the ear with ~600 live or dead 
iL3 N. brasiliensis worms. At 30 days post-infection, mice were reinfected with ~600 iL3 
N. brasiliensis worms. At day two post-reinfection, lungs were excised worms migrated 
out and enumerated. Values represent mean number of worms present in the lung ± S.E.M. 
B. Worm burden in the lung following intranasal infection with dead lung larvae. G4/IL-4 
mice (n=3) were primed with ~200 dead L4 or ~600 iL3 N. brasiliensis worms. At 30 days 
post infection, mice were infected with ~600 iL3 N. brasiliensis worms. At day two post-
reinfection, lungs were excised worms migrated out and enumerated. Values represent 
mean number of worms present in the lung ± S.E.M. Statistics were calculated using one-
way ANOVA with Tukey post test * P < 0.05 ** P < 0.01 *** P < 0.001.  
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3.3. Discussion 
 
The primary aims of the work described in this chapter were to create a robust and unique 
assay to measure priming of immune responses in specific tissues and use the assay to 
assess the role of different tissues in priming for protection against reinfection with N. 
brasiliensis. We have developed a unique assay restricting primary N. brasiliensis 
infection to specific tissue sites during infection. We have used this assay to pinpoint the 
critical peripheral site in conferring protective immunity against N. brasiliensis infection. 
The data in this chapter clearly demonstrate that the lung has the potential to be a very 
important site for conferring protection against reinfection with N. brasiliensis. We show 
that not only is the lung an important site for reducing the numbers of migrating larvae but 
that it is an important site for priming the protective CD4 Th2 immune response that 
occurs in the lung.  
Strikingly, priming in the lung tissue was sufficient to confer gut protective immunity to 
adult stages of the worm. This result indicates that there is a qualitative difference between 
priming in the lung tissue and priming in the gut tissue. Although priming in the gut tissue 
is sufficient to generate Th2 immune responses, protection is not as successful as the 
protection observed when mice are primed in the lung. The fact that only lung priming is 
able to achieve this level of protection indicates that the lung immune environment has a 
unique capacity to generate protective responses that can protect even at a distant site. Our 
conclusions are supported by other findings that suggest the lung is a critical tissue for 
protection from reinfection [160]. Work with schistosome parasites has revealed that there 
exists an important need for pulmonary T lymphocytes in establishing protection using an 
attenuated cercarial vaccination [184, 185]. Studies involving Strongyloides species have 
previously indicated that there is a role for parasites in modulating lung function and 
conferring protection from reinfection [186]. Investigation into immunisation against 
Ascaris migration has found intranasal administration to be most effective in protecting 
against parasite infection [187]. 
Although we found that the skin is not a site of protection or priming for protection in our 
studies, as is commonly thought, this does not mean that it may not be relevant for both 
priming and protection in the natural environment. Although we found limiting the primary 
immune response to the skin (through the injection of dead worms) did not confer 
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protection against reinfection in the lung, it could be imagined that under special 
circumstances of high infection rates or vaccination boosting that lung immunity could be 
generated [3, 161, 188, 189]. 
Priming at the gut site was sufficient to confer local immunity upon reinfection, however it 
did not confer protection against the lung stage parasite. The mechanisms of gut expulsion 
have been a focus of much research in the N. brasiliensis field, with roles for CD4 T cells, 
IL-4, IL-13 and STAT 6 being confirmed [157-159]. The finding that the gut is not a 
critical site for protection offers new avenues for the study of protective immunity against 
N. brasiliensis infection. 
3.4. Conclusions 
 
The aims of this chapter were to develop an assay to isolate tissue priming in the N. 
brasiliensis model and to use this model to assess the role of different tissues in priming 
protective immune responses. The development of a model assay using segregated priming 
infection has enabled us to dissect out the relative contributions of priming at the 
peripheral sites of migration to protective immunity.  
We have shown the lung to be an important site for immune priming to confer protective 
immunity. We find not only that worm numbers are reduced within lung tissues during 
reinfection, but also that it is an important site for priming the immune response to respond 
to reinfection both locally and at distant sites. We have provided strong evidence that the 
skin is not a candidate for the site of protective immunity using in vitro and in vivo 
methods. Priming at the gut site, while able to confer local immunity to reinfection, does 
not appear to be as critical as the lung, which can protect both locally and at a distant site. 
 
4. Chapter 4:  
Contribution of the lymph node vs lung CD4 T cell 
response in protection against N. brasiliensis 
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4.1. Introduction 
The studies outlined in chapter three reveal that primary infection in the lung tissue is 
important in the generation of protective immunity against N. brasiliensis. Mice primed 
solely at the lung site were protected from reinfection both locally and at the distant gut 
site. In this chapter we sought to build on this finding by exploring whether the cellular 
responses underpinning this protective immunity were occurring in the lung tissue itself or 
if they were reliant upon T cells derived from the local draining lymph node circulating via 
the blood. As a control we also investigated if our findings were specific to our N. 
brasiliensis model by comparing to a lung based Th1 mediated model of protective 
immunity. 
4.1.1. Immune responses of the lung 
The lung is a unique environment, heavily vascularised with a good supply of blood, 
circulating immune cells and also direct interaction with environmental antigen. The 
ability of the body to form iBALT [71, 83, 190] shows that immune responses can occur 
within the lung tissue, and mice that lack secondary lymphoid organs have been shown to 
generate lung based immune responses [70]. This data demonstrates that immune 
responses can occur within lung tissues, but how relevant are these immune responses to 
protective immunity? Moyron-Quiroz et al demonstrate protection in a viral model of 
infection, proposing that iBALT provided a niche for the maintenance of the memory T 
cell population [70]. The experiments contained within this chapter assess the role of 
immune responses mounted in the tertiary lymphoid tissues (the lung in our model) in 
conferring protective immunity against N. brasiliensis. 
To assess the roles of CD4 T cell responses in the lung and lymph nodes in protective 
immunity against N. brasiliensis we needed to separate the CD4 T cell responses of the 
two tissues. The immunosuppressant drug FTY720 has been shown to prevent lymphocyte 
recirculation by preventing egress into the blood from the secondary lymphoid tissues 
[125]. Several studies have effectively used FTY720 to prevent lymphocyte recirculation 
[101, 150] and it has been used with mixed success in a variety of disease models. FTY720 
has been demonstrated to delay graft rejection caused by Graft Versus Host Disease 
(GVHD) [145, 147, 148], prevent Th1 and Th2 mediated colitis [137, 149], suppress Th1 
and Th2 induced airway inflammation [151] and FTY720 also shows promise in the 
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treatment of multiple sclerosis [153, 154], with the drug currently in phase III clinical 
trials. We sought to take advantage of the unique properties of FTY720 to separate T cell 
responses of the lung tissue and the corresponding draining lymph node. 
To control for our findings in the N. brasiliensis model, we wanted to look at the effects of 
separating secondary and tertiary lymphoid responses in a Th1 mediated lung model of 
protective immunity. In the murine model of Mycobacterium tuberculosis infection, BCG-
vaccinated mice exhibit a one log10 reduction in their lung bacterial burden upon 
subsequent exposure to aerosolised M. tuberculosis, compared to naïve mice [191]. The 
protection observed in vaccinated mice is dependent on T helper 1 (Th1) CD4 T cell 
responses [192, 193], and the production of IFNγ [194]. 
This makes the BCG model of protective immunity a good candidate to control for our 
findings in the Th2 mediated N. brasiliensis model of protective immunity. 
4.1.2. Aims 
The following series of experiments were undertaken to first establish the concentration of 
FTY720 required to sequester lymphocytes into lymph nodes, thus blocking CD4 T cell 
recirculation between lung and lymph node. Upon establishing this model the effects of 
blocking CD4 T cell recirculation between lung and lymph node during N. brasiliensis 
infection were investigated, by assessing the impact of FTY720 treatment on worm burden 
in both primary and secondary infections. The final experiments within this series were 
aimed at addressing the changes in immune response mounted against N. brasiliensis 
infection after segregation of secondary and tertiary lymphoid responses. Results obtained 
using the N. brasiliensis model were then compared to a BCG model of lung based Th1 
mediated protective immunity. 
Specific aims: 
• To block circulation of CD4 T cells between the lymph node and lung using the 
drug FTY720 
• To assess the effects of blocking CD4 T cell circulation between the lymph node 
and lung in the N. brasiliensis model, on both protection from reinfection and the 
cellular immune response to N. brasiliensis 
• To compare our findings in the N. brasiliensis model with a lung based Th1 
mediated model of protective immunity 
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4.2. Results 
4.2.1. FTY720 administration in vivo sequesters CD4 T cells  
To test whether CD4 T cells were sequestered to the lymph nodes by FTY720 treatment 
FTY720 was administered by oral gavage in a volume of 200µL to G4/IL-4 mice. Mice 
received one dose of FTY720 treatment at 1.0, 0.5 or 0.1mg/kg and were bled an hour after 
treatment for time zero. The resulting lymphopenia in the blood over time is shown in Fig 
4.1. It was found that FTY720 treatment resulted in a decreased number of CD4 T cells 
very rapidly (within an hour of the first treatment) and at higher concentrations this effect 
was prolonged. Although reversible, the effects of high doses of FTY720 took between 
seven and fourteen days to dissipate. Figs 4.1B-D show the effects of FTY720 treatment 
on the cell populations in the lungs of naïve animals. Treatment with FTY720 for one, two 
or three days resulted in a loss of CD4 T cells from the lung and airways (Fig 4.1B), 
although the total numbers of CD45+ cells remained relatively unchanged (Fig 4.1C) as 
compared to untreated animals. In naïve FTY720 treated animals there are very few 
GFP+/IL-4 producing CD4 T cells as demonstrated in Fig 4.1D. 
As a result of these experiments a dose of 0.5mg/kg was used, as this dose induced rapid 
and prolonged lymphopenia. To ensure this dose was effective over time, animals were 
treated daily to separate secondary and tertiary residing lymphocytes and hence the 
immune responses of the secondary and tertiary lymphoid tissues. 
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Figure 4.1 FTY720 depletes circulating and lung residing CD4 T cells. 
A. Effects of FTY720 on circulating CD4 T cells. G4/IL-4 mice (n=3/group) received 1.0 
(squares), 0.5 (triangles), 0.1 (inverted triangles) mg/mL FTY720 or did not receive drug 
(control, diamonds) at day 0. At the indicated time points mice were tail bled, the resulting 
cells were stained with αTCR αB220 and αCD4 and FACs analysis was performed using a 
four colour flow cytometer. Values represent the mean number of CD4 T cells/mL of 
blood± S.E.M. Statistics were calculated using repeated measures two-way ANOVA with 
Bonferroni post test and FTY720 treated groups had significantly fewer CD4 T cells/mL 
(***) compared to control mice * P < 0.05 ** P < 0.01 *** P < 0.001. Both 0.5mg/kg and 
1.0mg/kg treatments significantly differed (*) from control. B - D. FTY720 treatment 
reduces the number of T cells resident in the lung. G4/IL-4 mice (n=3 per group) were 
treated with FTY720 (0.5mg/mL) for 0, 1, 2 or 3 days. Lungs were harvested, enriched for 
CD45+ cells by AutoMacs© bead separation and the resulting cells surface stained for 
CD4, CD62L and CD44 expression. FACs analysis was performed using a four colour 
flow cytometer.  Values represent the number of CD4 T cells (B) CD45+ cells (C) or 
GFP+ CD4 T cells (D) in the lung tissue ± S.E.M. Statistics were calculated using one-way 
ANOVA with Dunnets post test * P < 0.05 ** P < 0.01 *** P < 0.001. 
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4.2.1.1. Profile of lung residing CD4 T cells after FTY720 administration in 
naive mice. 
Once an effective dose for FTY720 treatment was established we wanted to look at the 
activation phenotype of any remaining tissue resident T cells. The activation profile of 
lung T cells in naïve mice either with or without FTY720 treatment is presented in Fig 4.2. 
Untreated naïve mice exhibit a large population of CD62Lhi CD44lo CD4 T cells –
consistent with a naïve phenotype and also a smaller CD62Llo CD44hi population more 
consistent with an effector phenotype. FTY720 treatment reduces the population of 
CD62Lhi CD44lo naïve like cells, consistent with reports in the literature [101, 102], 
however the effector like CD62Llo CD44hi population does not appear similarly affected 
by treatment. When observing GFP+ CD4 T cells they are spread between naïve and 
effector phenotypes – implying background measurements of GFP expression (Fig 4.2B). 
These results show that FTY720 treatment reveals a population of lung resident T cells. 
4.2.2. FTY720 treatment affects the number of circulating T cells during 
N. brasiliensis infection 
With the knowledge that FTY720 treatment prevents the recirculation of CD4 T cells in 
naïve animals we sought to confirm this effect during N. brasiliensis infection. In FTY720 
treated mice there is up to a 10 fold reduction in the numbers of circulating CD4 T cells 
during both primary and reinfection when compared to control animals (Fig 4.3B), 
although total numbers of circulating cells are similar between groups (Fig 4.3A). 
Interestingly when we looked at the proportions of CD4 T cells that were GFP+ in 
FTY720 treated animals receiving a secondary infection with N. brasiliensis (Fig 4.3C) we 
found an overrepresentation of GFP+ cells in drug treated animals. The proportion of 
GFP+ cells is almost double in FTY720 treated animals, however this finding must be 
assessed in respect of the fact that the numbers of GFP+ cells circulating in drug treated 
mice will still be significantly lower due to the reduction in the number of circulating CD4 
T cells seen in Fig 4.3B.  
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Figure 4.2 Profile of CD4 T cells in the lungs of naïve mice with and without FTY720 
treatment. 
G4/IL-4 mice (n=3 per group) were treated with FTY720 (0.5mg/mL) for 0 or 3 days. 
Lungs were harvested, enriched for CD45+ cells by AutoMacs© bead separation and the 
resulting cells surface stained for CD4, CD62L and CD44 expression. FACs analysis was 
performed using a four colour flow cytometer. FACs plots display cells from one 
representative animal. A. FTY720 treatment preferentially reduces naïve T cells in the lung 
tissues. Values represent proportion of CD4 T cells that are Teff/Tem like (CD44hi 
CD62Llo - green) or naïve (CD44lo CD62Lhi - pink). For number of events see Fig 4.1B 
B. Phenotype of GFP+ CD4 T cells in the lungs of FTY720 treated and naïve mice. Values 
represent proportion of CD4 T cells that are Teff/Tem like (CD44hi CD62Llo - green) or 
naïve (CD44lo CD62Lhi - pink). For number of events see Fig 4.1D. Data is representative 
of at least two independent experiments. 
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Figure 4.3 T cells in the blood during N. brasiliensis infection with FTY720 treatment. 
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G4/IL-4 mice (n=3/group, pooled) were infected with N. brasiliensis and also treated with 
FTY720 (1mg/kg) daily from one day prior to infection (open squares) or untreated (closed 
squares). At day 30 post infection mice were reinfected with N. brasiliensis. At the 
indicated time points blood was collected, red blood cells lysed and FACs analysis 
performed using a four colour flow cytometer. A. The total number of cells present in the 
blood of FTY720 treated and untreated N. brasiliensis infected mice is similar. Values 
represent the total number of live cells per mL of blood as counted under the microscope 
by trypan blue exclusion. Presented data is mean and S.E.M of three combined 
independent experiments (n=6-9/group total). Statistics were calculated using a non-
parametric Mann-Whitney test * P < 0.05 ** P < 0.01 *** P < 0.001. B. CD4 T cell 
numbers are reduced in the blood of FTY720 treated N. brasiliensis infected mice. Values 
represent the number of CD4 T cells per mL of blood. Presented data is mean and S.E.M 
of three combined independent experiments (n=6-9/group total). Statistics were calculated 
using a non-parametric Mann-Whitney test * P < 0.05 ** P < 0.01 *** P < 0.001. C. GFP+ 
cells are over represented in FTY720 treated N. brasiliensis reinfected mice. Values 
represent the number of GFP+ cells as a percent of the CD4 T cell population in a pooled 
sample from n=3 mice. Animals receiving FTY720 treatment have a significantly higher 
(*) percentage of GFP+ CD4 T cells, compared to mice that remain untreated. Data are 
representative of two independent experiments. Statistics were calculated using paired 
Student’s t test * P < 0.05 ** P < 0.01 *** P < 0.001. 
 
 
Chapter 4: Contribution of the lymph node vs lung CD4 T cell response in protection against N. brasiliensis 
 89 
4.2.3.  Worm burden in the N. brasiliensis model is unaffected by 
FTY720 treatment 
4.2.3.1. FTY720 administration does not affect primary worm burden or 
clearance in N. brasiliensis model 
In order to investigate the effect of blocking CD4 T cell recirculation between lung and 
lymph node on worm clearance during primary N. brasiliensis infection, mice were treated 
with 0.5mg/kg FTY720 daily (or left untreated) prior to infection with N. brasiliensis. At 
the peak time of infection in the lung (day two post infection) and gut (day six post 
infection) these tissues were harvested and the worms migrated out using a viable worm 
recovery assay. The number of viable worms recovered from the lung and gut during 
primary N. brasiliensis infection demonstrated no difference between treated and untreated 
mice (Fig 4.4A). In fact when a kinetic analysis of worm burden/migration was followed 
during FTY720 treatment no difference was observed in timing of migration or expulsion 
of adult worms from the host when compared to untreated control mice (Fig 4.4B). 
These results indicate that blocking CD4 T cell recirculation between lung and lymph node 
does not alter the migration pattern or expulsion kinetics of N. brasiliensis worms during 
primary infection.  This finding also suggests that the drug FTY720 does not directly affect 
the worms themselves. 
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Figure 4.4 FTY720 does not affect worm burden or migration kinetics during 
primary N. brasiliensis infection. 
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A. No difference in worm burden of lung or gut with FTY720 treatment during primary N. 
brasiliensis infection. G4/IL-4 mice (n=3/group/time point) were infected with N. 
brasiliensis and either remained untreated (control – black bars) or were treated with 
FTY720 from one day prior to infection (grey bars). Lungs were harvested two days post 
infection and guts at day 6 post infection. Worms were recovered from the tissues using 
the viable worm recovery assay (described in chapter two, materials and methods) and 
enumerated. Values represent mean number of larvae present in the tissue ± S.E.M. Data 
are representative of at least two independent experiments. Statistics were calculated for 
each tissue using Student’s t test * P < 0.05 ** P < 0.01 *** P < 0.001 B. No difference in 
kinetics of worm migration during primary N. brasiliensis infection with FTY720 
treatment. G4/IL-4 (n=4/group/time point) were infected with N. brasiliensis and either 
remained untreated (control – squares) or were treated with FTY720 from one day prior to 
infection (triangles). At the indicated time points lung (closed shapes) and gut (open 
shapes) tissues were harvested, worms migrated and enumerated. Values represent mean 
number of larvae present in the tissue ± S.E.M. Statistics were calculated for each tissue 
using two-way ANOVA with Bonferroni post test * P < 0.05 ** P < 0.01 *** P < 0.001. 
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4.2.3.2. FTY720 administration does not affect protection against reinfection in 
N. brasiliensis model 
As we observed no difference in kinetics of migration or expulsion during primary N. 
brasiliensis infection, we wanted to investigate whether prevention of T cell migration 
from the lymph nodes to the lung with FTY720 would affect protection from reinfection 
with N. brasiliensis. To answer this question mice were treated daily with 0.5mg/kg 
FTY720 from prior to primary infection until sacrificed, and 30 days after primary 
infection reinfected with N. brasiliensis. To assess levels of protection tissues were 
harvested at times consistent with peak worm burden (day two for lung and day six for gut) 
and viable worms migrated out and counted. Untreated mice with a primary N. brasiliensis 
infection were used to measure the levels of protection achieved in both FTY720 treated 
and untreated mice receiving a reinfection (or challenge). Lung data (Fig 4.5A) 
demonstrated no difference in the level of protection achieved between FTY720 treated 
and untreated mice when compared to primary infected control animals. A similar 
observation was found in the gut burden (Fig 4.5B).  
These experiments demonstrate that separation of lymph node T cell responses from local 
lung T cell responses does not alter protective immunity against N. brasiliensis. The 
implications of this finding are that a locally developed immune response is able to confer 
protection against reinfection in this model of protective immunity. 
4.2.3.3. Timing of FTY720 administration does not affect protection against 
reinfection in N. brasiliensis model 
Experiments were undertaken to investigate whether blocking CD4 T cell recirculation 
between lung and lymph node at varying times during N. brasiliensis infection has an 
impact on protective immunity. N brasiliensis infected mice were treated with FTY720 
prior to priming of an immune response, prior to challenge, or both and their protection 
from reinfection compared to untreated animals. Using the viable worm recovery assay 
worms were recovered from the lungs and guts at times of peak infection (as previously 
determined). As shown in Fig 4.6, mice were protected from reinfection when compared to 
primary N. brasiliensis infected controls, and this protection remained intact whether they 
had received FTY720 during primary infection, reinfection, both or were untreated. 
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This data confirms that blocking CD4 T cell recirculation between lung and lymph node 
does not affect protection from reinfection with N. brasiliensis, implying that protective 
responses can be initiated at the lung site. 
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Figure 4.5 FTY720 treatment does not affect protection against reinfection with N. 
brasiliensis.  
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FTY720 treatment does not affect protection against reinfection with N. brasiliensis in the 
lung or gut. G4/IL-4 mice (n=3 per group per time point) were infected with ~600 iL3 N. 
brasiliensis and either remained untreated (control – black bars) or were treated with 
FTY720 from one day prior to infection (grey bars). After 30 days mice were reinfected 
with~600 N. brasiliensis and a further group of naïve mice were infected with ~600 iL3 N. 
brasiliensis subcutaneously at the same time to allow for measurement of protection 
(primary – white bars). A. At two days post reinfection lung tissues were harvested, worms 
were migrated and enumerated. B. At six days post reinfection gut tissues were harvested, 
worms were migrated and enumerated. Values represent mean number of larvae present in 
the tissue ± S.E.M. Data representative of at least 3 independent experiments. Statistics 
were calculated using one-way ANOVA with Dunnets post test * P < 0.05 ** P < 0.01 *** 
P < 0.001. 
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Figure 4.6 FTY720 administration does not affect protection against reinfection with 
N. brasiliensis regardless of time of treatment. 
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G4/IL-4 mice (n=3/group/time point) were infected with N. brasiliensis and either 
remained untreated (white and black bars) or were treated with FTY720 (grey bars). Mice 
receiving FTY720 had several treatment regimes; FTY720 during primary infection only 
(1°, day -one to day nine of infection), FTY720 during reinfection only (2°, day 29 until 
sacrifice) or FTY720 during entire infection (1° & 2°, FTY720 from day -one to sacrifice). 
At 30 days post infection mice were reinfected with N. brasiliensis and a further group of 
naïve mice were infected with N. brasiliensis at the same time to allow for measurement of 
protection (primary – white bars). A. FTY720 treatment does not affect protection against 
reinfection with N. brasiliensis in the lung. Two days post reinfection lung tissues were 
harvested, worms were migrated and enumerated. Values represent mean number of larvae 
present in the tissue ± S.E.M. B. FTY720 treatment does not affect protection against 
reinfection with N. brasiliensis in the gut. Six days post reinfection gut tissues were 
harvested, worms were migrated and enumerated. Values represent mean number of larvae 
present in the tissue ± S.E.M. Data are representative of at least two independent 
experiments. Statistics were calculated using one-way ANOVA with Tukey post test * P < 
0.05 ** P < 0.01 *** P < 0.001. 
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4.2.4. The effects of FTY720 treatment on CD4 T cell responses against 
N. brasiliensis 
Immune responses usually follow a pattern after infection; an expansion phase 
characterised by the generation of effector cells from specific naïve precursors to combat 
infection, followed by a contraction phase where effector cells die off and memory is 
established. Upon reinfection an immune response tends to be faster and of greater 
magnitude, clearing the pathogen before it has time to establish. To build on the discovery 
that separation of lung and lymph node CD4 T cell responses did not alter protection 
against reinfection with N. brasiliensis, we investigated the effects of FTY720 treatment 
on the CD4 T cell response against N. brasiliensis. 
4.2.4.1. FTY720 administration during N. brasiliensis infection reduces 
magnitude but not pattern of lymph node response 
Investigation of the Th2 immune response against N. brasiliensis in the mediastinal (med) 
lymph node, as measured by GFP+ CD4 T cells, showed the expected trend in untreated 
animals (Fig 4.7A - left hand panel). An expansion of GFP+ cells was observed during the 
primary response, followed by a contraction to a baseline level and then upon reinfection a 
fast expansion of T cells up to a three fold greater magnitude than the initial primary 
response. 
When mice were treated with FTY720 (Fig 4.7A - right hand panel) the overall magnitude 
of response was reduced, with the total number of GFP+ CD4 cells during both primary 
infection and reinfection more than four times less than that seen in the untreated animals. 
However the general pattern of expansion and contraction followed by an enhanced re-
expansion upon reinfection remained, with a four-fold increase in GFP+ Th2 cells after 
reinfection when compared to primary infection.  
This data shows that treatment with FTY720 decreased the magnitude of the N. 
brasiliensis induced Th2 response in the med lymph node, but did not affect the generation 
of primary and secondary responses. 
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Figure 4.7 FTY720 treatment affects generation of primary immune responses in the 
lungs of N. brasiliensis infected mice. 
G4/IL-4 mice (n=3/group/time point) were infected with N. brasiliensis and either 
remained untreated (black bars) or were treated with FTY720 from one day prior to 
infection (grey bars). At 30 days post infection mice were reinfected with N. brasiliensis. 
Mediastinal lymph nodes and lung tissues were harvested during primary infection (day 
nine post infection), prior to reinfection (baseline – day 39 post infection) and during 
reinfection (day 36 post infection) and also from naïve animals. A. FTY720 treatment 
affects the magnitude but not the pattern of Th2 response in the mediastinal lymph node. 
Cells were isolated from the lymph nodes by enzymatic digestion before being stained and 
analysed by four colour flow cytometry. Values represent the number of GFP+ cells 
present in the CD4 T cell population of the mediastinal lymph node ± S.E.M. Data is from 
two combined experiments (n=4-9/group). Statistics were calculated using one-way 
ANOVA with Tukey post test * P < 0.05 ** P < 0.01 *** P < 0.001 B. FTY720 treatment 
affects the magnitude and the pattern of Th2 response in the lung. Cells were isolated from 
the lungs by enzymatic digestion and enriched for CD45+ cells by AutoMacs© bead 
separation before being stained and analysed by four colour flow cytometry. Values 
represent the number of GFP+ cells present in the CD4 T cell population of the lungs ± 
S.E.M. Data representative of at least two independent experiments. Statistics were 
calculated using one-way ANOVA with Tukey post test * P < 0.05 ** P < 0.01 *** P < 
0.001 
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4.2.4.2. FTY720 administration during N. brasiliensis affects the generation of 
primary CD4 T cell responses in the lung 
We next assessed the effects of FTY720 treatment on the generation of a Th2 response in 
the relevant tertiary lymphoid tissue for this model – the lung. Fig 4.7B (left hand panel) 
shows the Th2 response as measured by GFP+ CD4 T cells in the lung of untreated N. 
brasiliensis infected mice. Primary infection generated an expansion of GFP+ CD4 T cells 
above the level of naïve animals, followed by a contraction (seen prior to challenge) and 
upon reinfection, an expansion of GFP+ Th2 cells almost three times greater than during 
primary infection.  
When FTY720 treated mice were compared to the untreated N. brasiliensis infected mice 
we saw very little evidence of an expansion during the primary infection in FTY720 
treated mice, as the number of GFP+ CD4 cells was very similar to that seen in naïve 
animals (Fig 4.7B – right hand panel). However, there does seem to be a contraction stage 
and post reinfection the numbers of GFP+ CD4 T cells are increased 10 fold from those 
seen in the lung during primary infection.  
These results show that FTY720 treatment has affected the local response in the tertiary 
lymphoid tissue, causing a reduced primary response against N. brasiliensis. Interestingly, 
drug treatment did not prevent a more successful expansion of cells upon reinfection, 
suggesting that these cells were not recruited from the lymph node but expanded from an 
existing population of cells. 
4.2.4.3. FTY720 administration during N. brasiliensis infection reduces 
magnitude but not pattern of skin CD4 T cell response 
We next assessed the effect of FTY720 treatment at a tertiary site that is irrelevant for 
protective immunity in this model, the skin (see chapter 3). In previous experiments we 
had seen a difference in secondary and tertiary lymphoid responses against N. brasiliensis. 
When animals were treated with FTY720, we found secondary lymphoid responses 
decreased in magnitude but the pattern of expansion, contraction and re-expansion 
remained intact. Tertiary lymphoid responses in the lung (the site of protective priming in 
this model) were found to be of decreased magnitude and also deviated from the expected 
expansion/contraction/expansion immune response pattern, generating an expanded 
secondary response after a minimal primary response. In order to see whether this response 
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held true for all tertiary lymphoid tissues in this model, we investigated the effect of 
FTY720 treatment on the Th2 immune response in the skin after N. brasiliensis infection, 
as measured by GFP+ CD4 T cell numbers. 
We found that FTY720 treatment during N. brasiliensis infection reduced the magnitude of 
response at the skin site during primary and secondary infection. However, the expansion 
of Th2 cells upon reinfection was three fold greater than that of the primary response, the 
same as that seen in untreated N. brasiliensis infected animals, in contrast to my findings in 
the lung where a 10 fold expansion of Th2 cells was observed in FTY720 treated animals. 
These results show that the Th2 response at the skin site is decreased in magnitude but 
does not show a change in the overall relationship between immune cell expansion/ 
contraction and parasite infection/clearance with FTY720 treatment that was seen in the 
lung. In conjunction with the previous data this suggests that there is something unique 
about the lung-based immune response in this model, as prevention of lymphocytes 
trafficking to this tissue, although diminishing a primary Th2 immune response, does not 
prevent the generation of an enhanced local secondary immune response capable of 
protecting against reinfection with N. brasiliensis. 
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Figure 4.8 FTY720 treatment does not affect immune responses to N. brasiliensis in 
the skin. 
A. Th2 immune response in the skin of N. brasiliensis infected mice. G4/IL-4 mice (n = 
3/group/time point) were infected intradermally with N. brasiliensis. Ear tissues were 
harvested during primary infection (day 9 post infection) and also during reinfection (day 6 
post reinfection) and also from naïve animals. Ears were enzymatically digested and the 
resulting cells stained for four colour flow cytometric analysis. Values represent the 
number of GFP+ CD4 T cells present in the ear ± S.E.M. B. Th2 immune response in the 
skin of N. brasiliensis infected FTY720 treated mice. G4/IL-4 mice (n = 3/group/time 
point) were treated with FTY720 from one day prior to intradermal infection with N. 
brasiliensis. Ear tissues were harvested during primary infection (day nine post infection) 
and also during reinfection (day six post reinfection) and also from naïve animals. Ears 
were enzymatically digested and the resulting cells stained for four colour flow cytometric 
analysis. Values represent the number of GFP+ CD4 T cells present in the ear ± S.E.M. 
Statistics were calculated using one-way ANOVA with Tukey post test * P < 0.05 ** P < 
0.01 *** P < 0.001 
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4.2.5. Blocking recirculation of CD4 T cells between lung and lymph 
nodes in a Th1 model of lung mediated protective immunity 
To see if our findings were relevant to other lung models of protective immunity we 
wanted to compare our findings with the N. brasiliensis model in a Th1 mediated model of 
lung protective immunity. We chose the BCG model as it is dependent on both CD4 and 
IFNγ. Previously we have shown the effects of FTY720 treatment on N. brasiliensis 
infection; here we show the effects of FTY720 administration during BCG vaccination and 
challenge.  
4.2.5.1. FTY720 treatment inhibits T cell recirculation during BCG 
vaccination 
Initially, to confirm the FTY720 mediated sequestering of lymphocytes in the lymph nodes 
during BCG vaccination, mice were tail bled and the proportion of CD4+ T cells in the 
circulation were assessed by flow cytometry (Fig 4.9). FTY720 treatment reduced CD4 T 
cells as a percentage of recirculating lymphocytes approximately 10 fold from 20 % to 2 
%. 
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Figure 4.9 FTY720 treatment reduces circulating CD4 T cells after BCG vaccination 
C57BL6 mice (n= 5/group) were untreated or treated with FTY720 (1.0mg/kg) from the 
day prior to subcutaneous vaccination with 1 x 106 CFU. Blood was collected from the tail 
vein at the indicated time point, red blood cells lysed and resulting cells stained for four 
colour flow cytometric analysis. Cells were gated on lymphocyte population using forward 
and side scatter and CD4 T cells were assessed as a percentage of the lymphocyte 
population. Values represent percentage of CD4 T cells present in the lymphocyte 
population of the blood ± S.E.M. Statistics were calculated using a non-parametric Mann-
Whitney test* P < 0.05 ** P < 0.01 *** P < 0.001. 
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4.2.5.2. Blocking recirculation of CD4 T cells between lung and lymph nodes 
during primary BCG intranasal infection inhibits protection 
To test the effects of blocking CD4 T cell recirculation between lung and lymph node 
during primary infection with BCG, mice were treated with FTY720 prior to intranasal 
infection with BCG and the resulting bacterial burden compared to that of untreated BCG 
infected mice. 
FTY720 treated mice received 1mg/kg FTY720 daily by oral gavage from one day prior to 
intranasal infection with 106 colony forming units (CFU) BCG. At various time points post 
infection spleen, lung and liver were harvested, homogenised and plated onto selective 
7H11 supplemented agar plates to allow growth of bacteria. Bacteria were detected in lung 
homogenates as early as four days post infection and from day 25 post infection bacteria 
were grown from the homogenised spleen and liver tissue also. Fig 4.10 shows the 
bacterial burden in the spleen, liver and lungs of FTY720 treated and untreated animals at 
day 28 post infection and it can be seen that FTY720 treated animals have a heavier 
bacterial burden in all tissues. 
This data suggests that blocking CD4 T cell recirculation between lung and lymph node 
did not initially affect the bacterial load. However, over the course of the infection 
FTY720 treated mice that were unable to recruit lymphocytes from the secondary 
lymphoid organs were unable to control the BCG infection as well as control mice. This 
result indicates that T cell recruitment from the lymph node during primary BCG infection 
is important to control infection and limit dissemination. 
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Figure 4.10 FTY720 administration during primary BCG infection leads to increased 
bacterial dissemination. 
C57BL6 mice (n = 5/group) remained untreated or were treated with 1mg/kg FTY720 by 
gavage from the day prior to infection with 1 x 106 CFU BCG i.n. At 28 days post 
infection mice were sacrificed and lungs, livers and spleens harvested. Tissues were 
homogenised and plated on selective media to determine bacterial growth. Values 
represent the mean number of CFU per tissue ± S.E.M. Data are representative of at least 
two independent experiments. Statistics were calculated for each tissue using Student’s t 
test * P < 0.05 ** P < 0.01 *** P < 0.001. 
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4.2.5.3. Blocking CD4 T cell recirculation between lung and lymph node 
during BCG infectious challenge does not affect protection 
To further investigate the contribution of lymph node and lung CD4 T cell responses to 
protective immunity against BCG, experiments were carried out blocking the recirculation 
of CD4 T cells during vaccination and challenge. Treatment with FTY720 during 
vaccination, challenge or both aimed to explore when T cell trafficking between lymph 
node and lung tissues might be required to confer protection. 
Daily FTY720 treatment was established to prevent trafficking of CD4 T cells from lymph 
nodes to lung during vaccination, challenge or both (detailed in experimental design Fig 
4.11). To allow activated T cells to enter a resting memory phase and clear chronic 
bacterial infection all mice were treated with the antibiotic isoniazid for a duration of four 
weeks, beginning four weeks post vaccination. To allow normal recirculation prior to 
challenge infection, FTY720 treatment was ceased five weeks post vaccination. After 
challenge infection with 104 CFU BCG, mice were sacrificed and their lungs were 
homogenised and plated on 7H11 selective agar plates to allow bacterial growth. 
Growth of bacteria in the lungs of FTY720 treated and untreated, BCG vaccinated and 
challenged mice, was compared to bacterial growth in unvaccinated BCG challenged 
animals in order to observe protection conferred by vaccination (Fig 4.12). Mice that had 
been vaccinated and challenged with BCG exhibited a 4.5 fold reduction in bacterial 
burden compared to unvaccinated controls. Interestingly, mice that had received FTY720 
treatment only during challenge had an eight fold reduction in bacteria in the lungs. 
However, animals that had FTY720 treatment during vaccination or during both 
vaccination and challenge were unprotected – exhibiting similar levels of bacterial growth 
to unvaccinated control mice. 
These results show that the blocking CD4 T cell recirculation between lung and lymph 
node during vaccination can impact on the protection conferred; suggesting that a 
population of T cells derived from the lymph node during vaccination is important for 
protective immunity against BCG. This data also suggests that during challenge there is no 
requirement for lymph node derived T cells to confer protection, indicating that the 
population of protective cells has migrated to the lung tissue after vaccination but before 
challenge. 
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Figure 4.11 Experimental design to assess the effects of blocking CD4 T cell 
recirculation between lung and lymph nodes during BCG vaccination and challenge. 
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C57BL6 mice (n= 5/group/time point) were vaccinated s.c. with 1 x106 CFU BCG at day 
zero. Four weeks post vaccination (day 28) mice received the antibiotic isoniazid in their 
drinking water (1mg/ml) to clear any residual bacteria resulting from vaccination and at 
day 64 post vaccination mice were intranasally challenged with 1 x 104 CFU BCG. At the 
time of intranasal challenge a previously unvaccinated group was included to assess any 
protection conferred by BCG vaccination. Within BCG vaccinated and challenged animals 
several groups of mice were established to assess the effects of treatment with 1mg/kg 
FTY720 by daily gavage. These mice received FTY720 treatment only during primary 
infection (day -1 to day 35), only during challenge infection (from the day prior to 
challenge, day 63 to time of sacrifice), during both primary and challenge infection or not 
at all. At the indicated time points (red stars), mice were sacrificed and tissues harvested to 
assess bacterial burden or tissue immune response. 
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Figure 4.12 Effects of FTY720 administration on protection: a comparison of the 
BCG and N. brasiliensis models. 
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A. C57BL6 mice (n = 5/group/time point) were vaccinated and challenged with BCG 
(black bar), and treated with FTY720 as described in Fig 4.11 (grey bars). An unvaccinated 
group was challenged at the same time as vaccinated groups to measure protection 
conferred by vaccination (white bar). At day 28 post BCG challenge, lung tissues were 
harvested, homogenised and plated on selective agar plates to assess bacterial load. Values 
represent mean bacterial load in the lung tissue ± S.E.M. Data are representative of at least 
two independent experiments. B. G4/IL-4 mice (n=3/group/time point) were infected with 
N. brasiliensis and either remained untreated (black bar) or were treated with FTY720 
(grey bars). Mice receiving FTY720 had several treatment regimes as described in Fig 4.6. 
After 30 days mice were reinfected with N. brasiliensis and a further group of naïve mice 
were infected at the same time to allow for measurement of protection (white bar). At two 
days post reinfection lung tissues were harvested, worms were migrated and enumerated. 
Values represent mean number of larvae present in the tissue ± S.E.M. Data representative 
of at least two independent experiments. Statistics were calculated using one-way ANOVA 
with Tukey post test * P < 0.05 ** P < 0.01 *** P < 0.001. 
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4.2.5.4. The effects of blocking CD4 T cell recirculation from the lymph node 
on the lung immune response against BCG 
Blocking CD4 T cell recirculation between lung and lymph node using FTY720 in the N. 
brasiliensis model altered the pattern of the lung but not lymph node CD4 T cell responses. 
Our findings in the N. brasiliensis model showed a decrease in the number of IL-4 
producing T cells in the lung during primary infection, with a 10 fold increase upon 
reinfection in FTY720 treated animals (Fig 4.7B, Fig 4.13D). The following experiments 
assess the effects of FTY720 treatment on the lung response to BCG vaccination and 
challenge, showing data from mice receiving FTY720 treatment during vaccination and 
challenge. 
Lung tissues were harvested from BCG vaccinated and challenged mice at several time 
points during vaccination and challenge (as described in Fig 4.11). Single cell suspensions 
were prepared from the collagenase digested lung tissue and the resulting cells cultured in 
the presence of M. bovus culture filtrate protein (CFP) overnight. The cultured cells were 
stained intracellularly to measure the antigen specific production of IFNγ (Fig 4.13A and 
B).  
Control infected animals (Fig 4.13A) show the classic immune response pattern, with IFNγ 
producing CD4 T cells expanding during vaccination then contracting before expanding 
again following challenge infection. This result mirrors that seen in N. brasiliensis infected 
mice (Fig 4.7 and 4.13C). In the lung tissue of FTY720 treated animals (Fig 4.13B) there is 
an expansion of IFNγ+ CD4 T cells during primary vaccination but unusually no 
contraction is observed prior to challenge (baseline). This may be explained by increased 
recirculation due to the rest from FTY720 treatment in this model (Fig 4.11). Upon 
reinfection a five fold expansion of IFNγ producing T cells is observed, although this is not 
sufficient to protect from challenge infection (Fig 4.12). This result differs from that seen 
in the lungs of N. brasiliensis infected FTY720 treated mice where there is a minimal CD4 
T cell primary immune response barely above the background observed in naïve mice 
followed by a ten fold increase upon reinfection (Fig 4.7 and 4.13D). 
This experiment demonstrates that FTY720 treatment has different effects in the BCG 
model compared to our findings in the N. brasiliensis model, specifically when assessing 
antigen specific CD4 T cell responses within the lung tissue. 
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Figure 4.13 The effect of FTY720 administration on the antigen specific CD4 T cell 
response in the lung: A comparison of the BCG and N. brasiliensis models. 
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A and B. C57BL6 mice (n= 5/group/time point) were vaccinated with BCG and treated 
with FTY720 during vaccination and challenge infection as described in Fig 4.11. The 
production of IFNγ was assessed from CD4 T cells isolated from naïve animals, those at 
the peak immune response to primary infection (Day 21), prior to intranasal challenge 
(base line – day 62 post primary) and during the peak of challenge infection (day 14 post 
challenge). IFNγ production was measured by intracellular cytokine staining after 
overnight in vitro restimulation with CFP and analysis performed on a four colour flow 
cytometer. Data in A represents production of IFNγ by CD4 T cells isolated from the 
mediastinal lymph nodes, and data in B represents production of IFNγ by CD4 T cells 
isolated from the lung. Values represent the mean number of IFNγ+ CD4 T cells after 
overnight restimulation ± S.E.M. Data representative of three independent experiments. C 
and D. G4/IL-4 mice (n=3/group/timepoint) were infected with N. brasiliensis and were 
treated with FTY720 from one day prior to infection. At 30 days post infection mice were 
reinfected with N. brasiliensis. Mediastinal lymph nodes and lung tissues were harvested 
during primary infection (day nine post infection), prior to reinfection (baseline – day 39 
post infection) and during reinfection (day six post reinfection) and also from naïve 
animals. C. Cells were isolated from the lymph nodes by enzymatic digestion before being 
stained and analysed by four colour flow cytometry. Values represent the mean number of 
GFP+ cells present in the CD4 T cell population of the mediastinal lymph node ± S.E.M. 
D. Cells were isolated from the lungs by enzymatic digestion and enriched for CD45+ cells 
by AutoMacs© bead separation before being stained and analysed by four colour flow 
cytometry. Values represent the number of GFP+ cells present in the CD4 T cell 
population of the lungs ± S.E.M. Data representative of at least two independent 
experiments. Statistics were calculated using one-way ANOVA with Tukey post test * P < 
0.05 ** P < 0.01 *** P < 0.001 
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4.3. Discussion 
The objectives of this chapter were to prevent recirculation of CD4 T cells between the 
lymph nodes and lung tissue using the drug FTY720, and to assess the effects on both 
protection from reinfection and the cellular immune response in the N. brasiliensis model. 
We have assessed the blocking of CD4 T cell recirculation between lung and lymph node 
using FTY720, confirming the effects of FTY720 treatment on sequestration of circulating 
CD4 T cells in naïve animals, and observed a reduction in both blood and tissue dwelling T 
cells in treated animals. We also investigated the effects of FTY720 during N. brasiliensis 
infection and also BCG vaccination, and found a suppression of CD4 T cell recirculation in 
both models. 
Separation of lymph node and lung CD4 T cell responses through FTY720 treatment does 
not affect protective immunity against N. brasiliensis. It is perhaps not surprising that we 
observed no difference in kinetics of migration or worm burden in primary N. brasiliensis 
infection, as the immune response occurs at a time after worms have already left the 
tissues. However, it was quite unexpected that protection against parasite reinfection was 
undiminished when FTY720 was administered to separate the T cell responses of 
secondary and tertiary lymphoid tissues. This finding suggests that the local immune 
response that is mounted at the lung site is sufficient to protect against reinfection, 
supporting the theory of effector lymphoid tissue being important in protective responses.  
The expansion of antigen specific IL-4 producing CD4 T cells in the lung during 
reinfection was a surprising finding, particularly given the dramatic suppression seen in the 
lung immune response during primary infection. The ability of local lung immune 
responses to protect has been documented before, in a viral model using mice lacking 
secondary lymphoid organs [70, 90]. The appearance of iBALT after infection has been 
observed by several groups [71, 190], although the mechanisms behind iBALT generation 
remain unclear [83]. However the finding that local lung based immune responses are 
sufficient to protect against reinfection with N. brasiliensis is a novel finding. Also of 
interest is that the immune response at a different peripheral site, the skin, was not 
similarly affected.  
Strikingly the result that blocking CD4 T cell recirculation throughout infection does not 
affect protection suggests that not only is the local tissue response important during 
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reinfection, but infers that potentially ELT can be generated locally during a primary 
response without input from the secondary lymphoid organs. 
Our investigations have demonstrated that Th1 mediated lung protective immunity differs 
from Th2. Protection afforded by BCG vaccination was abrogated by treatment with 
FTY720 during vaccination, but not if FTY720 was given prior to infectious challenge. 
This differs from our findings with N. brasiliensis where we observed no difference in 
protection regardless of the timing of drug treatment. Worthy of note, FTY720 treated 
mice receiving primary intranasal BCG infection displayed increased dissemination of 
bacteria in lungs, liver and spleen. This finding contrasts with our data, which showed no 
difference in migration kinetics or worm burden in primary N. brasiliensis infection. This 
data clearly indicates that there are significant differences in the way that BCG and N. 
brasiliensis infections are controlled by the T cell response. The implications of these 
findings are significant in terms of vaccine development against different types of 
pathogens; although these results suggest that ELT in the lung tissue is important for 
protection in both models they also suggest that the BCG model requires T cells derived 
from the lymph nodes to develop ELT, which is not necessarily the case in the N. 
brasiliensis model. 
Some of the observed differences between the Th1 and Th2 mediated models may stem 
from the inherent differences in the model pathogens. BCG is a small bacterium that can 
persist long term within the host, surviving within infected macrophages. In contrast, N. 
brasiliensis is a relatively large helminth with a much shorter infection of the host. The 
host infection cycle of N. brasiliensis is completed within 10 days in immune competent 
animals in contrast to the chronic infection established by BCG infection, which requires 
antibiotic clearance. These differences within the two models could lead to differences in 
antigen dose and persistence within the host tissues. 
Interestingly the antigen specific cellular immune responses also differ between the two 
models. Using FTY720 throughout N. brasiliensis infection we see a minimal IL-4 
response in the lung during primary infection that contracts before expanding upon 
reinfection. However in the BCG model when FTY720 treatment is received throughout, 
we see a low IFNγ lung response during primary infection, with numbers increasing prior 
to challenge and then increasing further upon reinfection. Although the differences in the 
FTY720 treatment regimes and cellular manipulations between the two models may 
account for this difference, the increase in cells capable of producing IFNγ in response to 
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BCG does not result in protection against reinfection. This interesting finding may be 
explained by the suggestion that IFNγ is not a reliable correlate of protection in the BCG 
model [195]. 
4.4. Conclusions 
The aims of this chapter were to assess the ability of immune responses based in the 
peripheral lung tissue to confer protection in the N. brasiliensis model, and also to compare 
these finding to a Th1 mediated model of lung based protective immunity. From the above 
experiments we conclude that peripheral lung based immune responses are sufficient to 
confer protection against reinfection with N. brasiliensis. Furthermore we find that even if 
CD4 T cell recirculation is prevented throughout N. brasiliensis infection protection is 
unimpaired, suggesting an alternative development of effector lymphoid tissue through 
priming in lung tissue or a selective resistance of memory T cells to FTY720, allowing the 
development of ELT. Strikingly we see differences between the N. brasiliensis and BCG 
models of lung based protective immunity. We find that blocking CD4 T cell recirculation 
during BCG vaccination impedes the development of protective ELT, although blockade 
immediately prior to challenge infection does not. These results suggest that while the 
development of ELT in the lung tissue is an important component of protective immunity 
in both models, the generation of ELT has different requirements in the two models we 
assessed. 
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5.1. Introduction 
5.1.1. Currently known requirements for protective immunity in N. 
brasiliensis model 
Within our research group much data has been accumulated on the immune parameters of 
protection against reinfection with N. brasiliensis. Our model of protective immunity has 
been assessed in several strains of mice deficient in cytokines, signalling molecules or 
receptors (detailed in Table 5.1). A role for CD4 T cells in protection against reinfection in 
the lung is suggested by the data in Table 5.1, as MHC II deficient animals that lack CD4 
T cells have reduced protection. Interestingly, IL-4 appears to be important to the 
protective response in the lung, but not the gut although the STAT 6 pathway has an 
important role in both lung and gut protection. This is likely due to redundancy between 
IL-4 and IL-13, with IL-13 also mediating worm expulsion through the shared IL-4Rα 
[158]. The result that IL-5 -/- mice retain protection against reinfection implies that 
eosinophils do not play a critical role in our model of N. brasiliensis protective immunity, 
in contrast to the findings of others in transgenic models over expressing IL-5 [3, 162].  
Mouse Strain Lung Gut 
WT 100 100 
IL-5 -/- 97 85 
Mu -/- 77 89 
MHC II -/- 47 9 
STAT 6 -/- 39 22 
IL-4 -/- 25 93 
Table 5.1 Immune requirements for protection from N. brasiliensis reinfection 
Various strains of mice (as indicated) were infected with N. brasiliensis. At 30 days post 
infection mice were reinfected with N. brasiliensis. At two days post reinfection lung 
tissues were harvested and at six days post infection gut tissues were harvested, worms 
migrated out and enumerated. Values represent percent protection in the lung as compared 
to that seen in the tissues of corresponding wild type animals (100% = protection 
maintained, 0% = protection lost). 
Also notable is that Mu -/- mice deficient in B cells and therefore the production of N. 
brasiliensis specific IgG1 and IgE exhibit a minor loss of protection, indicating that 
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although N. brasiliensis induces a strong IgE response, antibody is not critical in mediating 
protection against reinfection. 
A role for CD4 T cells in gut expulsion has previously been shown [157], but the role of 
CD4 T cells in lung protective responses is unclear. The experiments detailed within this 
chapter assess the role of CD4 T cells in lung mediated protective immunity against N. 
brasiliensis. We aim to build on the work of the previous chapters by characterising the 
CD4 T cells resident in the lung by assessing their activation phenotype. The 
transmembrane glycolipid CD45 is expressed on CD4 T cells and the differential 
expression of the isoform CD45RB can be used to distinguish between naïve and memory 
CD4 T cells [196]. It is thought that CD45RB associates with CD4 and TCR complex in 
memory T cells, but not in naïve cells enabling faster reactivation upon antigen exposure. 
Interestingly it was observed that Th2 cells display an intermediate level of expression of 
CD45RB [196]. The adhesion molecule CD44 plays an important role in the 
immunological synapse, and surface expression of CD44 is often used as a measure of 
activation [197]. When assessed in combination with expression of CD62L (L-selectin, 
required for entry into secondary lymphoid organs), CD4 T cells can be categorised as 
naïve (Tn – CD45RB hi CD62L hi CD44 lo), effector (Teff - CD45RB lo/int CD62L lo 
CD44 hi), effector memory (TEM - CD45RB lo CD62L lo CD44 hi) or central memory 
(TCM – CD45RB lo CD62L hi CD44 hi). Th1 effector cells were not observed to express 
the CD45RB int phenotype [196], however expression of the survival marker CD127 (IL-
7Rα) can also be used to distinguish between Tn, Teff, TEM and TCM as it is not expressed 
on Tn or Teff, but is present on TEM and TCM [198]. 
This array of cellular reagents have allowed the characterisation of the lung residing CD4 
T cells during N. brasiliensis infection and reinfection, providing novel and precise 
mechanistic data to aid in the understanding of protective immunity in this model. 
5.1.2. Aims 
The following series of experiments were undertaken to investigate the CD4 T cell 
responses mediating protective immunity against N. brasiliensis. Once the relevance of 
CD4 T cells in this model was confirmed, the cells were studied in terms of effector 
function and relevance to protective immunity. 
• To characterise the key CD4 T cell subtypes of the protective response against N. 
brasiliensis 
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• To compare these findings in a Th1 mediated CD4 model of protective immunity 
5.2. Results 
5.2.1. Depletion of CD4 T cells abrogates protection against N. 
brasiliensis 
To ascertain the importance of the CD4 T cell response to protection from reinfection, 
CD4 T cells were depleted using an αCD4 antibody clone, GK1.5. Previous work has 
identified an important role for CD4 T cells in gut expulsion [157] and findings within our 
own research group in MHC II -/- mice (Table 5.1) have suggested that there may be a role 
for CD4 T cells in lung mediated protective immunity against N. brasiliensis. The 
following experiments investigate the importance of CD4 T cells in mediating protective 
immunity against N. brasiliensis. 
5.2.1.1. anti CD4 administration depletes CD4 T cells 
To assess depletion of CD4 T cells by αCD4 antibody, mice were injected i.p. with one 
dose of antibody (GK1.5) at varying concentrations and their blood was collected and 
monitored for the presence of CD4 T cells over time (Fig 5.1A). White blood cells were 
enriched by lysis of red blood cells and these cells were then stained for expression of 
TCRβ, CD4 and B220, before being analysed using flow cytometry. 
A single dose of antibody was found to deplete circulating CD4 T cells for at least 28 days 
at all concentrations tested (Fig 5.1A). At this last time point mice were sacrificed and 
lymph node and spleen were harvested and assessed for the presence of CD4 T cells, 
which showed that these tissues had successfully been depleted of CD4 T cells (see 
appendix Fig A.2).  
A further experiment investigated the effects of antibody depletion of CD4 T cells in the 
lungs of naïve mice. Mice received 0.5mg of αCD4 by i.p. injection and were sacrificed 
three days later. Lungs were perfused, harvested, collagenase digested and assessed for the 
presence of CD4 T cells by flow cytometry. We found that CD4 T cells in the lung were 
successfully depleted (99% depletion) by this method (Fig 5.1B – lower right panel). 
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Figure 5.1 Depletion of CD4 T cells using αCD4 antibody. 
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A. Titration of rat IgG2b anti-CD4 depleting mAb. G4/IL-4 mice (n = 3/group) were 
treated with the indicated concentration of anti-CD4 antibody (clone GK1.5) by 
intraperitoneal injection at time zero. Mice were tail bled at the indicated time points and a 
known volume of blood collected. Red blood cells were lysed and circulating cells were 
analysed by four colour flow cytometry. The number of CD4 T cells per mL of blood was 
calculated by multiplying the percentage of CD4 positive lymphocytes as determined by 
flow cytometry with the total number of live cells as determined by trypan blue exclusion. 
Values represent the number of CD4 T cells per mL of blood ± S.E.M. Statistics were 
calculated using Kruskal Wallis analysis with Dunns post test * P < 0.05 ** P < 0.01 *** P 
< 0.001. B. anti-CD4 treatment depletes CD4 T cells in the lung tissue. G4/IL-4 mice 
(n=3/group) were treated with 0.5mg anti-CD4 antibody (GK1.5 clone) and three days 
later lung tissues were harvested and enzymatically digested. CD45 positive cells were 
enriched by AutoMacs© bead separation before being stained and analysed by four colour 
flow cytometry. Upper panels show cells gated on the lymphocyte population by forward 
and side scatter and details gating of CD3+ and B220+ cells. Lower panels show 
expression of CD8 and CD4 on cells within the CD3+ gate. Facs plots are from one 
representative animal per group. 
 
Chapter 5: Characterisation of CD4 T cells mediating protection against N. brasiliensis  
 123 
5.2.1.2. Depletion of CD4 T cells abrogates protection against N. brasiliensis 
To test if CD4 T cells are required to mediate lung protective immunity against N. 
brasiliensis infections, mice were depleted of CD4 T cells either prior to reinfection or 
throughout priming and reinfection with N. brasiliensis. This depletion was carried out in 
N. brasiliensis infected mice treated with FTY720 as well as untreated N. brasiliensis 
infected control animals (experiment overview Fig 5.2). Mice were sacrificed after 
reinfection with N. brasiliensis and organs were assessed for worm burden, lungs two days 
post challenge and guts on six days post challenge.  
Viable worms migrated from tissues were enumerated and compared to those migrated 
from primary infected control animals to assess protection. Depletion of CD4 T cells 
during reinfection or throughout infection abrogated protection in the lung and gut of 
FTY720 treated mice as shown in Fig 5.3A. A requirement for CD4 T cells was also 
observed in the gut, as depletion of CD4 T cells throughout infection or prior to reinfection 
abrogated the protection observed in CD4 replete animals Fig 5.3B. Similar results were 
observed in mice that were not treated with FTY720. 
These results suggest a critical role for CD4 T cells in mediating protective immunity 
against N. brasiliensis. 
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Figure 5.2 Experimental design to assess the relevance of CD4 T cells to protective 
immunity against N. brasiliensis. 
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On the day prior to infection G4/IL-4 mice (n=3/group/time point) were treated with 
FTY720 or remained as untreated controls. Within these two groups an anti-CD4 antibody 
depletion regime was established where mice received depleting antibody (clone GK1.5, 
0.5mg/mouse i.p.) on the day prior to N. brasiliensis infection (at day -1) and also prior to 
reinfection at day 39, prior to reinfection alone, or remained untreated. At the time of 
reinfection a group of naïve mice received a primary N. brasiliensis infection in order to 
compare the protection attained by the reinfected mice. At two days post reinfection lung 
tissues were harvested and at six days post reinfection gut tissues were harvested, worms 
were migrated and enumerated and the effects of CD4 T cell depletion on protection 
against reinfection observed. 
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Figure 5.3 Depletion of CD4 T cells abrogates protection against reinfection with N. 
brasiliensis.  
On the day prior to infection G4/IL-4 mice (n=3 per group per time point) were treated 
with FTY720 or remained as untreated controls. Within these two groups an anti-CD4 
antibody depletion regime was established where mice received depleting antibody (clone 
GK1.5, 0.5mg/mouse i.p.) prior to N. brasiliensis infection at day -1 and also prior to 
reinfection at day 39 (αCD4 1° & 2°), prior to reinfection alone (αCD4 2°), or did not 
receive depleting antibody (No αCD4). At the time of reinfection a group of naïve mice 
received a primary N. brasiliensis infection in order to compare the protection attained by 
the reinfected mice. A. At two days post reinfection lung tissues were harvested and 
worms were migrated and enumerated. Data presented as combined results of three 
independent experiments (n=9-14/group total) B. At six days post reinfection gut tissues 
were harvested, worms were migrated and enumerated. Values represent mean number of 
larvae present in the tissue ± S.E.M. Data presented as combined results of two 
independent experiments (n=4-9/group total). Statistics were calculated using Kruskal 
Wallis analysis with Dunns post test * P < 0.05 ** P < 0.01 *** P < 0.001. 
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5.2.2. Adoptive transfer of CD4 T cells into naïve hosts confers 
protection 
Having demonstrated the importance of CD4 T cells in mediating protective immunity 
against N. brasiliensis, I decided to investigate whether transfer of T cells into naïve hosts 
could protect them against N. brasiliensis infection. 
5.2.2.1. Comparison of adoptive transfer techniques to establish lung localised 
cell transfer 
Before testing whether transfer of T cells could protect against N. brasiliensis I first needed 
to optimise a method of transferring cells to the lungs of recipient mice. To determine the 
optimal technique I tested two methods of cell adoptive transfer, intravenous (i.v.) and 
intranasal (i.n.). These methods were assessed using both lung derived cells and lymph 
node derived cells, as “addressins” present on the cells may have influence over their 
recirculation – mucosal addressin α4β1 for lung, CD62L for lymph node homing. 
Lung or lymph nodes from donor mice were harvested and collagenase digested. Single 
cell suspensions were washed then labelled with CFSE and counted, before being 
transferred into recipients either i.n. or i.v. Two days later (at the time point when worms 
would be at peak numbers within the lung tissue) mice were sacrificed and their tissues 
investigated for transferred cells. Lung cells were transferred at 5 x 105 cells per animal 
and lymph node cells were transferred at 5 x 106 cells per animal, a 10 fold difference. 
Recovery of cells was assessed in terms of total numbers and also percentage of transferred 
cells. 
Cells that were transferred i.v. could be located in the lymph nodes (Fig 5.4A) and spleens 
(see appendix Fig A.3) of recipient animals in high numbers. Approximately five percent 
of i.v. transferred cells could be recovered from the mediastinal lymph node and a similar 
proportion was also recovered from the spleen. However i.v. transferred cells did not home 
efficiently to the lung (Fig 5.4B) as less than 0.5% of transferred cells were recovered from 
that tissue. There was no apparent difference in homing between cells derived from donor 
lymph node or lung. 
Cells that were transferred i.n. could be recovered from within the lung and airways with 
relatively good efficiency, with a 6-7% recovery (Fig 5.4B). Recovery of i.n. transferred 
cells from the mediastinal lymph node (Fig 5.4A) or spleen (see appendix Fig A.3) resulted  
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Figure 5.4 Recovery of cells from lymph node and lung tissue after adoptive transfer 
using different techniques. 
Lymphocytes were isolated from the lungs (white bars) or lymph nodes (black bars) of 
Balb/c mice and labelled using CFSE before being transferred into recipient Balb/c mice (n 
= 3/ group) via intranasal or intraveneous route. Two days after cell transfer recipient mice 
were sacrificed and lungs and mediastinal lymph nodes harvested. A. Mediastinal lymph 
nodes were enzymatically digested and analysed using four colour flow cytometry for the 
presence of CFSE labelled CD4 T cells. B. Lung tissues were enzymatically digested and 
CD45 positive cells were enriched by AutoMacs© bead separation before being stained 
and analysed by four colour flow cytometry. Values represent the number of cells 
recovered as a percentage of adoptively transferred cells ± S.E.M. Statistics were 
calculated for each cell type transferred using Student’s t test * P < 0.05 ** P < 0.01 *** P 
< 0.001 
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in less than 0.2% of transferred cells being recovered. There was no apparent difference in 
homing between cells derived from donor lymph node or lung. 
So to effectively transfer cells to the lung the method we chose to use was i.n. adoptive 
transfer. 
5.2.2.2. Transfer of N. brasiliensis experienced CD4 T cells into naïve mice 
confers protection against N. brasiliensis. 
To investigate whether CD4 T cells are truly essential to confer protective immunity 
against N. brasiliensis, I transferred CD4 T cells from a previously primed mouse via 
adoptive transfer and assessed the potential to confer protection to a naïve animal. Cells 
were isolated from the lymph node or lung of primary infected IL-4/G4 mice by 
collagenase digestion day 25 post infection. Tissues were processed into single cell 
suspensions and enriched for CD4 T cells using positive selection with CD4 AutoMacs© 
magnetic beads. CD4 enriched cells were adoptively transferred i.n. into recipient Balb/c 
animals. One day after cell transfer recipient mice were subcutaneously infected with 600 
iL3 N. brasiliensis and a control group received a primary infection to assess protection. 
Lung CD4 T cells were transferred at a higher number (4 x 106/recipient) than lymph node 
derived CD4 T cells (8 x 105/recipient) as we were able to recover greater numbers from 
donor mice. At days two and six post infection lung tissues were harvested and worm 
burden assessed. 
Strikingly, transfer of CD4 T cells from either the lung or lymph node into naïve animals 
was sufficient to confer protection against reinfection with N. brasiliensis, as a reduced 
worm burden is observed in those mice which received transferred cells (Fig 5.5). 
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Figure 5.5 Adoptive transfer of N. brasiliensis experienced CD4 T cells can confer 
protection 
Lungs or mediastinal lymph nodes were harvested from donor G4/IL-4 mice at day 25 
after N. brasiliensis primary infection. Tissues were enzymatically digested and CD4 T 
cells were purified using AutoMacs© bead separation. Isolated CD4 T cells were intra 
nasally adoptively transferred into naïve Balb/c recipients (n = 4/group) at a final number 
of 4 x 106 lung derived cells and 8 x 105 lymph node derived cells. At one day post cell 
transfer recipient mice were infected with N. brasiliensis, and at this time a naïve control 
group was also infected to assess any protection conferred by the transferred cells. At two 
days post N. brasiliensis infection mice were sacrificed; lung tissues harvested and worms 
were migrated and enumerated. Values represent mean number of larvae present in the 
tissue ± S.E.M. Data representative of two independent experiments. Statistics were 
calculated using one way ANOVA with Tukey post test * P < 0.05 ** P < 0.01 *** P < 
0.001. 
Chapter 5: Characterisation of CD4 T cells mediating protection against N. brasiliensis  
 131 
5.2.2.3. Transfer of N. brasiliensis experienced CD4 T cells into athymic nude 
mice confers protection against N. brasiliensis. 
To build on the finding that adoptive transfer of CD4 T cells into naïve recipients 
conferred protection, we aimed to further define the protective CD4 T cells. Four groups of 
mice received i.n. adoptive transfer of approximately 4 x 105 CD4 T cells; one group 
received CD4 T cells from the lungs of FTY720 treated N. brasiliensis infected mice, 
another group received CD62L lo sorted CD4 T cells from the lungs of FTY720 treated N. 
brasiliensis infected mice, the third group received CD4 T cells from the mediastinal 
lymph node of N. brasiliensis infected mice and the fourth group received cells from the 
mesenteric lymph node of naïve mice. Cells in group four were initially CD4 T cell 
enriched, however a problem with cell death occurred and it was not possible to enrich the 
replacement naïve cells. Recipients in group four did however receive an equivalent 
number of CD4 T cells to other groups. A fifth group did not receive any cells (see Fig 5.6 
for experimental plan). The recipient mice in this experiment were athymic nude mice that 
lack mature T cells [199]. This strain of mice was used to ensure that any protection 
conferred to these mice would be derived solely from the transferred T cells 
One day post adoptive transfer of cells the recipient mice were infected with 600 iL3 N. 
brasiliensis, s.c. and on days two and six worm burden in the lung and gut were assessed 
using the viable worm recovery assay. Day six post infection the lungs and mediastinal 
lymph nodes of animals were also collected and assessed in terms of CD4 T cell response. 
The phenotype of the adoptively transferred cell populations is shown in Fig 5.7; group 
one are predominantly CD62L lo, CD44 hi, group two have been sorted as CD62L lo and 
as such are CD62L lo and CD44 hi, group three are a mixed population of CD62L lo CD44 
hi and CD62L hi CD44 lo cells, and group four are predominantly CD62L hi CD44 lo 
consistent with their isolation from naïve animals. An interesting point to note is that GFP 
expression is limited to cells that are CD62L lo and CD45RB lo. Cells of group one and 
two are predominantly CD45RB lo – consistent with effector/effector memory phenotype. 
The effects of cell transfer on protective immunity are detailed in Fig 5.8. It can be seen 
that mice were most effectively protected when they had received T cells that were derived 
from the lungs of FTY720 treated N. brasiliensis infected animals when compared to 
control animals that did not receive any transfer of cells (Fig 5.6). The cells transferred to 
these most efficiently protected groups were CD62L lo CD44 hi and CD45RB lo, 
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consistent with effector/effector memory phenotype as seen in Fig 5.7. Animals that 
received cells derived from the lymph node of N. brasiliensis infected animals were also 
protected to some degree, however animals receiving transfer of naïve cells were 
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Figure 5.6 Experimental design to assess whether effector lymphoid tissue can protect 
against reinfection with N. brasiliensis.  
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Donor G4/IL-4 mice were treated with FTY720 from one day prior to N. brasiliensis to 
generate lung effector lymphoid tissue (A), infected with N. brasiliensis (B) or remained 
naïve (C). At day 25 post infection lung tissues were harvested from donor group A, 
mediastinal lymph nodes were harvested from donor group B and mesenteric lymph nodes 
were harvested from donor group C. Both lung and lymph nodes were enzymatically 
digested and enriched for CD4 T cells using AutoMacs© bead separation, with the 
exception of group C which was not enriched. CD4 T cells were further sorted from group 
A donors into a CD62L lo population. Recipient athymic nu/nu mice (n = 5/group) could 
be classified into five groups; those receiving CD4 T cells isolated from antigen 
experienced lung tissue (group 1), those receiving CD62L lo CD4 T cells isolated from 
antigen experienced lung tissue (group 2), those receiving CD4 T cells isolated from 
antigen experienced lymph node tissue (group 3 – positive control), those receiving 
lymphocytes isolated from naïve lymph node tissue  (group 4 – negative control) and those 
that did not receive cell transfer (group 5). Cells were adoptively transferred in 
approximately equal numbers (~4 x 105) using an intranasal transfer method. One day after 
cell transfer, recipient mice and control mice (group 5 – negative control) received N. 
brasiliensis infection. Lung tissues were harvested two days post infection and worms 
were migrated and enumerated to measure any protection conferred by cellular transfer. 
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Figure 5.7 Phenotypic profile of CD4 T cells prior to adoptive transfer. 
A sample of cells isolated from donor G4/IL-4 mice as previously described in Fig 5.6 
were analysed using multicolour FACs analysis on a LSR II flow cytometer to assess their 
activation phenotype at the time of adoptive transfer. Cells were isolated from tissues as 
previously described in Fig 5.6 and stained with antibodies against CD45RB, CD62L, 
CD44, CD3 and CD4. DAPI was used to exclude dead cells and GFP reporter was also 
present as donor mice were from a G4/IL-4 background. Plots are gated on DAPI negative 
CD3/CD4 positive cells and are representative of the transferred cell population.  
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Figure 5.8 Adoptive transfer of CD45RB lo CD62L lo CD44 hi CD4 T cells (ELT) can 
confer protection to N. brasiliensis in athymic nude mice. 
Athymic nu/nu mice (n = 5/group/time point) received adoptive cell transfer as described 
in Fig 5.6. One day post cell transfer mice were infected with N. brasiliensis. A. At two 
days post transfer lung tissues were harvested, worms were migrated and enumerated. B. 
At six days post reinfection gut tissues were harvested, worms were migrated and 
enumerated. Values represent mean number of larvae present in the tissue ± S.E.M. 
Statistics were calculated using one way ANOVA with Tukey post test * P < 0.05 ** P < 
0.01 *** P < 0.001. This experiment was performed once. 
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Figure 5.9 Phenotype of lung isolated CD4 T cells from N. brasiliensis infected 
athymic mice. 
Athymic nu/nu mice (n = 5/group/time point) received adoptive cell transfer as described 
in Fig 5.6. One day post cell transfer mice were infected with N. brasiliensis. At day six 
post adoptive transfer lung tissues were harvested, enzymatically digested and CD45 
positive cells were enriched by AutoMacs© bead separation. Isolated cells were stained 
with antibodies against CD45RB, CD62L, CD44, CD3 and CD4 and analysed by flow 
cytometry using an LSR II flow cytometer. DAPI was included to exclude dead cells and 
GFP reporter was also present as donor mice were from a G4/IL-4 background. Facs plots 
are gated on DAPI negative CD3/CD4 positive cells and are from one representative 
animal per group. A table with mean and S.E.M. from all recipients is included in appendix 
as Table A1. 
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unprotected. This protection result was observed in the lung and gut (Fig 5.8A and B). The 
worm burden in the gut of control mice was unexpectedly low, however it can be seen that 
the pattern of protection observed in the lung tissue is repeated. 
The expression of surface markers on CD4 T cells in the lungs of the recipient mice were 
examined by flow cytometry on day six post N. brasiliensis infection. Similarly to before 
transfer (Fig 5.7), lung isolated CD4 T cells from groups one and two were predominantly 
CD45RB lo, CD62L lo and CD44 hi, CD4 T cells isolated from group three had a mixed 
population of CD62L lo CD44 hi CD45RB lo cells and CD62L hi CD44 lo and CD45RB 
hi cells, while CD4 T cells isolated from the lungs of group four displayed a predominantly 
CD62L hi, CD44 lo, CD45RB hi phenotype (Fig 5.9, also Table A1 in appendix). The 
observed CD4 T cells present in group five reflect the fact that T cell precursors are still 
present in nude mice, and that as the mice age it is possible some (few) T cells mature in 
the spleen [200]. The few CD4 T cells that were isolated from group five, which did not 
receive cell transfer, resemble the cells isolated from group four which received naïve 
cells.  
The results of this experiment show that lung derived effector memory like cells (effector 
lymphoid tissue) are capable of mediating protection in otherwise naïve T cell deficient 
hosts. 
5.2.3. Kinetic profile of lung CD4 T cells during N. brasiliensis infection 
and reinfection 
To observe the generation of protective effector lymphoid tissue in the lung the CD4 T cell 
response in the lungs of FTY720 treated and untreated N. brasiliensis infected mice was 
profiled throughout the course of infection. CD4 T cells were assessed in terms of 
activation by expression of CD62L, CD44 and CD45RB and also by assessing function in 
terms of IL-4 production as measured by GFP expression. 
Mice were treated with 0.5mg/kg FTY720 daily from day -1 (if required) and animals were 
infected subcutaneously with 600 iL3 N. brasiliensis at day zero and reinfected at day 30. 
At various time points during the course of infection animals were sacrificed and the 
immune response in the lung and mediastinal lymph node assessed using flow cytometry 
(experimental design Fig 5.10).  
Expression of CD45RB is high in naïve cells and upon activation is down regulated and 
therefore expression of CD45RB in effector and memory cells is low, with Th2 cells 
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described as intermediate [196]. We also found that during primary N. brasiliensis 
infection the expression of CD45RB on CD45RBlo cells was intermediate when compared 
to CD45RBlo in secondary infection (see appendix Fig A.4). In mice receiving a control  
 
Figure 5.10 Experimental design for following lung based CD4 T cell response. 
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infection there are two CD4 populations present in the lung, CD45RB hi and CD45RBlo 
(Fig 5.11 – left hand panel). In naïve mice the majority of the CD4 T cells present within 
the lungs are CD45RB hi, consistent with a naïve phenotype. Upon infection with N. 
brasiliensis the CD45RB lo population begins to increase, until at day 12 post infection 
there are relatively equal proportions of high and lo cells present. 
Prior to reinfection this balance of CD45RB hi and lo cells is preserved, however upon 
reinfection the CD45RB lo population increases (Fig 5.12 – left hand panel). It can also be 
seen that this CD45RB lo population is responsible for the production of IL-4, as measured 
by GFP expression. This is the case both primary and secondary infection and would be 
consistent with cytokine production from Teff or TEM cells. Further investigation of the 
CD45RB hi and lo populations shows that CD45RBhi cells are CD62Lhi, CD44lo, 
consistent with a naïve phenotype (Fig 5.13 – left hand panel). In addition the CD45RBlo 
population demonstrates low expression of CD62L and high expression of CD44, 
consistent with an effector or effector memory phenotype.  
In FTY720 treated naïve mice reduced numbers of CD4 T cells are present and those that 
are present represent a mixed population of both CD45RB hi and lo cells, in contrast to the 
mainly CD45RB hi population seen in untreated animals (Fig 5.11 – right hand panel). 
This finding is consistent with reports that naïve cells are preferentially depleted from 
peripheral organs with FTY720 treatment [101, 102]. Upon infection with N. brasiliensis, 
the ratio of CD45RB hi and lo cells begins to alter with the CD45RB lo population 
increasing, and the majority of CD4 T cells being CD45RBlo by day 12 post infection. 
Prior to reinfection in FTY720 treated mice (Fig 5.12 – right hand panel) there is one 
population of CD4 T cells present in the lung that are CD45RB lo, suggesting they have 
been previously activated. These cells are functionally active as they are responsible for 
the production of IL-4 as measured by GFP expression. The measured GFP expression in 
primary infection is negligible in FTY720 treated animals, however the cells producing IL-
4 are CD45RB lo – consistent with an activated phenotype. Furthermore these CD45RB lo 
cells express low levels of CD62L and high levels of CD44 (Fig 5.13 – right hand panel), 
similarly to the CD45RB lo population in untreated mice.  
Treatment with FTY720 during N. brasiliensis infection has revealed the development of 
effector lymphoid tissue in the lung. This data suggests that a population of CD44hi, 
CD62Llo CD45RBlo cells has been selectively generated within the lungs of FTY720 
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Figure 5.11 Kinetics of the lung CD4 T cell response against primary N. brasiliensis 
infection. 
G4/IL-4 mice (n = 5/group/time point) were treated with FTY720 from the day prior to 
infection with N. brasiliensis or remained untreated. At the indicated time points lung 
tissues were harvested and enzymatically digested before being enriched for CD45+ cells 
using AutoMacs© magnetic bead separation. The enriched cells were stained and analysed 
using multicolour FACs analysis on a LSR II flow cytometer. Facs plots are gated on 
DAPI negative CD3/CD4 positive cells and are from one representative animal per group. 
A table with mean and S.E.M. from all individuals is included in appendix as Table A2. 
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Figure 5.12 Kinetics of the lung CD4 T cell response against N. brasiliensis 
reinfection. 
G4/IL-4 mice (n = 5/group/time point) were treated with FTY720 from the day prior to 
infection with N. brasiliensis or remained untreated. At 30 days post infection mice were 
reinfected with N. brasiliensis. At the indicated time points lung tissues were harvested and 
enzymatically digested before being enriched for CD45+ cells using AutoMacs© magnetic 
bead separation. The enriched cells were stained and analysed using multicolour FACs 
analysis on a LSR II flow cytometer. Facs plots are gated on DAPI negative CD3/CD4 
positive cells and are from one representative animal per group. A table with mean and 
S.E.M. from all individuals is included in appendix as Table A3. 
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Figure 5.13 Phenotype of CD4 T cell CD45RB hi and lo populations isolated from the 
lung. 
G4/IL-4 mice (n = 5/group/time point) were treated with FTY720 from the day prior to 
infection with N. brasiliensis or remained untreated. At 30 days post infection mice were 
reinfected with N. brasiliensis. At the indicated time points lung tissues were harvested and 
enzymatically digested before being enriched for CD45+ cells using AutoMacs© magnetic 
bead separation. The enriched cells were stained and analysed using multicolour FACs 
analysis on a LSR II flow cytometer. The FACs plots shown in this figure represent cells 
from the lungs of mice from day six post reinfection gated on DAPI negative CD3/CD4 
positive cells, showing the activation phenotype of CD45RB hi and lo cells in terms of 
CD44 and CD62L expression. FACs plots are from one representative animal per group. 
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treated mice. When this data is evaluated in respect to the work presented in chapter 4 the 
observed population of Teff/ TEM cells appear to mediate protection from reinfection with 
N. brasiliensis. 
5.2.4. T regulatory cells do not appear to have a central role in 
protection against reinfection in N. brasiliensis model. 
The diminished primary response and enhanced response to reinfection observed in the 
lungs of FTY720 treated animals (Fig 4.7) raised the possibility that FTY720 
administration may have affected regulation by Tregs. To address this we determined if 
there was any difference in the number and phenotype of FoxP3+ Tregs in the lungs of 
FTY720 treated mice. Using Foxp3gfp reporter mice [201] we investigated the number of 
FoxP3+ cells in FTY720 treated and untreated N. brasiliensis infected mice.  
Expression of CD103 has been shown to be a marker of effector or memory Tregs [202] 
and may maintain Tregs at the infection site [203]. We measured CD103 expression to 
indirectly assess functionality, as in our N. brasiliensis model there is no specific antigen 
to directly measure suppressive activity using in vitro assays. 
We found no significant difference in Tregs as a proportion of CD4 cells in the lung (Fig 
5.14A). Both FTY720 treated and control mice had elevated proportions of Tregs when 
compared to naïve mice, as might be expected in an infection situation. Interestingly there 
was also no difference in CD103 expression as measured by median fluorescence intensity 
(Fig 5.14B), indicating equal functionality of Tregs in FTY720 treated or control animals. 
These results suggest that the protection observed in FTY720 treated mice is not due to an 
alteration in the immune regulation by Tregs.  
5.2.5. NKT cells are irrelevant to confer protection against N. 
brasiliensis reinfection 
NKT cells are a lineage of T cells expressing CD4 that differ from conventional CD4 T 
cells as they recognise glycolipid antigen presented on CD1 molecules. As NKT cells can 
express CD4, we sought to assess if there was a role for NKT cells in protection against 
reinfection with N. brasiliensis. Mice deficient in CD1 lack NKT cells [176], so N. 
brasiliensis infections were established in CD1 -/- mice and corresponding C57BL6 
control animals. Upon reinfection worm burdens in the lung and gut of reinfected animals 
were assessed and compared to primary infected controls. 
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Worm burdens in both the lungs and guts of CD1 -/- mice were diminished after 
reinfection with N. brasiliensis (Fig 5.15 A and B). The protection observed in CD1 -/- 
animals was comparable to that of the C57BL6 controls, suggesting that NKT cells do not 
play an important role in protection against reinfection with N. brasiliensis. 
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Figure 5.14 Effect of FTY720 treatment on Treg number and activation profile in N. 
brasiliensis reinfection model.  
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Foxp3gfp reporter mice (n = 4/group/time point) treated with FTY720 from the day prior to 
infection with N. brasiliensis or remained untreated. After 30 days mice were reinfected 
with N. brasiliensis. A naïve group was also included to establish the background levels of 
Treg number and activation. At the indicated time points lung tissues were harvested and 
enzymatically digested before being enriched for CD45+ cells using AutoMacs© magnetic 
bead separation. The enriched cells were stained and analysed a four colour flow 
cytometer. A. The percentage of CD4 T cells that were Tregs was calculated by measuring 
the percentage of GFP+ cells in the CD4 T cell population. Values represent percentage of 
GFP+ cells in the CD4 T cell population ± S.E.M. B. Activation of Foxp3 positive cells 
was assessed by measuring the relative expression of CD103 on GFP positive cells. Values 
represent median fluorescence intensity of CD103 expression on GFP+ cells in the CD4 T 
cell population ± S.E.M. Data representative of two independent experiments. Statistics 
were calculated using Kruskall Wallis with Dunns post test * P < 0.05 ** P < 0.01 *** P < 
0.001. 
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Figure 5.15 CD1 -/- mice are protected from reinfection with N. brasiliensis. 
CD1 -/- (white bars) and C57BL6 mice (black bars) (n=3/group/time point) were infected 
with N. brasiliensis. At 30 days post infection mice were reinfected with N. brasiliensis 
and at this time a further group of naïve mice were infected with N. brasiliensis to allow 
for measurement of protection (primary). A. At two days post reinfection lung tissues were 
harvested, worms were migrated and enumerated. B. At six days post reinfection gut 
tissues were harvested, worms were migrated and enumerated. Values represent mean 
number of larvae present in the tissue ± S.E.M. Data representative of at least two 
independent experiments. Statistics were calculated for each mouse strain using Student’s t 
test * P < 0.05 ** P < 0.01 *** P < 0.001 
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5.2.6. TEM CD4 T cells in the lungs of BCG vaccinated and challenged 
mice do not correlate with protection 
The phenotype of lung CD4 T cells was investigated in the lungs of FTY720 treated and 
control mice in the BCG model of protective immunity after infectious challenge to 
compare with our findings in the N. brasiliensis model. Expression of the activation 
markers CD62L and CD44 and the survival marker CD127 (IL-7Rα) was used to 
discriminate between Tn (CD62Lhi CD44lo CD127hi), Teff (CD62Llo CD44hi CD127lo), 
TEM (CD62Llo CD44hi CD127hi) and TCM (CD62Lhi CD44hi CD127hi) CD4 T cells. 
The major population of CD4 T cells present within the lungs of mice after BCG infectious 
challenge is TEM cells, in both FTY720 treated and control mice (Fig 5.16). FTY720 
treatment during challenge infection resulted in reduced numbers of Tn and TCM. However 
mice receiving FTY720 only during primary vaccination had restored levels of both Tn 
and TCM after challenge infection.  
Our findings in the N. brasiliensis model identified a protective population of TEM like 
cells within the lung tissues. In the BCG model TEM cells dominate the CD4 T cell 
response to challenge infection in FTY720 treated and control treated mice (Fig 5.16). In 
contrast to our findings in the N. brasiliensis model, TEM cells do not correlate with 
protection in the BCG model.  
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Figure 5.16 TEM cells do not correlate with protection in the BCG model 
C57BL6 mice (n = 5/group/time point) were vaccinated and challenged with BCG and 
remained untreated or were treated daily with 1mg/kg FTY720 as described in Fig 4.11. At 
the indicated time points post BCG infectious challenge lung tissues were harvested and 
enzymatically digested before being enriched for CD45+ cells using AutoMacs© magnetic 
bead separation. The enriched cells were stained and analysed a four colour flow 
cytometer. Expression of the activation markers CD62L and CD44 and the survival marker 
CD127 (IL-7Rα) was used to discriminate between Tn (CD62Lhi CD44lo CD127hi), Teff 
(CD62Llo CD44hi CD127lo), TEM (CD62Llo CD44hi CD127hi) and TCM (CD62Lhi 
CD44hi CD127hi) CD4 T cells. Data showing bacterial counts from lung tissue is found in 
Figure 4.12 A. A. Displays data collected from mice with No FTY720 treatment B. 
Displays data collected from mice with FTY720 treatment during vaccination only C. 
Displays data collected from mice with FTY720 treatment during challenge infection only 
D. Displays data collected from mice with FTY720 treatment during vaccination and 
challenge infection. Values represent mean number of CD4 T cells displaying indicated 
activation phenotype ± S.E.M. Data representative of at least two independent 
experiments. 
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5.3. Discussion 
The results in this chapter attempt to clarify the role and phenotype of CD4 T cells in 
protective immunity against N. brasiliensis. The loss of protection against reinfection 
resulting from the antibody-mediated depletion suggests that CD4 T cells mediate 
protective immunity against N. brasiliensis. Although the work of Katona et al [157] 
shows a requirement for CD4 T cells in gut expulsion of N. brasiliensis worms, the role of 
CD4 T cells in relation to immunity at the lung site has not previously been investigated. 
Thus, the ability to confer protection in naïve animals through the adoptive transfer of N. 
brasiliensis experienced CD4 T cells is a novel finding. This result suggests that not only 
are CD4 T cells the key mediators of protective immunity against N. brasiliensis, but 
protection against reinfection occurs rapidly, as the lung burden of protected mice is 
reduced when assessed at 24 hours. Furthermore CD4 T cells isolated from the lungs of 
FTY720 treated mice were sufficient to protect against reinfection. This finding supports 
the ability of peripheral T cell responses to confer protective immunity.  
The ability of adoptively transferred T cells to confer protection rules out tissue 
remodelling as being critical for protection against reinfection. The physiological changes 
in the lung observed after N. brasiliensis infection have been documented by Reece et al 
who describe an environment altered at the cellular and molecular level [173]. The authors 
propose that these changes play a role in modulating subsequent allergen induced 
inflammatory responses. However the data presented here demonstrates that CD4 T cells 
alone are sufficient to confer protection against N. brasiliensis infection in naïve mice. 
Exploring the surface activation markers of CD4 T cells in the lungs of FTY720 treated 
and control mice revealed interesting results. The cell surface marker CD45RB was used to 
distinguish CD45RB lo effector and memory from CD45RB hi naïve cells. During primary 
N. brasiliensis infection we observed that the CD4 T cell population in the lungs of 
FTY720 treated animals progressed from a mixed population of both CD45RB hi and lo 
cells to a population dominated by CD45RB lo CD4 T cells. Production of GFP 
(representative of effector cytokine IL-4) during primary infection was restricted to cells 
that were CD45RB lo. Prior to challenge almost all CD4 T cells were CD45RB lo but 
produced very little GFP, suggesting that they were a population of resting memory cells. 
Upon reinfection the population of CD4 T cells expanded, remained CD45RB lo and 
rapidly began to express GFP to greater levels than observed in primary infection. The 
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phenotype of CD45RB hi cells was CD62L hi and CD44 lo, consistent with naïve cells and 
the CD45RB lo cells were CD62L lo CD44 hi, consistent with Teff or TEM. 
We explored the activation phenotype of lung resident CD4 T cells in the BCG model of 
protective immunity to compare with our findings in the N. brasiliensis model. We found 
that the TEM subset dominated the lung response in all groups, but as not all groups were 
protected against infectious challenge, this did not correlate with protection. FTY720 
treatment during challenge infection prevented recirculation of Tn and TCM from the 
lymphoid tissues as reported by others [101, 102]. Our findings with the N. brasiliensis 
model identified a protective TEM population of cells, however the TEM populations in the 
BCG model do not appear to correlate with protection. This implies that TEM are not the 
protective CD4 cell type in the BCG model, or alternatively that there are differences in 
the quality or threshold of TEM required in protected versus unprotected animals.  
CD4 is expressed on subsets of Tregs and also NKT cells and as such these cells may have 
been transferred within our CD4 purified cell population during adoptive transfer in our N. 
brasiliensis protection model. To confirm that protection was not due to disregulation of 
the immune response we investigated Treg number and function in the N. brasiliensis 
model. Although we found differences in the total number of Tregs FTY720 treated 
animals displayed a trend towards increased numbers of Tregs and as such, would be 
subjected to more regulation. Expression of the integrin CD103 has been associated with 
Tregs in parasitic infection [167] and has also been associated with effector/memory 
function [202] and tissue retention [203]. Our data showed no differences in the expression 
of CD103 in FTY720 treated compared with control animals as measured by median 
fluorescence intensity. Together these results would suggest that reduced Treg function 
does not play a role in the protection against N. brasiliensis observed in FTY720 treated 
mice. 
The role of NKT cells in protective immunity against N. brasiliensis was assessed using 
CD1 -/- mice, which are unable to present antigen to NKT cells. As N. brasiliensis 
infection progresses the immune system is exposed to many antigens from the worms 
themselves to their secreted products, which potentially include glycolipid antigen. NKT 
cells are known to produce large amounts of cytokine upon activation, including IL-4, 
suggesting these cells as a relevant candidate to confer the observed protective immunity 
against N. brasiliensis. The infection of CD1 -/- mice allowed us to investigate the role for 
NKT cells in conferring protective immunity in our N. brasiliensis infection model. We 
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found no difference in protection against N. brasiliensis in CD1 -/- mice when compared to 
C57BL6 control animals. Worm burdens of both the lung and gut tissues were significantly 
reduced when compared to animals receiving primary infection. This would suggest that 
NKT cells do not play a critical role in protection against reinfection with N. brasiliensis. 
 
5.4. Conclusion 
The aim of this chapter was to confirm the role of CD4 T cells in N. brasiliensis protective 
immunity and characterise the phenotype of the protection conferring cells. Depletion 
studies with αCD4 and adoptive transfer of CD4 T cells with TEM phenotype confirmed 
their critical role in conferring protection against reinfection with N. brasiliensis. 
Furthermore, treatment with FTY720 revealed the development of a distinct CD45RB lo 
population of CD4 T cells in the lungs of infected mice during primary N. brasiliensis 
infection. These CD45RB lo cells also expressed low levels of CD62L and high CD44 
consistent with a Teff or TEM phenotype. The CD45RB lo cells persisted and upon 
reinfection rapidly expressed GFP at levels higher than those seen in primary infection. 
These CD45RB lo cells were able to confer protection when adoptively transferred into 
naïve athymic mice. Studies employing transgenic and knock out animals demonstrate that 
CD4 expressing Tregs or NKT cells do not play an important role in the protection against 
reinfection with N. brasiliensis. 
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6. Chapter 6: 
General Discussion 
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The work detailed within this thesis sought to investigate the mechanisms of protective 
immunity in the N. brasiliensis infection model. Initially we aimed to identify at which 
peripheral tissue sites immune priming occurred which led to protection against reinfection 
with N. brasiliensis. We developed and used a partial infection assay where primary worm 
infection was restricted to specific tissue sites to identify the lung as an important site in 
the generation of protective immunity against N. brasiliensis. The use of G4/IL-4 reporter 
mice allowed us to sensitively measure the production of effector cytokine IL-4 in 
response to N. brasiliensis infection, revealing a correlation between increased numbers of 
IL-4 producing CD4 T cells in the mediastinal lymph node and protection at the lung site.  
The second key aim of this work was to investigate the contribution of lymph node and 
lung based CD4 T cell responses to the protective immune response against N. brasiliensis. 
Manipulation of CD4 T cell recirculation between lymph node and lung was achieved 
using the lymphocyte sequestering drug FTY720. The approach of using FTY720 
treatment in the GFP reporter mice revealed that protection was unimpeded by drug 
treatment, although changes in the CD4 Th2 cell response within the lung tissue were 
observed. The finding that lymphocyte recruitment from the lymph node was not required 
to confer protection implicated a role for effector lymphoid tissue in protective immunity 
against N. brasiliensis.  
To build on this finding we aimed to characterise the protective CD4 T cell phenotype 
within the lung. Studies confirmed the crucial role of CD4 T cells in the protective immune 
response as depletion of these cells abrogated protection and strikingly, localised adoptive 
transfer of N. brasiliensis experienced CD4 T cells into lung tissues of naïve hosts was 
sufficient to confer protection against reinfection. The development of the lung resident 
CD4 T cell response was observed in FTY720 treated and control mice. In the lungs of 
FTY720 treated mice a population of Tem like cells developed over the course of primary 
infection that was maintained up to 30 days post infection. Upon reinfection these cells 
expanded and rapidly produced effector cytokine; furthermore, transfer of these Tem like 
cells into athymic recipients conferred protection. A role for NKT cells potentially 
transferred within the CD4 T cell population was ruled out by the finding that CD1 -/- 
mice retained protection against reinfection to the same level as control mice.  
A central aim for this thesis was to formulate a hypothesis on the protective mechanism 
generated during N. brasiliensis infection. Our findings indicate an important role for ELT 
in the conferring of protective immunity against N. brasiliensis. Interestingly our results 
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also reveal a potential alternative mechanism of development for ELT. Lastly it was aimed 
to compare our findings in the N. brasiliensis model with a Th1 mediated model of lung 
based protective immunity. This aim was achieved by using the BCG model of protection 
conferred by vaccination. Although the findings with the BCG model confirmed an 
important role for ELT, the generation of protective ELT has different requirements within 
this model. 
The following chapter discusses our findings in the context of both our aims and the 
findings of others within the scientific community. 
6.1. The lung is a key site for the generation of protective 
immunity against N. brasiliensis 
The extensive migration of N. brasiliensis through its host presents a number of peripheral 
locations where protective immunity could occur. During an infection with N. brasiliensis, 
parasitic larvae traverse the skin, entering into the circulation and bursting into the 
parenchyma of the lung as early as 14 hours post infection. A brief period of maturation in 
the lung is followed by migration to the gastrointestinal tract where worms fully mature, 
mate and lay eggs. Reinfection results in a reduced worm burden in the lung and gut 
tissues. The peripheral tissues of skin, lung and gut all experience localised infection 
during primary worm infection and the initial question addressed in this thesis asked which 
of these three peripheral tissues is responsible for the protective immune response against 
N. brasiliensis.  
We found no role for the skin in priming for protective immunity. In vitro experiments 
investigated the ability of worms to physically migrate through the skin (Fig 3.2), finding 
that worms could traverse naïve and immune skin with equal efficiency. Further in vivo 
experiments (Fig 3.3) confirmed that parasitic larvae were able to migrate away from the 
infection site in the skin as early as five minutes post infection in both naïve and immune 
animals – suggesting any protective response observed in N. brasiliensis infection was not 
due to an immune response mounted at the skin site of infection. This contrasts with the 
findings of others who have reported that iL3 can be trapped at the infection site, unable to 
migrate to the lung [3]. This difference may be explained by the different model systems 
used as these experiments were performed in transgenic mice over-expressing IL-5 where 
we have used Balb/c background animals.  
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To assess at which site primary infection was important to protect against reinfection we 
generated a model that isolated primary N. brasiliensis infection to specific tissue sites (Fig 
3.4). Using this model we showed that when mice were primed in the lung, or skin and 
lung they were protected against reinfection in the lung and gut tissues. This finding 
suggests the lung is an important site for when conferring protective immunity, especially 
when considered with the results of earlier experiments that showed no difference in 
penetration of and migration away from naïve and immune skin (Figs 3.2, 3.3). Further 
evidence for the importance of lung priming in the protective response was the striking 
finding that lung restricted primary infection could confer protection against gavaged L5 
worms (Fig 3.8).  
The protective response at the gut site has been a focus of research in the N. brasiliensis 
field with evidence to show that CD4 T cells, IL-4, IL-13 and STAT 6 play a major role in 
expulsion [157-159]. Although we have identified the lung as an important site for priming 
of protective responses, we also found that priming at the gut site was able to generate 
local protection from reinfection. Evidence collected within our group and also within this 
thesis shows there are differences in the parameters of lung and gut immunity against N. 
brasiliensis. A requirement for IL-4 in lung protection that is not necessary for protection 
within the gut is shown in Table 5.1.  This may be a reflection of the redundancy in the 
roles of IL-4 and IL-13 in gut expulsion of worms, where the as yet unknown mechanisms 
of protection within the lung must be more dependent on IL-4. 
The studies included within this thesis clearly demonstrate an important role for the lung in 
protective immunity against N. brasiliensis. Not only have we found that the lung is an 
important site for reducing the numbers of migrating larvae but that it is the key site for 
priming the protective CD4 Th2 response that occurs in the lung. Furthermore it was found 
that priming in the lung could confer protective immunity against gut dwelling adult 
worms. The importance of the lung in the N. brasiliensis model has not been previously 
reported, although a recent paper hints at the importance of targeting the worms early in 
the protective response [160]. These unique findings create a new focus in the study of 
protective immunity in the N. brasiliensis model. 
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6.2. CD4 T cell effector responses in the lung can confer 
protective immunity against N. brasiliensis 
To determine the location of protective cells in the context of immune system structure we 
separated peripheral tertiary and secondary lymphoid tissues. Initially we developed a 
model using FTY720 to separate CD4 immune events of the secondary and tertiary 
lymphoid tissues. After titration of the drug in naïve mice confirmed the lymphocyte 
sequestering properties observed by others, we assessed drug function during N. 
brasiliensis infection (Fig 4.3). We found a dramatic decrease in circulating CD4 T cells 
and a significant drop in CD4 T cell numbers in the peripheral lung tissue. 
We found that the confinement of T cell responses to either secondary or peripheral 
lymphoid tissues with FTY720 did not affect the immune response against N. brasiliensis, 
despite a reduction in magnitude. Worm burdens in primary infection were comparable 
between FTY720 treated and control animals, with no difference observed in the migration 
or expulsion of the parasites. Reinfection of FTY720 treated animals confirmed the same 
level of protection as that of control animals. This result suggests that the localised T cell 
response occurring in the lungs is sufficient to confer protection against N. brasiliensis. 
The discovery that lung localised adoptive transfer of CD4 T cells can confer protection in 
naïve animals further confirmed this finding (Fig 5.5). 
Our results support a role for effector lymphoid tissue in protective immunity. Effector 
lymphoid tissue describes the retention of antigen specific memory T cells within 
peripheral tissues, where they are poised to respond immediately to a reinfection 
conferring protective immunity. The original hypothesis of ELT postulated that after 
primary infection memory T cells migrated to peripheral tissues where they are maintained 
as peripheral resident ELT. Our finding that preventing T cell recirculation using FTY720 
treatment did not affect protection against N. brasiliensis raises the intriguing possibility of 
an alternative mechanism of ELT generation where the localised peripheral primary T cell 
response can give rise to Tem like cells that can persist in the peripheral location to 
become ELT (Fig 6.1). 
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Figure 6.1 Hypothesis for the alternative generation of ELT. 
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During primary N. brasiliensis infection in the presence of FTY720 treatment antigen 
bearing APC can activate effector T cell responses in the lung and also in the draining 
lymph node, however drug treatment prevents recirculation of CD4 T cells between the 
two tissues (A). The resulting lung residing Teff either apoptose or persist in the lung 
tissue, becoming TEM like cells (B). Cells within the lymph node also go on to become 
TMEM, however FTY720 treatment prevents recirculation to the lung tissue. Upon 
reinfection with N. brasiliensis (C) TEM cells residing in the lung that were generated 
during primary infection are re-activated, leading to pathogen clearance and protective 
immunity. New Teff may also be generated. In the lymph node TMEM are re-activated and 
new Teff are also generated, however they do not contribute to protection from reinfection 
as they can not recirculate to the lung tissue due to FTY720 treatment.  
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Figure 6.2 Hypothesis of selective escape from FTY720 treatment. 
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During primary N. brasiliensis infection in the presence of FTY720 treatment antigen 
bearing APC can activate effector T cell responses in the draining lymph node, but not the 
lung tissue. Drug treatment prevents recirculation of CD4 T cells between the two tissues, 
however some antigen specific Teff cells escape FTY720 treatment and recirculate to lung 
tissue (A). Cells within the lymph node go on to become TMEM (B), and despite FTY720 
treatment some TMEM recirculate to the lung tissue. Upon reinfection with N. brasiliensis 
(C) TEM cells residing in the lymph node that were generated during primary infection are 
re-activated, new Teff may also be generated. Some antigen specific Teff and TMEM cells 
escape FTY720 treatment and recirculate to the lung tissue where they and other 
previously escaped TMEM cells mediate pathogen clearance and protective immunity.  
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Recirculation of T cells is prevented by FTY720 treatment, however there is a possibility 
that some T cells are resistant to FTY720 treatment and are able to recirculate to the 
periphery and establish ELT (Fig 6.2). We observed that in the circulating CD4 T cells that 
remained after FTY720 treatment GFP+ cells were over-represented. However, the number 
of blood circulating CD4 T cells post FTY720 treatment is very low, and although FTY720 
treated animals had a higher percentage of GFP+ cells than of control animals, the actual 
numbers were quite different. Untreated animals had 10x more circulating CD4 T cells per 
mL of blood, of which 0.5 – 1% were GFP+; FTY720 treated animals had fewer 
circulating CD4 T cells of which 0.5 – 2% were GFP+ (Fig 4.3), still quantitatively much 
fewer but not disproving the hypothesis of targeted resistance from FTY720. The number 
of GFP+ cells circulating is at its lowest at day 2 post challenge, yet this is when protection 
is occurring. We know worms (and therefore antigen) arrive as early as 14 hours post 
infection in the lung. This means the T cells are able to orchestrate protection between 14 
hours and 48 hours post infection (when we measure lung worm burdens). If T cells were 
being recruited from the lymph node by selective escape from FTY720 treatment, these 
cells would need to have been exposed to antigen in the lymph node, activated, possibly 
proliferate and also traffic to the lung site and orchestrate protection all in a very short time 
window. If certain T cells are able to selectively escape FTY720 treatment to establish 
ELT and confer protection they are unable to do it during BCG vaccination, as FTY720 
treatment during vaccination abrogates protection. This may be due to experimental 
limitations (as discussed later in 6.4 Th1 vs Th2) but could also support that selective 
escape of protective cells is unlikely.  
6.3. Characterising the CD4 T cell protective response 
An important aim of this body of work was to characterise the key CD4 T cell lineage 
responsible for mediating protective immunity against N. brasiliensis. Following the 
immune response and phenotyping the CD4 T cells mediating protective immunity against 
N. brasiliensis in the lung has revealed the development of a TEM like population of CD4 T 
cells that can swiftly produce cytokine upon reinfection (Figs 5.11, 5.12, 5.13). We used 
expression of CD45RB on the cell surface to distinguish Teff/ TMEM from naïve cells 
[196], as naïve cells express high levels of CD45RB compared to the lower levels 
expressed on Teff and TMEM (see appendix Fig A.4). The CD4 T cells in the lungs of 
FTY720 treated animals develop from a mixed population of CD45RB hi and lo cells into 
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a predominantly CD45RB lo population during primary N. brasiliensis infection in 
FTY720 treated mice, suggesting a transition from a mixed population of naïve and 
TMEM/Teff cells into a predominantly TMEM/Teff phenotype. This suggests activation and 
also possible expansion of CD4 T cells in the lung tissue as numbers increase over time 
within the tissue, yet FTY720 treatment prevents the recirculation of CD4 T cells. This 
raises several questions that need to be further addressed. 
Firstly, do the lung resident T cells proliferate within lung tissues during primary and also 
reinfection with N. brasiliensis? Evidence from Harris et al would suggest not, as their 
experiments with in vitro cultured and activated transgenic CD4 T cell adoptive transfers 
found that Th2 cells would not proliferate within the lung, although they could be activated 
to produce cytokines [204]. However these experiments differ from ours as they use 
experimentally manipulated in vitro grown T cells, transferred i.v. rather than i.n. and also 
used a very different model antigen. Our experimental model allows sensitive tracking of 
in vivo generated antigen specific CD4 T cells, responding to a parasite infection with a 
potentially vast array of antigens. Obhrai et al show that maintenance and antigen specific 
response of existing peripheral memory CD4 T cells does not require secondary lymphoid 
tissues, however development of CD4 TMEM from Teff does. This would dispute the 
proposed alternative hypothesis of development of ELT in the periphery. This study used a 
Th1 mediated model of immunity and this may account for the requirement for secondary 
lymphoid organs in memory development as IFNγ is a toxic compound a that can kill Th1 
effectors through activation induced cell death (AICD). We use a Th2 model of protective 
immunity and IL-4 does not display the same toxicity as IFNγ, and there is evidence to 
suggest Th2 cells do not undergo AICD [205]. This may make an alternative method of 
ELT development a possibility in our model. The work of Marc Jenkins looks at the 
precursor frequencies of antigen specific T cells in an OVA model, showing that there are 
very few naïve precursors for OVA [206]. This work would imply that it is unlikely that 
we would find N. brasiliensis specific naïve precursor cells within the lung tissue to 
become activated and develop ELT. The model used for these experiments looks for T 
cells specific for only one antigen. The protective epitopes of N. brasiliensis have yet to be 
identified but there is a strong likelihood that a polyclonal T cell response is mounted 
against N. brasiliensis, further increasing the chance of having naïve antigen specific 
precursors within the lung residing CD4 T cell population.  
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As reviewed in the introductory chapter there is increasing evidence to suggest that T cells 
can be both primed for activation and proliferation within peripheral tissues [88, 89], 
including the lungs [90]. Wakim et al demonstrate the ability of DC to present antigen in 
the periphery with their transplant experiments using an HSV model [13]. They also show 
the antigen specific proliferation of tissue residing T cells. Mice lacking secondary 
lymphoid organs are able to mount lung based immune responses through the generation of 
iBALT. It is possible that we are generating a similar situation chemically using FTY720. 
Further experiments should be performed to assess proliferation within the lung tissues 
during FTY720 treatment to investigate the possibility of proliferation within the lung 
versus the potential selective escape of T cells from the sequestering effects of FTY720 
(chapter 4). 
A second question raised by our findings is how do these protective TEM like cells 
develop? When we take CD4 T cells from the lungs of naïve, primary infected and 
reinfected mice and compare the expression of CD45RB between the groups we see 
differences in expression. CD4 T cells from naïve mice are CD45RB hi and cells from 
mice with primary or reinfections are CD45RB lo, interestingly although the CD4 T cells 
from primary infected mice exhibit low expression of CD45RB it is not as low as the 
expression on CD4 T cells during reinfection (see appendix Fig A.4). In FTY720 treated 
mice CD45RB expression becomes lowered during primary infection, remaining low prior 
to reinfection, when CD45RB lo cells begin to make GFP/IL-4 and mediate protection 
(Figs 5.11, 5.12, 5.13). These results indicate that TEM like cells have developed from the 
small number of Teff cells generated during primary infection. In support of this theory 
several groups have published findings showing the generation of memory T cells from T 
effector cells.  
Lastly, can these TEM like cells confer protection after longer periods of time? Our 
experiments look at reinfections occurring 30 days after primary infection as we have 
previously seen the primary immune response has contracted at this point (see appendix 
Fig A.1). Experiments within our group have looked at longer term protection in the N. 
brasiliensis model and although gut protection was robust, there did seem to be some 
decline in lung protection (see appendix FigA.5). The experiments of Ely et al show in 
their viral model that in the antigen specific memory population TEM cells are dominant in 
the first 1-3 months but at later times (13-14 months post infection) TCM like cells 
dominate the memory population[207]. It would be of interest to observe the protection 
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conferred by ELT at longer times after primary infection to see if there is perhaps a 
requirement for secondary lymphoid derived TMEM in the long term maintenance of ELT in 
the N. brasiliensis model. 
The finding that NKT cells are not required for protection against reinfection provides us 
with information about the nature of the N. brasiliensis antigen(s) protective immunity is 
mounted against. Glycolipid antigens presented on CD1 molecules have been shown to 
activate NKT cells and the finding that CD1-/- mice remained protected to the same degree 
as control animals suggests that the N. brasiliensis antigens stimulating the immune 
response are not glycolipids. There remains the question of whether carbohydrates play a 
role in the induction of the strong N. brasiliensis induced Th2 immune responses, however 
the evidence presented within this thesis shows a clear role for CD4 T cells that are 
activated specifically by peptides presented on MHC II. 
6.4. A comparison of Th1 vs Th2 mediated lung immunity 
Most studies of peripheral memory T cells (and by proxy ELT) are conducted in models of 
CD8 or Th1 mediated protection so we compared our findings in the N. brasiliensis model 
to a Th1 model of lung immunity, BCG. Vaccination with BCG can confer protection 
against challenge infection with aerosolised M. bovus of up to one log10. IFNγ plays a 
critical role in BCG protective immunity, as in animals where IFNγ has been neutralised 
the protection afforded by BCG vaccination is abrogated [194].  
Our initial investigations into primary BCG infection showed that FTY720 treatment 
prevented effective control of the infection and we observed increased dissemination to 
spleen and liver in FTY720 treated animals. This contrasted with our finding that FTY720 
treatment had no effect on worm burden or migration kinetics in primary N. brasiliensis 
infected animals. 
Although lung based T cells (ELT) were able to confer protection in both the N. 
brasiliensis and BCG models, the generation of the ELT differs. We found in the N. 
brasiliensis model, protection occurs regardless of when FTY720 is present, however in 
the BCG model timing of drug treatment is critical and FTY720 treatment during 
vaccination can prevent protective ELT from forming. Although mice receiving FTY720 
during BCG vaccination lost the protection afforded by the vaccine, animals receiving drug 
treatment immediately prior to BCG challenge infection retained their protection (Fig 
4.12). This result indicates that there is a requirement for lymphocyte trafficking to the 
Chapter 6: General discussion 
 167 
lung during or after primary infection to establish ELT in the BCG model that we do not 
see in our N. brasiliensis model. 
The requirement for lymphocyte trafficking during/after vaccination in the BCG model 
implies that lymph node derived T cells are required to “seed” the lung tissue with 
protective memory cells to form ELT. This also suggests that the localised antigen specific 
T cell responses observed within the lung during primary vaccination in FTY720 treated 
mice are insufficient to establish a protective population of memory cells that are retained 
within the lung. The need for lymph node derived T cells to form peripheral memory tissue 
is supported by the work of David Woodlands group who propose that peripheral memory 
CD8 T cells are maintained by continual recruitment in their sendai virus model of 
protective immunity [107]. The difference observed in the BCG model may be due to the 
toxicity of IFNγ [208-210], with the IFNγ producing cells dying after performing their 
effector function during primary infection; therefore requiring additional cells to become 
established resident memory T cells. This would potentially not be an issue for Th2 cells as 
IL-4 is a growth/survival factor and previous studies have shown that although Th1 
effectors die from activation induced cell death, Th2 cells do not [106, 205].  
A further implication of the requirement for lymph node derived T cells in the BCG model 
is support for an alternative generation of ELT during primary lung N. brasiliensis 
infection. Our two hypotheses are that ELT can be generated within the lung tissue without 
lymph node derived T cells in the N. brasiliensis model or, alternatively, that memory T 
cells destined to become ELT are resistant to FTY720 treatment and able to traffic to the 
periphery regardless of drug treatment. Data generated with the BCG model suggests that 
T cell trafficking is effectively blocked by FTY720 treatment as primary infection is 
inadequately controlled without circulating T cells and more importantly, blocking T cell 
trafficking during primary infection prevents the establishment of protective ELT in the 
lung. This also suggests that BCG falls within the more classical definition of ELT 
generation with ELT becoming established after T cell migration following a primary 
infection, where N. brasiliensis clearly does not. 
Interestingly we observed differences in lung based antigen specific T cell responses 
between the N. brasiliensis and BCG models. N. brasiliensis exhibits a reduced primary 
Th2 response in the lung followed by a contraction and expansion upon reinfection. In the 
BCG model we see reduced primary response but prior to challenge there are more antigen 
specific IFNγ producers than during primary infection. This is most likely occurring due to 
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the break in FTY720 treatment in the BCG model allowing recirculation of T cells; 
however this finding is interesting in the respect that the reduced population of Th2 cells 
are able to confer protection, yet the increased number of antigen specific IFNγ cells are 
unable to confer protection in the BCG model. This implies that it is not necessarily the 
magnitude of effector response, but the quality that confers protection – although this may 
also have to do with the differences between IL-4 and IFNγ. 
Another difference between the BCG and N. brasiliensis models was the importance of 
TEM like cells in conferring protective immunity. We show in chapter five that TEM like 
cells correlate with protective immunity in N. brasiliensis models; the results with the 
BCG model were less clear. The majority of CD4 T cells during the secondary immune 
response displayed a Tem phenotype in both protected and unprotected mice. This finding 
that TEM are important in peripheral immunity is not surprising given previous data 
showing the preferential location of TEM cells in peripheral tissues [211]. 
 
The BCG model was chosen to compare with our Th2 mediated N. brasiliensis model, as it 
is a CD4 T cell mediated lung based model of protective immunity, however there are 
differences between the two models. The BCG model differs from N. brasiliensis infection 
model in several respects;  
Firstly BCG infection is bacterial and usually chronic. This may in some way account for 
the different immune strategies in the generation of ELT against BCG and N. brasiliensis 
infection. T cells may need to be recruited to the site of BCG infection to replace cells that 
die via IFNγ toxicity or exhaustion. This would not be the case in N. brasiliensis infection 
as the worms are in the lung only transiently (days one to three of infection) so an on going 
immune response would not need to be supported. Furthermore, IL-4 does not share the 
toxicity of IFNγ - perhaps supporting the development of effectors into TEM like cells. This 
would be supported by previous findings within our group showing that IL-4 deficient 
mice are 75% less protected at the lung site upon reinfection (Table 5.1). The chronicity of 
bacterial infection also caused some variations within our infection model, we have 
affected a “cure” between primary and re-infection by clearing the bacteria with antibiotic 
treatment (Fig 4.11), to ensure neither model has persisting antigen between primary and 
reinfection. FTY720 treatment also differs, as there is a break in treatment in the BCG 
model. This lapse in FTY720 treatment had the potential to allow recirculation after 
bacterial clearance via antibiotics, however we found mice treated with FTY720 during 
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vaccination until day 35 failed to develop ELT. This indicates T cell recirculation to 
develop ELT must occur earlier – most likely during primary infection. The finding that a 
TCM like population can be derived during vaccination and confer protection via adoptive 
transfer (L. Connor, “Dissecting the protective memory immune response against 
Tuberculosis”) supports a role for lymph node generated TCM in ELT generation in this 
model. 
Secondly, vaccination with BCG does not occur directly in the lung; although bacterial 
antigen specific lung based IFNγ producing CD4 T cells were found there. This difference 
may in some way contribute to the necessity for further CD4 T cell recruitment to generate 
protective ELT in this model. Differences between N. brasiliensis and BCG in the 
generation of ELT – was this due to systemic vaccination of BCG rather than lung based 
vaccination priming? 
Thirdly, the bacterial infection caused by BCG causes a different type of physical damage 
to the lung tissue than the tissue burrowing N. brasiliensis. Granulomatous lesions are 
characteristic of the immune response to BCG, whereas N. brasiliensis cause a lot of tissue 
damage with their movement, and tissue remodelling follows infection. Our finding that 
CD4 T cells can transfer protection to naïve hosts would suggest that the physical changes 
to the structure of the lung by N. brasiliensis infection and the subsequent tissue 
remodelling are not required for protection as recently suggested by Reece et al [173]. This 
does not rule out a role for alternate activation of macrophages playing an important role in 
protection against reinfection with N. brasiliensis, however if this is indeed the case then 
this response in some way requires CD4 T cells for initiation or maintenance. 
Lastly, measurement of IL-4 during N. brasiliensis infection is possible directly ex vivo 
due to the use of GFP reporter mice, however in the BCG model T cells had to be 
restimulated ex vivo with BCG antigens and intracellularly stained to measure IFNγ 
production. The ex vivo restimulation method of measuring antigen specific cells does not 
provide an exact picture of in vivo events, due to the further manipulation required. 
However as the experimental results were compared to appropriate controls, this should 
not be an impediment to a comparison of the immune responses between the two models. 
The several differences between the BCG and N. brasiliensis models are important to be 
considered when interpreting the results within this thesis. However there are important 
similarities too; both models are CD4 mediated and also have an important role for 
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macrophages – BCG with the development of granulomatous lesions and engulfment and 
killing of bacteria with ROI, and N. brasiliensis with the recruitment and activation of 
alternately activated macrophages [171, 173] which are thought to play a role in tissue 
repair and remodelling [19]. Regardless of the differences between the BCG and N. 
brasiliensis models our findings provide evidence for the importance of ELT in protective 
immunity in both models. Furthermore a comparison of the two models has revealed 
potential differences in the mechanisms of generation of ELT – a striking finding. 
6.5. The role of effector lymphoid tissue in protective immunity 
The findings within this thesis combined with recent cutting edge research [70, 108] 
strongly suggest that ELT is an important part of the memory response that is capable of 
protecting during reinfection without the additional support of secondary lymphoid derived 
T cells. The mechanisms behind generation of ELT are less clear. Experiments in CD8 and 
Th1 models suggest that there is a requirement for lymph node derived T cells trafficking 
to the periphery [107] to establish ELT as proposed in the original opinion paper [104]. 
However the experiments within this thesis suggest there may be an alternative method of 
ELT generation, through the priming and maintenance of T cell responses in peripheral 
tissues. 
There is a potential for qualitative differences in the responses of lymph node based 
memory T cells and those cells based in peripheral tissues. It is possible that the peripheral 
environment influences the responses of memory T cells allowing for faster activation and 
effector function [212]. Studies by Bertolino et al [88] shows that adoptively transferred 
naïve auto reactive CD8 T cells can be primed in liver and that these cells divide up to four 
times in 24 hours, where those in the lymph node take two to three days to recirculate to 
peripheral tissues. The T cells within the liver were activated very quickly, up regulating 
activation markers within two hours of transfer. In the instance of lung tissue, endothelial 
cells secrete cytokines and other factors contributing to the immune response. These 
environmental differences may contribute to the effectiveness of ELT. 
The possibility of development and maintenance of protective memory cells in the lung 
tissue during N. brasiliensis infection, forming ELT has been proposed (Fig 6.1).  The 
finding that FTY720 separation of tertiary and secondary lymphoid tissues did not inhibit 
protection (chapter 4), combined with the finding that adoptive transfer of TEM like lung 
CD4 T cells from FTY720 treated mice could confer protection (Fig 5.8) would appear to 
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support an alternative method of ELT development. This alternative development is not 
necessarily exclusive of the classic mechanism, lymph node derived ELT development 
could occur simultaneously with the alternative mechanism being revealed only when 
secondary lymphoid responses are inhibited. This mechanism may be restricted to Th2, 
helminth or even specifically N. brasiliensis infection. The experiments of Moyron-Quiroz 
et al explore the role of ELT in a viral model using mice lacking secondary lymphoid 
organs [70, 71]. They found that iBALT developed in the lungs of previously infected 
mice and suggested that this provided a niche for maintenance of a local memory T cell 
population. These results support the ability of lung localised tertiary lymphoid responses 
to generate and maintain ELT. 
Lastly, treatment with FTY720 may support the generation of ELT. Ledgerwood et al 
[130] propose that FTY720 treatment can trap T cells within peripheral tissues. We notice 
that FTY720 treatment reveals a lung residing population of CD4 T cells although the 
reduced number of CD4 T cells we observed in the lung suggests this may be only a small 
subset of CD4 T cells. The research of Idzko et al suggests that FTY720 traps DC within 
the lung tissue, preventing their trafficking to the lymph nodes [140]. These experiments 
used a local intratracheal administration of FTY720 and it remains to be seen if the 
systemic gavaged delivery method would have a similar effect. Data collected within our 
own group suggests that local FTY720 administration within the skin can result in 
impaired DC trafficking to the draining lymph node, however not all subsets of DC are 
affected equally (R. Hunter, unpublished data). The trapping of antigen loaded mature DC 
within peripheral tissues alongside a similarly confined CD4 T cell population could 
potentially result in an environment that is conducive to the establishment of ELT through 
the proposed alternative mechanism. Furthermore, drawing on the theories of Booki Min 
[69], T cell sequestration caused by FTY720 treatment may be helping to create “space” in 
the TCR diversity of lung residing memory T cells. Booki’s hypothesis is that if the 
repertoire of memory TCR diversity is limited, spontaneous proliferation of naïve T cells 
with different TCR specificity occurs to expand the TCR repertoire – independently of 
homeostatic proliferation. FTY720 treatment reducing the number of lung resident T cells 
could also affect TCR diversity in our model, causing the proliferation and enhanced 
retention of N. brasiliensis antigen specific cells that add to the diversity of the T cell 
repertoire. It would be interesting to immunoscope the profile of lung CD4 T cells in 
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FTY720 treated animals before during and after priming and reinfection to examine TCR 
diversity of the lung resident T cells. 
6.6. Conclusions 
My thesis sought to identify which tissues are important sites for priming protective 
immunity against N. brasiliensis. The contribution of lung tissues in the protective 
response was assessed by blocking CD4 T cell recirculation between lymph nodes and 
lung tissue using FTY720. We clearly identified that lung based immune responses were 
sufficient to protect against reinfection with N. brasiliensis, although it may reflect the 
escape of TEM cells from FTY720 treatment. Lung localised adoptive transfer of CD4 T 
cells into naïve animals conferred protection, confirming that CD4 T cells can mediate 
protection. The finding that depletion of CD4 T cells abrogated protective immunity 
indicated the key role CD4 T cells play in protection against reinfection with N. 
brasiliensis.  
A characterisation of the CD4 T cell response ruled out a role for NKT cells as the 
protective CD4 lineage as CD1 -/- animals were completely protected against reinfection. 
Kinetic analysis of the development of CD4 T cells FTY720 treated and untreated animals 
during N. brasiliensis infection revealed a TEM like population of cells in the lung during 
primary infection. The TEM -like population of cells expanded upon reinfection and 
produced the Th2 associated cytokine IL-4. Localised lung adoptive transfer of these TEM 
like cells into naïve athymic recipients was sufficient to confer immunity against N. 
brasiliensis.  Collectively these results demonstrate that a peripheral based CD4 immune 
response is sufficient to confer protection in the N. brasiliensis model of Th2 protective 
immunity. This finding supports the theory of effector lymphoid tissue and may 
demonstrate an alternative process for the development of effector lymphoid tissue in the 
periphery. 
6.7. Future Directions 
The experiment within this thesis have led to the development of two hypotheses to 
explain our findings; the alternative development of ELT hypothesis and the selective 
escape of protective CD4 T cells from FTY720 treatment. Future experiments would aim 
to determine which of these two hypotheses is the most likely.  
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Experiments investigating whether proliferation of CD4 T cells occurs within the lung 
tissue would be an important question to address. Labelling of lung tissue with coloured 
dye and incorporation of BrDU into the DNA of proliferating cells would determine if 
CD4 T cells proliferated within lung tissues, or “escaped” from the draining lymph node 
during reinfection with N. brasiliensis in FTY720 mice.  
The experiments of Roberts et al suggest that TEM cells are important at early times post 
infection, however TCM dominate at later time points [106]. Investigating the effects of 
FTY720 treatment on ELT mediated protection in the N. brasiliensis model at later times 
following infection (more than 30 days) may reveal an additional requirement for T cell 
recruitment from the lymph nodes. 
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Figure A.1 Kinetics of the GFP+ CD4 T cell response following primary and 
secondary infection with N. brasiliensis. 
G4/IL-4 reporter mice (n=4) were infected with N. brasiliensis, rested for 30 days before 
reinfection. At the indicated time points mice were sacrificed, mediastinal lymph nodes 
were harvested and the number of GFP+ CD4 T cells assessed using flow cytometry. 
Values represent mean number of GFP+ CD4 T cells ± SEM and are representative of at 
least three independent experiments. 
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Figure A.2 Depletion of CD4 T cells using an αCD4 antibody - titration of anti-CD4 
antibody 
G4/IL-4 mice (n = 3/group, pooled) were treated with the indicated concentration of anti-
CD4 antibody (clone GK1.5) by intraperitoneal injection at time zero. At day 28 post 
depletion lymph nodes (A) and spleens (B) were harvested and the number of CD4 T cells 
assessed using four colour flow cytometry. CD4 T cells were identified as lymphocytes 
based on forward and side scatter properties and were CD4 (clone RM4-5)/TCRβ positive. 
Values represent the mean number of CD4 T cells per tissue. 
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Figure A.3 Recovery of CD4 T cells from spleen after adoptive transfer using 
different techniques. 
Lymphocytes were isolated from the lungs (white bars) or lymph nodes (black bars) of 
Balb/c mice and labelled using CFSE before being transferred into recipient Balb/c mice (n 
= 3/ group) via intranasal or intraveneous route. Two days after cell transfer recipient mice 
were sacrificed and spleens harvested. Spleens were enzymatically digested and analysed 
using four colour flow cytometry for the presence of CFSE labelled CD4 T cells. Values 
represent the number of cells recovered as a percentage of adoptively transferred cells ± 
S.E.M. 
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Figure A.4 CD45RB expression on CD4 T cells isolated from mice naïve, infected or 
reinfected with N. brasiliensis. 
G4/IL-4 mice (n=3/group/time point) were treated with FTY720 from one day prior to N. 
brasiliensis infection or remained untreated. Mice were reinfected with N. brasiliensis at 
day 39 At six days post reinfection lung tissues were harvested, enzymatically digested and 
CD45 positive cells were enriched by AutoMacs© bead separation. Isolated cells were 
stained with antibodies against CD45RB, CD62L, CD44, CD3 and CD4 and analysed by 
flow cytometry using an LSR II flow cytometer. DAPI was included to exclude dead cells 
and GFP reporter was also present as donor mice were from a G4/IL-4 background. Facs 
plots are gated on DAPI negative CD3/CD4 positive cells and are from one representative 
animal per group. 
 
Appendix 
 180 
4 9 20 30
0
25
50
75
100
Lung
Gut
180 420
%
 P
ro
te
ct
io
n
Reinfection (days post infection)  
 
Figure A.5 Duration of protective immunity, reinfection at various time points after 
infection. 
Balb/c mice (n=3/timepoint) were infected with N. brasiliensis and then reinfected at the 
indicated time points. Following reinfection, lungs & guts were excised on days two and 
six post reinfection respectively and the number of viable parasites in the tissues were 
recovered by migration and enumerated. For each time point aged matched naïve mice 
were given the identical challenge infection with 600 L3 and the numbers of viable worms 
recovered from tissues. The degree of protection for each time point was determined from 
the ratio of reduced worm burden in reinfected versus naïve mice, with reinfected mice 
typically resulting in a ten fold reduction in worm numbers. If reinfected mice were able to 
achieve ten fold reduction in worm numbers when compared to aged match naïve mice 
receiving primary infection then we defined that time point as maintaining 100 % 
protection. If reinfected mice failed to reduce worm burdens when compared to the burden 
in similarly infected, aged matched, naïve mice then we defined it as 0% protection. 
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Table A.1 Phenotype of lung isolated CD4 T cells from N. brasiliensis infected 
athymic mice. 
G4/IL-4 mice (n = 5/group/time point) were treated with FTY720 from the day prior to 
infection with N. brasiliensis or remained untreated. At the indicated time points lung 
tissues were harvested and enzymatically digested before being enriched for CD45+ cells 
using AutoMacs© magnetic bead separation. The enriched cells were stained and analysed 
using multicolour FACs analysis on a LSR II flow cytometer. The CD45RB hi populations 
of groups 1-5 werenot found to be statistically significant (ns). The CD45RB lo 
populations exhibited significant differences with group 1 having significantly more 
CD45RB lo cells than group 4 (*), and group 2 having significantly more CD45RB lo cells 
than groups 3 (**), 4 (***) and 5 (**). Statistics were calculated using one way ANOVA 
with Tukey post test * P < 0.05 ** P < 0.01 *** P < 0.001. 
 
 
Table A.2 Kinetics of the lung CD4 T cell response against primary N. brasiliensis 
infection. 
G4/IL-4 mice (n = 5/group/time point) were treated with FTY720 from the day prior to 
infection with N. brasiliensis or remained untreated. At the indicated time points lung 
tissues were harvested and enzymatically digested before being enriched for CD45+ cells 
using AutoMacs© magnetic bead separation. The enriched cells were stained and analysed 
using multicolour FACs analysis on a LSR II flow cytometer. FTY720 treated mice had 
significantly less CD45RB hi cells than control mice (***) and also significantly more 
CD45RB lo cells than control mice (***). Statistics were calculated using two way 
ANOVA with bonferroni post test * P < 0.05 ** P < 0.01 *** P < 0.001. 
Group CD45RB hi ±  S.E.M. CD45RB lo ±  S.E.M. 
1 11.65 ±1.73 34.13 ± 2.84 
2 6.98 ± 0.60 42.98 ± 1.75 
3 15.34 ± 1.32 21.68 ± 1.40 
4 13.54 ± 1.56 14.60 ± 1.27 
5 9.64 ± 0.74 20.71 ± 1.98 
 Control  FTY720  
Days post 
Infection 
CD45RB lo CD45RB hi CD45RB lo CD45RB hi 
Naive 9.91 ± 0.23 81.66 ± 0.48 34.82 ± 1.25 46.06 ± 2.03 
3 3.12 ± 0.07 90.36 ± 0.25 8.21 ± 0.73 76.54 ± 1.56 
6 28.54 ± 0.56 37.02 ± 0.94 33.08 ± 0.31 28.7 ± 2.14 
9 28.92 ± 0.61 58.6 ± 0.87 45.58 ± 0.41 33.42 ± 0.39 
12 41 ± 1.32 36.32 ± 1.21 69.7 ± 2.74 5.19 ± 0.81 
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Table A.3 Kinetics of the lung CD4 T cell response against N. brasiliensis reinfection. 
G4/IL-4 mice (n = 5/group/time point) were treated with FTY720 from the day prior to 
infection with N. brasiliensis or remained untreated. At 30 days post infection mice were 
reinfected with N. brasiliensis. At the indicated time points lung tissues were harvested and 
enzymatically digested before being enriched for CD45+ cells using AutoMacs© magnetic 
bead separation. The enriched cells were stained and analysed using multicolour FACs 
analysis on a LSR II flow cytometer. FTY720 treated mice had significantly less CD45RB 
hi cells than control mice (***) and also significantly more CD45RB lo cells than control 
mice (***). Statistics were calculated using two way ANOVA with bonferroni post test * P 
< 0.05 ** P < 0.01 *** P < 0.001. 
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